UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-K


[X]ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 20182021
OR
[  ]TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _______ to _______
Commission File Number 814-01253
VENTURE LENDING & LEASING IX, INC.
(Exact name of registrant as specified in its charter)

Maryland82-2040715
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)

104 La Mesa Drive, Suite 102, Portola Valley, CA 94028
(Address of principal executive offices)
(Zip Code)

Registrant’s telephone number, including area code:  (650) 234-4300

Securities Registered Pursuantregistered pursuant to Section 12(b) of the ActAct: None
: None
Securities Registered Pursuant to Section 12(g) of the Act:Act: Common Stock,stock, $0.001 par value
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes [ ] No [X]
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes [ ] No [X]
Indicate by check mark whether the registrant (i) has filed all reports required to be filed by Section 13 or 15(d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (ii) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes [ ] No [ ]
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part II of this Form 10-K or any amendment to this Form 10-K. [X]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer [ ]Accelerated filer [ ]Non-accelerated filer [x]Smaller reporting company [ ]Emerging growth company [ ]





If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.[ ]
Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. [ ]
Indicate by check mark if the registrant is a shell company (as defined in Rule 12b-2 of the Act).  Yes [ ] No [X]
As the registrant’s shares are not publicly-traded, the aggregate market value of the voting stock held by non-affiliates of the registrant cannot be determined.
The number of shares outstanding of each of the issuer’s classes of common stock, as of March 14, 20192022, was 100,000.





Document Incorporated by Reference
                                                                    
Document Description10-K Part
Specifically Identified Portions of the Registrant'sRegistrants Proxy Statement for the Annual Meeting of Shareholders to be held
May 15, 201918, 2022III


2


PART I.
ITEM 1.BUSINESS
ITEM 1.    BUSINESS
Introduction.
Venture Lending & Leasing IX, Inc. (the “Fund”) was incorporated in Maryland on June 28, 2017 as a non-diversified, closed-end management investment company electing status as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”) and is managed by Westech Investment Advisors, LLC (the “Manager” or “Management”). The Fund is a wholly-owned subsidiary of Venture Lending & Leasing IX, LLC, a Delaware limited liability company (the “Company”). The Fund’s investment objective is to achieve superior risk-adjusted investment returns. The Fund will primarily provide debt financing to carefully selected companies that have received equity funding from traditional sources of venture capital equity funding (e.g.,(i.e. a professionally managed venture capital firm), as well as non-traditional sources of venture capital equity funding (e.g., angel investors, strategic investors, family offices, crowdfunding investment platforms, etc.) (collectively, “Venture-Backed Companies”), generally in the form of secured loans. Secondarily, the Fund may provide debt financing to more mature public and late-stagelater-stage private companies. In most cases, the Fund will receive warrants for equity securities of the companies in connection with these loans. The Fund may also make debt investments that are atypical in that, for example, the companies to which the financing is provided may be public companies, may not have venture backing, or may not offer senior securities (“Special Situation Financings”), including bridge financings and subordinated debt. The Fund may also make direct equity investments in Venture-Backed Companies. The Fund expects to eventually elect to be treated for federal income tax purposes as a Registered Investment Company (“RIC”) under the Internal Revenue Code (the “Code”).
Prior to commencing its operations on May 2, 2018, the Fund had no operations other than accruing organizational expenses and the sale to the Company of 100,000 shares of common stock, $0.001 par value (“Shares”)to the Company for $25,000 in June 2017 and2017. The Fund had elected to be treated for federal income tax purposes, as a regulated investment company (“RIC”) under the receiptInternal Revenue Code of $25,000 from the Company as consideration for the purchase of the Shares. This issuance of stock was required by the California Commissioner of Corporations in order for the Fund to apply for a finance lender's license, which was issued to the Fund on September 22, 2017.1986 (the “Code”).
The Fund’s Sharesshares of common stock, $0.001 par value (“Shares”) are held entirely by the Company. As capital is required to finance the acquisition of loans, additional capital will beis provided by the Company.
Investment Program.
General. The Fund’s primary investment strategy is to provide debt financing, in the form of secured loans, to carefully selected Venture-Backed Companies. In most cases, the Fund will receive warrants to acquire equity securities in connection with its venture loans. The Fund’s investment objective is to achieve superior risk-adjusted investment returns. The Fund may invest up to 20% of the aggregate cost of all investments of the Fund, determined cumulatively over the life of the Fund, in Special Situation Financings. In some instances, the Fund’s Special Situation Financing investments may be in companies that have been bootstrapped (i.e. funded solely by the personal assets of their founders or other individuals), without substantial equity investment from investors or participation of venture capital investors. The Fund does not intend to invest in any company to secure control of its securities primarily for the purpose of making a profit in the sale of the controlled company’s securities, and, for the avoidance of doubt, any such investment would not constitute a Special Situation Financing. Additionally, theThe Fund may also invest directly in equity securities of Venture-Backed Companies (including equity securities of companies whose loans are held by the Fund), in amounts up to 10% of the aggregate amount of all investments of the fund determinedFund (determined cumulatively over the life of the FundFund) in direct equity investment opportunities such as convertible debt, secondary common stock purchases or other equity instruments issued by companies of diverse capitalization and creditworthiness, including, without limitation, early-stage private companies, public and later-stage private companies, and companies undergoing restructuring or recapitalization of their existing debt or equity financing (provided, however, that any amounts paid by the Fund to acquire equity securities pursuant to the receipt or exercise of warrants or stock received in connection with the Fund’s venture loans shall not be taken into account in determining whether such 10% threshold has been met). Such direct investments generally will be in equity securities of borrowers in the Fund’s portfolio, although equity securities of other companies could also be purchased. This aggregate investment strategy involves a high degree of risk, including: illiquidity of portfolio investments; risk of default by borrowers, many of whom have no or little operating profit or cash flow as of the commencement of a financing transaction; interest rate risk; litigation risk; the speculative nature of investments in warrants for stock or directly in stock; and the risks involved in investing in privately-held and emerging companies. The Fund will make available significant managerial assistance through its officers to certain companies whose securities are held in the Fund’s portfolio, as described herein under the caption “Regulation.”
The Fund intends to use a buy-and-hold strategy where debt investments are held to maturity. All securities are evaluated on a regular basis to determine whether there should be any change to this strategy. Some debt investments are restructured, which may result in the extension of the original maturity date or other change in the instrument, including but not limited to, conversion of all or part of the instrument to equity. The Fund does not intend to purchase publicly-held securities; however, some publicly-held securities may be acquired through warrant exercises, mergers, acquisitions, and IPOs of the companies in which investments are made. Additionally, in some cases, publicly-traded securities may be issued in conjunction with loans made to public companies. When a company’s securities become publicly-traded, the Fund may hold these securities and sell them or may choose to distribute the securities directly to the Company. If held, publicly-traded securities are monitored on an on-going basis, and a variety of factors regarding the issuing company (e.g., trend in stock price, underlying business fundamentals and potential for growth, information regarding the lock-up, etc.) are used to determine when to sell these securities.
As a BDC, the Fund must invest at least 70% of its total assets in qualifying assets (“Qualifying Assets”) consisting of (a) interests in Eligible Portfolio Companies and (b) certain other assets including cash and cash equivalents. An “Eligible Portfolio Company” is a United States company that is not an investment company as defined or excluded from the definition of an investment company in Section 3 of the 1940 Act, and that either: (i) does not have a class of securities listed on a national securities exchange, or does have a class of
3


securities listed on a national securities exchange, but has an aggregate market value of outstanding voting and non-voting common equity of less than $250$250.0 million; or (ii) is actively controlled by a BDC and has an affiliate of a BDC on the Eligible Portfolio Company’s Board of Directors; or (iii) has total assets of not more than $4$4.0 million and capital and surplus of not less than $2$2.0 million; or (iv) meets such other criteria as may be established by the Securities and Exchange Commission (“SEC”). Control under the 1940 Act is presumed to exist where a BDC owns more than 25% of the outstanding voting securities of the Eligible Portfolio Company. Also included in Qualifying Assets are follow-on investments in a company that met the definition of Eligible Portfolio Company at the time of the Fund’s initial investment, but subsequently does not meet such definition because it has a class of securities listed on a national securities exchange, if, at the time of the follow-on investment, the Fund (a) owns at least 50% of (i) the greatest number of equity securities of such company, including securities convertible into or exchangeable for such securities, and (ii) the greatest amount of certain debt securities of such company held by the Fund at any time during the period when such company was an Eligible Portfolio Company, and (b) is one of the twenty largest holders of record of


the company’s outstanding voting securities. The Fund may invest up to 30% of its total assets in non-Qualifying Assets, including interests in companies that are not Eligible Portfolio Companies (for example, because the company’s securities are quoted on the NASDAQ Global Market (“NASDAQ”)) and Eligible Portfolio Companies as to which the Fund does not offer to make available significant managerial assistance. As a BDC, the Fund is generally prohibited under the 1940 Act from investing in securities issued by broker/dealers, investment advisers, and underwriters unless certain conditions are met. As of December 31, 2018,2021, the percentage of non-qualifying investments in the Fund was 3.8%13.2%.
The Fund intends to use a buy-and-hold strategy where debt investments are held to maturity. All securities are evaluated on a regular basis to determine whether there should be any change to this strategy. Some debt investments are restructured, which may result in the extension of the original maturity date or other change in the instrument, including but not limited to, conversion of all or part of the instrument to equity. The Fund does not intend to purchase publicly-held securities; however, some publicly-traded securities may be acquired through warrant exercises, mergers, acquisitions, and IPOs of the companies in which investments are made. Additionally, in some cases, publicly-traded securities may be issued in conjunction with loans made to public companies. When a company’s securities become publicly-traded, the Fund may hold these securities and sell them or may choose to distribute the securities directly to the members of the Company. If held, publicly-traded securities are monitored on an on-going basis, and a variety of factors regarding the issuing company (e.g., trend in stock price, underlying business fundamentals and potential for growth, information regarding the lock-up, etc.) are used to determine when to sell these securities. BDCs cannot acquire any assets other than those Qualifying Assets described in subparagraphs (1) through (8) below unless, at the time of the acquisition, the assets described in subparagraphs (1) through (8) below represent at least 70% of the value of the BDC’s total assets (the “70% basket”). Below is a general summary of Qualifying Assets in which the Fund may invest.
1. Securities issued in transactions not involving a public offering from issuers which are Eligible Portfolio Companies (including affiliated persons or persons that have been affiliated persons within the preceding 13 months) or from any other person, subject to such rules and regulations as the SEC may prescribe;
2. Securities purchased in transactions not involving any public offering from an issuer, or from any person who is an officer or employee of the issuer, if the issuer is a U.S. company that is not an investment company, but the issuer is not an Eligible Portfolio Company because it has issued a class of margin securities that is eligible for margin loans, and at the time of purchase the BDC owns at least 50% of (i) the greatest number of equity securities (on a fully diluted basis) of the issuer and (ii) the greatest amount of such issuer’s debt securities held by the BDC at any point in time during the period when such issuer was an Eligible Portfolio Company, and, (iii) the BDC is one of the 20 largest holders of the issuer’s outstanding voting securities;
3. Securities of any Eligible Portfolio Company that is controlled by the BDC (either alone or as part of a group acting together) and the BDC exercises a controlling influence over the management or policies, and has an affiliated person who is a director of, the Eligible Portfolio Company;
4. Securities issued in transactions not involving a public offering from U.S. non-investment company issuers subject to bankruptcy, reorganization, insolvency or similar proceeding or otherwise unable to meet their obligations without assistance (purchase may be made from affiliated persons or persons that have been affiliated persons within the preceding 13 months or in limited circumstances other persons);
5. Securities of an Eligible Portfolio Company purchased from any person in transactions not involving a public offering when no public market for the securities exists and the BDC owned at least 60% of the outstanding equity (on a fully diluted basis) of the issuer immediately prior to the purchase;
6. Securities received in exchange for or distributed with respect to the foregoing securities (including securities obtained pursuant to the exercise of options, warrants or rights relating to such securities);
7. Cash, cash items, U.S. Government securities or high-quality debt securities maturing in one year or less from the time of investment; and
8. Office furniture and equipment, interests in real estate, deferred organization and operating expenses, and other non-investment assets necessary and appropriate to the BDC’s operations.
“Making available significant managerial assistance” is defined under the 1940 Act, in relevant part, as (i) an arrangement whereby the BDC, through its officers, directors, employees or general partners, offers to provide and, if accepted, does provide, significant guidance and counsel concerning the management, operations or business objectives of a portfolio company; or (ii) the exercise by a BDC of a controlling influence over the management or polices of the portfolio company by the BDC acting individually or as part of a group acting together which controls the portfolio company. The officers of the Fund intend to offer to provide managerial assistance, including advice on equipment acquisition and financing, cash flow and expense management, general financing opportunities, acquisition opportunities and opportunities to access the public securities markets, to the great majority of companies to whom the Fund provides venture loans. In some instances, directors of the Fund might serve on the Board of Directors or as officers of borrowers.
Venture Loans. Venture loans generally will beare made pursuant to a negotiated loan agreement, and beare evidenced by promissory notes secured by specific equipment or other assets of the borrower financed with the proceeds of such loans, or secured by a broader lien on substantially all of the borrower’s assets where the purpose of the loan is to provide growth or general working capital to the borrower. The loans are typically secured by a first-position lien on such assets. The Fund will receivegenerally receives periodic payments (usually monthly) and may
4


receive a final payment equal to a percentage of the original loan amount, payable at maturity of the loan (whether as stated or accelerated).


The interest rate and amortization terms of venture loans and all other transaction terms will beare individually negotiated between the Fund and each borrower.
The documentation for venture loans will includeincludes representations, warranties, covenants and events of default intended to protect the Fund and which are customary for commercial transactions of this type and size. Typical material terms include restrictions on additional debt, covenants to maintain the loan collateral and keep it adequately insured and free of liens, prohibitions against sale or other disposition of the assets except under specified conditions, and acceleration provisions making the remaining outstanding amounts under the loan immediately due and payable and giving rise to a right to take possession of the collateral upon certain events of default, including failure to make required payments, insolvency, and failure to comply with covenants. There can be no assurance that the value of the collateral at the time of default will be at least equal to the outstanding amount due under the loan.
Typically, loans will beare structured as non-revolving commitments by the Fund to provide financing, in one or more advances over a specified period of availability, determined as part of the underwriting process. The commitmentcommitments of the Fund to finance future asset acquisitions or growth capital needs is typically subject to the absence of any default under the loan and compliance by the borrower with requirements relating to, among other things, the type of assets to be acquired, and if applicable, the borrower’s achievement of performance-based milestones. Although the Fund’s commitmentcommitments generally will provide that the Fund is not required to continue to fund additional asset purchases or growth capital if there has been a material adverse change in the borrower’s financial condition, a borrower’s financial condition may not be as strong at the time a loan is funded as it was when the related commitment wascommitments were made.
Warrants. The Fund generally will acquireacquires warrants to purchase equity securities of the borrower in connection with financings. It is anticipated that such warrants, generally, will be distributed by the Fund to the Company simultaneously with, or shortly following, their acquisition. The terms of the warrants, including the expiration date, exercise price, and terms of the equity security for which the warrant may be exercised, will beare negotiated individually with each borrower, and willare likely to be affected by the price and terms of securities issued by the company to its venture capitalists and other holders in equity financings close in time to the Fund’s making of the loan commitment. Based upon the Manager’s past experience, it is anticipated that most warrants will be exercisable forhave a contractual term of five to tenfifteen years, and will have an exercise price based upon the price at which the borrower most recently issued equity securities or, if a new equity offering is anticipated, the future price of such equity securities (and sometimes a “blended price”). In certain transactions, it is anticipated that warrants will be issued with an exercise price that is waived in connection with a liquidity event such as an initial public offering or acquisition. The equity securities for which the warrant will be exercised generally will be convertible preferred stock (of which there may be one or more classes) or common stock. Substantially all the warrants and underlying equity securities will be restricted securities under the Securities Act of 1933 (the “1933 Act”) at the time of issuance; the Fund generally negotiates registration rights with the borrower that may provide “piggyback” and S-3 registration rights, which permit the owner of the warrant under certain circumstances to include some or all of the securities that will be acquired upon exercise of the warrant in a registration statement filed by the borrower. The Fund generally will negotiate “net issuance” provisions in the warrants, which allow the owner of the warrant to exercise the warrant without payment of any cash, and thereby receive a net number of shares determined by the increase in the value of the issuer’s stock (at the time of exercise) above the exercise price stated in the warrant.
Equity Securities. The Fund did not during the prior year but may make direct investments in equity securities (including convertible notes) having an aggregate cost of up to 10% of the aggregate cost of all investments of the Fund determined cumulatively over the life of the Fund (provided, however, that any amounts paid by the Fund to acquire equity securities pursuant to the receipt or exercise of warrants or stock received in connection with the Fund’s venture loans shall not be taken into account in determining whether such 10% threshold has been met). For example, the Fund may invest equity in a follow-on round of financing to maintain or increase its ownership stake. In some cases, equity investments may be made in companies where the Fund does not have an existing loan. Additionally, the Fund anticipates selectively pursuing opportunistic equity purchases, which may take the form of primary or secondary stock purchases. The Manager expects that the equity securities generally will be convertible preferred stock, though it is possible the Fund would invest directly in common stock of Venture-Backed Companies or convertible notes which convert into common or preferred stock of Venture-Backed Companies. It is likely that, as in the case of warrants, direct equity investments, if made by the Fund, generally will be distributed to the Company simultaneously with, or shortly following, their acquisition,acquisition. However, although, in this case, as a result of U.S. federal income taxthe Code and 1940 Act requirements such equity investments may be held bycould, in certain circumstances, compel the Fund to hold such securities for a longer period of time prior to their distribution to the Company.
Investment Policies. For purposes of the investment policies (other than the diversification standards below), references to the percentage of the Fund’s total assets “invested” in securities of a company will be deemed to refer, in the case of debt financings, to the total amount of financings that the Fund has committed to provide, and in the case of equity investments, to the cost basis of such equity investments; the Fund will not be required to divest securities in its portfolio or decline to fund an existing commitment because of a subsequent change in the value of securities the Fund has previously acquired or committed to purchase.
Diversification Standards. The Fund will beis classified as a “non-diversified”“non-diversified,” closed-end investment company under the 1940 Act. UntilHowever, the Fund qualifiesseeks to continue to qualify as a RIC it will not be subject to theand therefore, must meet diversification requirements applicable to RICsstandards under the Code. Commencing with the first capital call, the Manager will seek to increase the diversification of the Fund’s portfolio so as to make it possible to meet the RIC diversification requirements, as described below.
To qualify as a RIC and obtain the special pass-through status available to RICs under the Code, the Fund must meet the issuer diversification standards under the Code that generally require that, at the close of each quarter of the Fund’s taxable year, (i) not more than 25% of the value of its total assets is invested in the securities of a single issuer, and (ii) at least 50% of the value of its total assets is represented by cash, cash items, government securities, securities of other RICs and other securities (counting each investment in such other securities only if the value of such securities does not exceed 5% of the value of the Fund’s total assets and the Fund does not own more than
5



10% of the outstanding voting securities of the issuer of such securities). For purposes of the diversification requirements under the Code, the percentage of the Fund’s total assets “invested” in securities of a company will be deemed to refer, in the case of financings in which the Fund commits to provide financing prior to funding the commitment, to the amount of the Fund’s total assets represented by the value of the securities issued by the borrower to the Fund at the time each portion of the commitment is funded.
Industry Segment Diversification. TheIf the Fund will generally seek to invest no more than 30%meets the initial requirements of a RIC, the Fund shall not lose its status as a RIC because of a discrepancy during a subsequent quarter between the value of its total assetsvarious investments unless the discrepancy exists immediately after the acquisition of any security and is wholly or partly the result of such acquisition. This is called the “fluctuation in securitiesvalue” exception. This exception also applies if distributions of companies in any single industry. The broad industry categories in whichcash cause the Fund anticipates that mostRIC to be out of its investments will fall (and within each of which there may be several “industries” for purposes ofcompliance with either the industry diversification policy) include computers and storage, semiconductor and equipment, internet, medical devices, software, and several other categories.25% or 5%/50% tests.
Investment Guidelines. In selecting investments for the Fund’s portfolio, the Manager will endeavor to meet the investment guidelines established and approved by the Fund’s Board of Directors. The Fund may, however, make investments that do not conform to one or more of these guidelines when deemed appropriate by the Manager. Such investments might be made if the Manager believes that a failure to conform in one area is offset by exceptional strength in another or is compensated for by a higher yield, favorable warrant issuance or other attractive transaction terms or features.  
Industry Segment Diversification. The Fund generally seeks to invest no more than 30% of its total assets in securities of companies in any single industry. Diversification is carefully considered at the inception of each loan, but percentages may vary from the guideline at any particular point in time. The broad industry categories in which the Fund anticipates that most of its investments will fall (and within each of which there may be several “industries” for purposes of the industry diversification policy) include computers and storage, semiconductor and equipment, internet, medical devices, software, and several other categories.
Stage of Development Guidelines. The Manager will seekseeks to diversify the Fund’s portfolio based on the development stage of the companies in which it invests. Generally, Venture-Backed Companies fall into several lifecycle stages, including the following:  

Early or seed stage companies represent the initial stages of a start-up company’s development. These companies have raised varying amounts of equity capital to prove a concept and qualify for larger sums of start-up capital. Their activities generally are limited to product development, scientific and market research, recruiting a management team and proving early business traction. These companies generally have investor syndicates that include early stage investors such as high net worth angel investors, venture capitalists, incubators, and crowd funding platforms.
Emerging growth stage companies have a proven early product/market fit and have initiated or are about to initiate full-scale operations and sales but may not be showing a profit.
Mezzanine stage companies are approaching or have attained break-even or profitability and are continuing to expand.
    
The Manager will referrefers to its investments in seed and start-up companies as “Early Stage” and investments in emerging growth companies and mezzanine companies as “Expansion Stage.” The Manager will seekseeks to diversify its investments across stages. The classification of companies by stages of development involves a subjective judgment by the Manager, and it is possible that other investors or market analysts would classify the same companies differently than the classificationclassifications used by the Fund.

Quality Guidelines. The Manager will seekseeks to invest the majority of the Fund’s aggregate investments (determined cumulatively over the life of the Fund) in investments that meet many of the following guidelines:

Company Guidelines.

The company has a minimum capitalization of at least $1$1.0 million.
The company has at least six months’ worth of available cash to fund its operations or indications from its equity investors that they will make investments necessary to provide such cash.
The company’s equity investors have indicated a current intention to make additional equity financing available to the company, or the company has a forecasted positive cash flow.
The company’s business plan contemplates sales of at least $25$25.0 million within five years.
The company has previously closed equity financing or will close equity financing prior to the funding of the loan.

Transaction Guidelines for Loans.

The term of the loan does not exceed 60 months and does not extend beyond December 31, 2028.
Debt service requirements of the loan are, in the opinion of the Manager, not likely to become an impediment to the company raising additional capital.
The loan is secured by all or substantially all of the borrower’s assets.

        


Equity Venture Capital Support Guidelines.

The company’s equity investors have (i) in the opinion of the Manager, significant venture capital and/or industry experience, and (ii) follow-on capital to support the company.

6


Special Situation Financings. The Manager may invest up to 20% of the Fund’s aggregate investments determined cumulatively over the life of the Fund in Special Situation Financings. Such Special Situation Financings could include debt investments targeted towards late-stage or public companies seeking additional growth capital to expand product offerings, increase market penetration or fund strategic acquisitions of other companies or technology. In these situations, the Fund would only consider making special situation financingsinvesting in this Special Situation Financings if it determined it to be of equivalent or better quality as compared to a senior secured loan made to the Fund’s more typical portfolio companies. Further, the Fund may also choose to subordinate existing outstanding debt as part of a restructuring or work-out arrangement in order to allow the company to successfully complete a transaction such as an acquisition or round of financing. There can be no assurance that the subordination will work to the benefit of the Fund. The Manager will target companies whose cash flow from operations and cash reserves are expected to service the Fund’s investment on a current basis. Investments may be structured as senior debt, convertible debt, or other debt/equity structures. In addition, Special Situation Financings could include investments in a “troubled” company undergoing a restructuring or recapitalization of its existing debt or equity, and making investments in subordinated debt, providing bridge financing to a company which is in the process of raising additional private equity, planning an initial public offering or is seeking to enter into a business combination through which it would be acquired. In some instances, these companies will have been bootstrapped (i.e. funded solely by the personal assets of their founders or other individuals), without any substantial investment from venture capital or other investors. As of December 31, 2018,2021, the Fund had not made any Special Situation Financings.Financings of about 1.3% of total commitments.
International Investments. As a BDC, the Fund may invest in companies which are not Qualifying Assets, as long as at the time of such investment, at least 70% of the value of the Fund’s total assets are invested in Qualifying Assets. An Eligible Portfolio Company must be organized under the laws of, and have its principal place of business in, the United States. Therefore, the Fund could invest up to 30% of its total assets in foreign-based companies. If reasonably practicable, investments in foreign-based companies would be secured by foreign-based assets in addition to being secured by any assets located in the United States.
Leverage. The Fund borrowed money and intends to continue borrowing from and could enter into secured contracts, which instruments may be considered debt securities, with banks, insurance companies and other lenders to obtain additional funds to originate loans (and possibly for Special Situation Financings), if such borrowings are available on terms that are acceptable to the Manager and Board of Directors of the Fund. It is possible, due to potential future tightening of the credit markets, that the Fund may not be able to secure such borrowings on acceptable terms. For example, while eachAny borrowings of the Fund will be subject to the asset coverage requirements under the 1940 Act, including borrowings in excess of 5% of total assets for temporary purposes, and all borrowings for emergency purposes that are not “temporary.” In April 2019, the Fund’s predecessor funds managed bysole shareholder approved the Manager has utilized leverageFund to maximize returnapply the reduced asset coverage requirements in Section 61(a)(2) of the 1940 Act, which permits the Fund to investors, Venture Lending & Leasing V, Inc., afterdouble the financial crisis of 2008, was only able to acquire a loan facility in themaximum amount of $30 million, much smaller thanleverage that it may incur by reducing the facilities used byasset coverage requirement applicable to the funds that preceded Fund V. However, the subsequent three funds, Venture Lending & Leasing VI, Inc., Venture Lending & Leasing VII, Inc., and Venture Lending & Leasing VIII, Inc. have operated in an improving economic environment. During Fund VI’s existence, the credit markets allowed itfrom 200% to initially obtain a credit line of $40 million and as the capital markets improved, it eventually increased the line to $160 million. During Fund VII’s existence, the credit markets have continued to improve allowing it to initially obtain a credit line of $125 million which was later increased to $255 million. During Fund VIII’s existence, the credit markets have remained open allowing it to initially obtain a credit line of $125 million which was later increased to $280 million.150%.
Temporary Investments. Pending investment, and until distributions to the stockholders are made, the Fund will invest excess cash in: (i) time deposits, certificates of deposit and similar instruments of highly-rated banks; (ii) securities issued or guaranteed by the U.S. government, its agencies or instrumentalities; (iii) repurchase agreements that are: (a) issued by highly-rated banks or securities dealers; and (b) fully collateralized by U.S. government securities; (iv) short-term high-quality debt instruments of U.S. corporations; and (v) money market funds and other pooled investment funds whose investments are restricted to those described above. The average maturity of such investments, weighted by their par value, will not exceed 90 days.
Other Investment Policies. The Fund will not sell securities short (except to the extent the Fund has a warrant for, or owns, shares equal to the number of shares which is the subject of the proposed short sale), purchase securities on margin (except to the extent the Fund’s permitted borrowings are deemed to constitute margin purchases), purchase or sell commodities or commodity contracts (except interest rate hedging transactions in connection with the Fund’s permitted borrowings), or purchase or sell real estate. The Fund may, however, write puts and calls, and acquire options, as a hedge for equity investments or to increase return through a covered call. The Fund will not underwrite the securities of other companies, except to the extent they may be deemed underwriters upon the disposition of restricted securities acquired in the ordinary course of their business. The Fund may, however, use borrowed funds for its lending activities. See the discussion herein under the caption “Risk Factors - General - Leverage.”
The Fund’s investment objectives, investment policies and investment guidelines (other than its intended status as a BDC) are not fundamental policies and may be changed by the Fund’s Board of Directors at any time.
Regulation. As a BDC, the Fund is required to invest in Eligible Portfolio Companies and (with certain exceptions) make available to them significant managerial assistance. Eligible Portfolio Companies, and the regulations governing assets a BDC can acquire, are described under the heading “Investment Program” above.  


The Fund, as a BDC, may sell its securities at a price that is below its net asset value per share, provided that a majority of the Fund’s disinterested directors, or not interested parties of the Fund under Section 2(a)(19) of the 1940 Act (i.e., independent director), has determined that such sale would be in the best interests of the Fund and its shareholder and upon the approval by the holders of a majority of its outstanding voting securities, including a majority of the voting securities held by non-affiliated persons, of such policy or practice within one year of such sale. A majority of the disinterested directors also must determine in good faith, in consultation with the underwriters of the offering if the offering is underwritten, that the price of the securities being sold is not less than a price which closely approximates market value of the securities, less any distribution discounts or commissions. As defined in the 1940 Act, the term “majority of the outstanding voting securities” of the Fund means the vote of (i) 67% or more of the Fund’s Shares present at a meeting, if the holders of more than 50% of the outstanding Shares are present or represented by proxy, or (ii) more than 50% of the Fund’s outstanding Shares, whichever is less.
7


Many of the transactions involving a company and its affiliates (as well as affiliates of those affiliates) which were prohibited without the prior approval of the SEC under the 1940 Act prior to its amendment by the 1980 provisions are permissible for BDCs, including the Fund, upon the prior approval of a majority of the Fund’s disinterested directors and a majority of the directors having no financial interest in the transactions. However, certain transactions involving certain persons related to the Fund, including its directors, officers, and the Manager, may still require the prior approval of the SEC. In general, (i) any person who owns, controls, or holds power to vote, more than 5% of the Fund’s outstanding Shares; (ii) any director, executive officer, or general partner of that person; and (iii) any person who directly or indirectly controls, is controlled by, or is under common control with, that person, must obtain the prior approval of a majority of the Fund’s disinterested directors, and, in some situations, the prior approval of the SEC, before engaging in certain transactions involving the person or any company controlled by the Fund. The 1940 Act generally does not restrict transactions between the Fund and its eligible portfolio companies. While a BDC may change the nature of its business so as to cease being a BDC (and in connection therewith withdraw its election to be treated as a BDC) only if authorized to do so by a majority vote (as defined by the 1940 Act) of its outstanding voting securities, shareholder approval of changes in other fundamental investment policies of a BDC is not required (in contrast to the general 1940 Act requirement, which requires shareholder approval for a change in any fundamental investment policy).
Dividends and Distributions. The Fund intends to distribute to its shareholder all equity securities received from portfolio companies simultaneously, or shortly following, their acquisition and substantially all of its net investment income and net realized capital gains, if any, as determined for income tax purposes less appropriate reserves. Applicable law, including provisions of the 1940 Act, may limit the amount of dividends and other distributions payable by the Fund. Income dividends will generally be paid quarterly to shareholders of record on the last day of each preceding calendar quarter end. Substantially all of the Fund’s net capital gain (the excess of net long-term capital gain over net short-term capital loss) and net short-term capital gain, if any, will be distributed annually, or on a more frequent basis as determined by the Manager.
Until June 30, 2022, the Fund may make loan commitments to reinvest the proceeds of matured, repaid or resold investments, net of required distributions to its shareholder, principal payments on borrowings and expenses or other obligations of the Fund, in new loans. The Manager shall be permitted to extend the investment period by up to two (2) additional calendar quarters in its sole and absolute discretion. Following the end of the commitment period, the Fund will begin to distribute to investors all proceeds received from principal payments and sales of investments, net of reserves and expenses, principal repayments on the Fund’s borrowings, amounts required to fund financing commitments entered into before such date, and any amounts paid on exercise of warrants. Distributions of such amounts are likely to cause annual distributions to exceed the earnings and profits of the Fund available for distribution, in which case such excess will be considered a tax-free return of capital to a shareholder to the extent of the shareholder’s adjusted basis in its shares and then as capital gain. The Fund may borrow money to fund shareholder distributions, to the extent consistent with the 1940 Act and a prudent capital structure.
Competition. Other entities and individuals compete for investments similar to those proposed to be made by the Fund, some of whom may have greater resources than the Fund. Furthermore, the Fund’s need to comply with provisions of the 1940 Act pertaining to BDCs and if the Fund qualifies as a RIC, provisions of the Code pertaining to RICs might restrict the Fund’s flexibility as compared with its competitors.  The need to compete for investment opportunities may make it necessary for the Fund to offer borrowers more attractive transaction terms than otherwise might be the case.
Executive Officers. The following are the executive officers of the Fund. All officers serve at the pleasure of the Fund’s Board of Directors.
Name and Position with FundAgeOccupation During Past Five Years
David R. Wanek, President and Chief Executive Officer49Chief Executive Officer for the Fund since 2022. Mr. Wanek has held the position of President of the Fund since 2019 and held other positions with Westech Investment Advisors since 2001.
Jay L. Cohan, Vice President57Vice President for the Fund since 2017. Mr. Cohan has held Vice President, Assistant Secretary and other positions with Westech Investment Advisors since 1999.
Jared S. Thear, Vice President, Chief Financial Officer, Chief Compliance Officer, Treasurer, and Secretary45Vice President, Chief Financial Officer, Chief Compliance Officer, Treasurer and Secretary for the Fund since 2021. Mr. Thear has held the same positions with Westech Investment Advisors since 2021. Prior to joining Westech Investment Advisors, he worked at Deloitte & Touche for 20 years and held various leadership roles. From 2014 to 2021, he led Deloitte's Northwest region Asset Management practice for the audit function.
Rodolfo Ruano, Vice President and Assistant Secretary54Vice President and Assistant Secretary for the fund since 2021. Mr. Ruano has held the position of Vice President of Westech Investment Advisors since 2021. Investment partner for Westech Investment Advisors since 2011.
Employees. The Fund has no employees; all of its officers are officers and/or employees of the Manager, and all of its required services are performed by officers and employees of the Manager.
Available Information.Information. The Fund'sFund’s office is located at 104 La Mesa Drive, Suite 102, Portola Valley, CA 94028, and the phone number is (650) 234-4300. The Manager maintains a website at https://westerntech.com/.
The SEC maintains a website, www.sec.gov,, that contains reports, proxies and information statements filed by the Fund.
8


ITEM 1A.      
RISK FACTORS.
GENERAL
    
No Operating History; Reliance on Management.Management The Fund is newly organized and could require substantial time to become fully invested. Pending investment, all cash that the Fund receives pursuant to capital calls from the Company will be committed to short-term, high-grade investments that present relatively low investment risk but provide a correspondingly lower return.


. The Fund will be wholly dependent for the selection, structuring, closing and monitoring of its investments on the diligence and skill of the Manager, acting under the supervision of the Fund’s Board of Directors. Although the operating principals of the Manager have a long history of combined experience in investing in venture lending transactions and equity investments, there can be no assurance that the Fund will attain its investment objective. Furthermore, the Manager does not have substantial experience investing in special situation financingsSpecial Situation Financings such as convertible and subordinated debt of public and late-stage private companies. The officers of the Manager will have primary responsibility for the selection of the companies in which the Fund will invest, the negotiation of the terms of such investments and the monitoring and servicing of such investments after they are made. Although the officers of the Manager intend to devote such time as is necessary to the affairs of the Fund, they are not required to devote full time to the management of the Fund. Furthermore, there can be no assurance that any officer will remain associated with the Manager or that, if an officer ceased to be associated with the Manager, the Manager would be able to find a qualified person or persons to fill the position.
Illiquid and Long-Term Investment.Investment After. On last day of the calendar quarter of the fifth anniversary followingof the first investment by the Fund (or, if earlier, the Company), the Fund will cease to make any new equity investments as well as investments in venture loans (except pursuant to commitments made before the fourth anniversary, or if applicable, the extended commitment date (up to 2 calendar quarters)), following the earlier of the first investment by the Fund or the Company) and will distribute to its shareholder all proceeds received from principal payments and sales net of: (i) reserves and expenses; (ii) principal repayments on the Fund’s borrowings; (iii) amounts required to fund financing commitments entered into before such fourth anniversary, or if applicable, the extended commitment date; and (iv) any amounts paid on exercise of warrants or otherwise paid to protect the value of existing investments (including, for example, pay-to-play provisions and purchases of equity securities in “down rounds” to avoid dilution). The Fund’s Amended and Restated Articles of Incorporation provide that, on December 31, 2028, the Fund automatically will be dissolved without any action by its shareholder. From and after such dissolution, the Fund’s activities will be limited to the winding-up of its affairs, the liquidation of its remaining assets and the distribution of the net proceeds thereof to its shareholder. Although the Fund generally would not make any loan with a stated maturity date later than December 31, 2028, it is possible that, due to a default by a borrower or a transaction restructuring due to a borrower’s financial difficulties, such a loan may remain outstanding in whole or in part beyond its original maturity date. Furthermore, the Fund may not be able to sell warrants it receives from borrowers, or the equity securities (including those received upon exercise of warrants or conversion of debt instruments or in connection with restructuring of a troubled loan), to the extent those investments were retained by the Fund and not distributed earlier to its shareholder, for a significant period of time due to legal or contractual restrictions on resale or the absence of a liquid secondary market. As a result, the liquidation process might not be completed for a significant period after the Fund’s dissolution. In addition, it is possible that, if certain of the Fund’s assets are not liquidated within a reasonable time after the Fund’s dissolution, the Fund may elect to make a distribution in kind of all or part of such assets to its shareholders. In such case, the shareholders would bear any expenses attendant to the liquidation of such assets.
Although shares of the Fund have been registered under the Securities Exchange Act of 1934 (the “Exchange Act”), there will be no trading market for shares in the Fund (which are all owned by the Company), and thus shares of the Fund should be considered illiquid.
Competition.Competition. Other entities and individuals compete for investments similar to those made by the Fund, some of whom, with respect to investments in the form of loans, and many of whom, with respect to the equity investments and Special Situation Financings,convertible and subordinated debt, have greater resources than the Fund. Furthermore, competition could increase given the low barriers to entry in the industry. Additionally, the Fund’s need to comply with provisions of the 1940 Act pertaining to BDCs and if the Fund qualifies as a RIC, provisions of the Code pertaining to RICs, might restrict the Fund’s flexibility as compared with its competitors. The need to compete for investment opportunities may make it necessary for the Fund to offer borrowers or companies in which it makes equity investments more attractive terms than otherwise might be the case. If the Fund encounters increased competition from other entities or individuals or is hindered by the provisions of the BDC’s or RIC’s, the Fund may not fund new investments, which would impact the operations of the Fund.
Convertible Debt. Convertible debt instruments issued by public and late-stage private companies may comprise some of the Special Situation Financings in which the Fund may invest. Convertible debt generally offers lower interest yields than non-convertible debt of similar quality. The market value of debt tends to decline as interest rates increase and, conversely, to increase as interest rates decline. The market value of convertible debt, however, often reflects the market price of common stock of the issuing company when that stock price is greater than the conversion price of the convertible debt. The conversion price is the predetermined price at which the debt instrument could be exchanged for the associated stock. As the market price of the underlying common stock declines, the price of the convertible debt tends to be influenced more by the yield of the debt instrument. Thus, it may not decline in price to the same extent as the underlying common stock.
Subordinated Debt.Debt. Some of the Special Situation Financings in which the Fund may invest may consist of subordinated debt instruments, which tend to be predominantly high-yield non-convertible debt securities. Investments in high-yield securities involve substantial risk of loss. Sub-investment grade non-convertible debt securities, or comparable unrated securities, are commonly referred to as “junk debt” and are considered speculative with respect to the issuer’s ability to pay interest and principal and are susceptible to default or decline in market value due to adverse economic or business developments. The market values for high-yield securities tend to be very volatile, and these securities are less liquid than investment grade debt securities.
Leverage.Leverage. The Fund borrowedcurrently borrows money and intends to continue borrowing from and could enter into secured contracts, which instruments may be considered debt securities, with banks, insurance companies, and other lenders to obtain additional funds to originate
9


loans (and possibly Special Situation Financings), if such borrowings are available on terms that are acceptable to the Manager and Board of Directors of the Fund. It is possible, due to potential future tightening of the credit markets, that the Fund may not be able to secure such borrowings on acceptable terms. For example, while each of the Fund’s predecessor funds managed by the Manager has utilized leverage to maximize return to investors, Venture Lending & Leasing V, Inc. (“Fund V”), after the financial crisis of 2008, was only able to acquire a loan facility in the amount of $30.0 million, much smaller than the facilities used by the funds that preceded Fund V. However, the subsequent


three funds, Venture Lending & Leasing VI, Inc. (“Fund VI”), Venture Lending & Leasing VII, Inc. (“Fund VII”), and Venture Lending & Leasing VIII, Inc. (“Fund VIII”) have operated in an improving economic environment, During Fund VI’s existence, the credit markets allowed it to initially obtain a credit line of $40.0 million and as the capital markets improved, it eventually increased the line to $160.0 million. During Fund VII’s existence the credit markets have continued to improve allowing it to initially obtain a credit line of $125.0 million which later increased to $255.0 million. During Fund VIII’s existence the credit markets have remained open allowing it to initially obtain a credit line of $125.0 million which later increased to $280.0 million. Any borrowings of the Fund will be subject to the asset coverage requirements under the 1940 Act, including borrowings in excess of 5% of total assets for temporary purposes, and all borrowings for emergency purposes that are not “temporary.” Under the 1940 Act, the Fund may not incur borrowings unless, immediately after the borrowing is incurred, such borrowings would have “Asset Coverage” of at least 200%, generally, and of at least 150% if certain conditions are met. “Asset Coverage” means the ratio which the value of the Fund’s total assets, less all liabilities not represented by (i) the borrowings and (ii) any other liabilities constituting “senior securities” under the 1940 Act, bears to the aggregate amount of such borrowings and senior securities. The practical effect of this limitation is to limit the Fund’s borrowings and other senior securities to 50% of its total assets less its liabilities other than the borrowings and other senior securities. The 1940 Act also requires that, if the Fund borrows money, provisions be made to prohibit the declaration of any dividend or other distribution on the shares (other than a dividend payable in shares), or the repurchase by the Fund of shares, if, after payment of such dividend or repurchase of shares, the Asset Coverage of such borrowings would be below 200% (or 150%, as applicable). In April 2019, the Fund’s sole shareholder approved the Fund to apply the reduced asset coverage requirements in Section 61(a)(2) of the 1940 Act, which permits the Fund to double the maximum amount of leverage that it may incur by reducing the asset coverage requirement applicable to the Fund from 200% to 150%. If the Fund is unable to pay dividends or distributions in the amounts required under the Code, it might not be able to qualify for the pass-through status as a RIC or, if qualified, to continue to so qualify.
The Fund has a secured, syndicated debtloan facility with a borrowing availability of $200$350.0 million and the outstanding balance under the facility as of December 31, 20182021 was $6.0$263.0 million.
The use of leverage increases investment risk. The Fund’s use of leverage is premised upon the expectation that the Fund’s all-in borrowing costs will be lower than the return the Fund achieves on its investments. To the extent the income or capital gains derived from investments purchased with borrowed funds exceeds the cost of borrowing, the Fund’s overall return will be greater than if leverage had not been used. Conversely, if the income or capital gain from the investments purchased with borrowed funds is not sufficient to cover the cost of borrowing, or if the Fund incurs capital losses, the return to the Fund will be less than if leverage had not been used, and therefore the amount available for distribution will be reduced or potentially eliminated.
Lenders requirehave required that the Fund pledge portfolioall assets as collateral for borrowings and requirehave required that the Company provide guarantees or other credit enhancements. The Company, however, will not pledge its assets to secure such borrowings as this could result in unrelated business taxable income to its tax-exempt members. If the Fund is unable to service the borrowings, the Fund may risk the loss of such pledged assets.
Lenders also requirerequired that the Fund agree to loan covenants limiting the Fund’s ability to incur additional debt or otherwise limiting the Fund’s flexibility, and loan agreements may provide for acceleration of the maturity of the indebtedness if certain financial tests are not met. To minimize risks associated with borrowing money at floating rates and lending money at fixed rates, the Fund may enter into interest rate hedging transactions with respect to all or any portion of the Fund’s borrowings. There can be no assurance that such interest rate hedging transactions will be available in forms acceptable to the Fund. In addition, entering into interest rate hedging transactions increases costs to the Fund. Finally, it is possible that the Fund could incur losses from being “over hedged,“over-hedged,” which would result if the debt that was hedged is repaid faster than expected.
Regulation. The Fund has elected to be treated as a BDC under the Small Business Incentive Act of 1980, which modified the 1940 Act. Although BDCs are not required to register under the 1940 Act and are relieved from compliance with a number of the provisions of the 1940 Act, there are now greater restrictions in some respects on permitted types of investments for BDCs. Moreover, the applicable provisions of the 1940 Act continue to impose numerous restrictions on the activities of the Fund, including restrictions on leverage and on the nature of its investments. While the Fund is not aware of any judicial rulings under, and is aware of only a few administrative interpretations of, the Small Business Incentive Act of 1980, there can be no assurance that such Act will be interpreted or administratively implemented in a manner consistent with the Fund’s objectives or manner of operation.
Litigation.  The Fund could be subject to litigation by borrowers, based on theories of breach of contract to lend, “lender liability,” or otherwise in connection with its loan and investment transactions. The defense of such a lawsuit, even if ultimately determined to be without merit, could be costly and time-consuming to the Fund. The Fund may become party to certain lawsuits from time to time in the normal course of business. While the outcome of any legal proceedings cannot now be predicted with certainty, the Fund does not expect any such proceedings will have a material effect upon the Fund’s financial condition or results of operation. Management is not aware of any material pending legal proceedings involving the Fund.
Tax Status.Status. The Fund must meet a number of requirements, including those described herein under the caption “Federal Income Taxation,”“Diversification Standards” and in Note 9 to the financial statements included in this filing, to qualify for the pass-through status as a RIC and, if qualified, to continue to so qualify. For example, the Fund must meet specified asset diversification standards under the Code which might beprove difficult to meet if thecertain borrowers under some loans draw downwith larger commitments drew on their committed financing at a rate faster rate than other borrowers to whom smaller commitments were made, particularly during the early periods of the Fund’s operations. If the Fund experiences difficulty in meeting the diversification requirement for any fiscal quarter of its taxable year, it might accelerate capital calls or, if available, borrowings in order to increase the portion of the Fund’s total assets represented by cash, cash items, and U.S. government securities as of the close of the following fiscal quarter and thus attempt to meet the diversification requirement. The Fund, however, would incur additional interest and other expenses in connection with any such accelerated borrowings, and increased investments by the Fund in cash, cash items, and U.S. government securities (whether the funds to make such investments are derived from called equity capital or from accelerated borrowings) are likely to reduce the Fund’s return. Furthermore, there can be no assurance that the Fund would be able to meet the diversification
10


requirements through such actions. Failure to qualify as a RIC would deny the Fund pass-through status and, in a year in which the Fund has taxable income, would have a significant adverse effect on the return of the Fund. Tax laws are dynamic and tax laws either in the U.S. or in foreign jurisdictions could change causing a different than expected outcome.
The Fund has received an opinion that, assuming the Fund’s election to be a BDC under Sections 6(f) and 54 of the 1940 Act will be valid and will remain in effect and that the Fund otherwise meets the qualification requirements set forth in Section 851(b) and the distribution requirements in Section 852(a) of the Code, if the Fund’s status as a RIC is challenged by the Internal Revenue Service (the “IRS”) in court and properly litigated, a court of competent jurisdiction will respect that status for federal income tax purposes. If the SEC were to disallow the Fund’s election to be treated as a BDC, then the Fund would not be eligible to be treated as a RIC and, therefore, would


be subject to federal corporate tax on its income and gains. The opinion referred to above is based on the Code, regulations thereunder, IRS rulings, procedures and pronouncements, court decisions and other applicable law as of the date hereof, and certain representations that the Fund has made to its legal counsel. Legal opinions, however, are not binding on the IRS or the courts, and no ruling has been or will be requested from the IRS. No assurance can be given that the IRS will concur with such opinion.
Allocation of Expenses. If the Fund is not deemed to be engaged in a trade or business, individuals and certain other persons who are members of the Company will be required to include in their gross income an amount of certain Fund expenses relating to the production of gross income that are allocable to the Company. These members, therefore, will be deemed to receive gross income from the Fund in excess of the distributions they actually receive. Such allocated expenses were deductible by an individual Membermember as a miscellaneous itemized deduction, for 2017, subject to the limitation on miscellaneous itemized deductions not exceeding 2%2.0% of adjusted gross income to the extent the Fund is not engaged in a trade or business. However, for the years 2018 through 2025, no deduction for such expense would be allowed. For the tax years 2026 and beyond, the provision will expire and the expenses would be deductible under the pre-2018 law as currently written.
Calculation of Management Fee. As compensation for its services to the Fund, the Manager will receive an investment management fee from the Fund (the “Management Fee”), commencing when capital is first called from the members of the Company. The aggregate annual amount of Management Fee for each annual period (which will be comprised of four whole fiscal quarters and which, in the case of the first year, will commence on the first day of the first fiscal quarter commencing on or following the first capital commitment) will be calculated as a percentage of committed capital, as follows:


Management Fee
Year 11.575%
Year 21.600%
Year 31.575%
Year 41.500%
Year 51.250%
Year 60.900%
Year 70.600%
Year 80.350%
Year 90.150%
There will be no Management Fee payable after the ninth-year anniversary of the first capital contribution date.
The calculation of the Management Fee could result in fees being disproportionately large relative to the value of the Fund’s portfolio if the total assets of the Fund are low compared to the committed capital. This could occur, for example, if the Fund does not originate as many loans as anticipated, or if the loans in the Fund’s portfolio are repaid at a rapid rate during such period.
Risks Related to Cybersecurity.Cybersecurity. Increased reliance on technology by the Fund and its service providers and portfolio companies has increased the risks posed to their respective information systems. The Fund and its service providers and portfolio companies are susceptible to operational and information security risks that include, among other things: human error and negligence; theft; the unauthorized monitoring, release, misuse, loss, destruction or corruption of confidential and highly restricted data; denial of service attacks; unauthorized access to relevant systems; compromises to networks or devices that the Fund and its service providers use to service the Fund’s operations; and operational disruption or failures of physical infrastructure or operating systems.

Cyber-attacks against or security breakdowns of the Fund or its service providers or portfolio companies may adversely impact the Fund and its shareholders, potentially resulting in, among other things: financial losses; the inability of Fund shareholders to transact business and the Fund to process transactions; exposure of personal information belonging to the Fund and its shareholders and violations of applicable privacy and other laws; regulatory fines, penalties, reputational damage, reimbursement or other compensation costs; and/or additional compliance costs. The Fund may incur additional costs for cybersecurity risk management and remediation purposes. In addition, cybersecurity and privacy risks may also impact the Fund’s transactional counterparties, governmental and other regulatory authorities, exchange and other financial market operators, banks, brokers, dealers, insurance companies and other financial institutions, which could cause the Fund to suffer losses.

In general, cybersecurity attacks and breaches include, but are not limited to, efforts by bad actors to gain unauthorized access to systems, networks, devices or other digital systems (e.g., through “hacking” or malicious software coding) for purposes of misappropriating assets or sensitive information, corrupting data or causing operational disruption. Cyber-attacks also may be carried out in a manner that does
11


not require gaining unauthorized access, such as causing denial-of-service attacks on websites (i.e., efforts to make services unavailable to intended users) or using a phishing scheme to impersonate an executive or vendor to cause an unauthorized transfer of funds. There can be


no assurance that the Fund or its service providers or portfolio companies will not suffer losses relating to cyber-attacks or other information security breaches in the future.

While information risk management systems and business continuity plans have been developed which are designed to reduce the risks associated with cybersecurity, there are inherent limitations in any cybersecurity risk management systems or business continuity plans, including the possibility that certain risks have not been identified and that cyber-attacks may be highly sophisticated. There can be no assurance that the programs, plans and systems in place will prevent a cyber-attack or otherwise prevent cyber losses.

In addition, federal, state and foreign governments and agencies have adopted and could in the future adopt regulations covering issues such as user privacy. If the Fund’s and/or its services providers’ or portfolio companies’ privacy or data security measures fail to comply with current or future laws and regulations, they may be subject to additional litigation, regulatory investigations or other liabilities that could result in financial loss, litigation, regulatory investigations and penalties, and other liabilities that could damage their reputation and adversely impact the Fund’s and/or its service providers’ or portfolio companies’ performance and financial condition.

MeToo Movement.The #MeToo, “Time’s Up” and related social movements have focused attention on issues relating to gender equality in the workplace and raised awareness of the obligation to prevent sexual harassment and other forms of sexual misconduct in the workplace. Recently, companies have lost executives and faced major lawsuits and fines due to allegations of sexual harassment, gender discrimination and other misconduct, including negligence or misconduct in handling such allegations. There is no guarantee that the Fund’s portfolio companies will not experience negative fallout stemming from allegations of sexual harassment, gender discrimination and other misconduct resulting from the actions and/or inactions of such companies, their employees, and/or affiliates.

Brexit Risk.Risk. The risk of investing in portfolio companies based out of or related to Europe may be heightened due to the 2016 referendum in which the United Kingdom (“UK”) voted to exitformally leaving the European Union (“EU”). There is significant uncertainty about how negotiations relating to the UK’s withdrawal will be conducted, as well as the potential consequences and precise timeframe for “Brexit.” on January 31, 2020.

On March 29, 2017, the UK formally notified the European Council of its intention to withdraw from the EU and begin the two-year period set out for withdrawal discussions in the Treaty on European Union. The UK is scheduled to exit the EU on March 29, 2019, but the fate of Brexit remains unclear as the terms of the eventual Brexit must be agreed to and the exit deadline may be extended under EU law, especially ifDecember 24, 2020, the UK and the EU are unable to agree toreached an agreement (the “Agreement”) on a Brexit deal prior to the March 2019 deadline. The UK could also, in theory, cancel Brexit if the restnew trade and cooperation arrangement governing certain aspects of the future relationship between the parties. The Agreement applied on a provisional basis in the EU consents.until it was formally ratified by the EU Parliament and has applied permanently from May 1, 2021. While the Agreement provides clarity with respect to future trade in certain goods between the U.K. and the EU, it does not cover all aspects of the parties’ future relationship. The application and interpretation of the Agreement, therefore, may take several years to be clarified and resolved.

Accordingly, there remains significant uncertainty regarding the ultimate effects of Brexit will depend on agreementsand the long-term nature of the political and economic relationship between the UK negotiates to retain access to EU markets either during a transitional period or more permanently.and the EU. Brexit could lead tohas created legal and tax uncertainty, which may last for years to come, and could lead to potentially divergent national laws and regulations as the UK determines which EU laws to replace or replicate.regulations. While it is not possible to determine the precise impact these eventsthat Brexit, including the implementation of the Agreement or any future agreement between UK and the EU, may have on the Fund duringat this periodtime and beyond, the impact on the UK and European economies and the broader global economy could be significant, resulting in negative impacts, such asincluding increased volatility and illiquidity, and potentially lower economic growth, on markets in the UK, Europe and globally, which maythereby adversely affectaffecting the value of the Fund'sFund’s investments. In addition, if one or more other countries were to exit the EU or abandon the use of the euro as a currency, the value of investments tied to those countries or the euro could decline significantly and unpredictably.


Climate Change, and Natural Disaster Risk.and Public Health Crises Risk. Climate change and related legislation, regulation, and accords, both domestic and international, intended to control the impact of climate change may significantly affect the value ofproduce direct or indirect adverse consequences to the Fund’s investments.investments, significantly affecting their value. Extreme weather patterns or natural disasters, such as the Tohoku earthquake and resulting tsunami in Japan in 2011, the Alaska earthquake in 2018, major hurricanes in the United States in 2017, 2018 and 2018,2020, or the threat thereof, could also adversely impact Fund portfolio companies’ facilities, operations, and services, as well as certain industries, or group of industries, and regions related to the Fund’s investments. In addition, climate change regulation, or business trends driven by climate change,Additionally, public health crises, such as the COVID-19 pandemic, could result in direct or indirect adverse consequencestravel restrictions and shipping and labor disruptions, which may adversely affect Fund portfolio companies’ facilities, operations, and services.

Coronavirus ("COVID-19"). The ongoing COVID-19 pandemic has caused significant disruption in the international and U.S. economies and financial markets. The spread of COVID-19 has caused reduction in business activity, financial transactions, labor shortages, supply chain interruptions and overall economic and financial instability. The ongoing effects of COVID-19 remain challenging to predict due to multiple uncertainties, including, but not limited to the Fund’s investments.duration and resurgences of the outbreak, the application and effectiveness of health and safety measures that are voluntarily adopted by the public or required by government or public health authorities, including vaccines and treatments and the speed and strength of an economic recovery.

The full extent of the impact of the COVID-19 pandemic on the Fund’s portfolio companies’ business operations and results of operations is unknown at this time and will depend on many factors outside of the Fund’s control, including, without limitations, the timing, extent, trajectory and duration of the pandemic. Management is continuing to work with the Fund’s portfolio companies that may be directly or indirectly affected by the outbreak to evaluate the continued impact on the borrowers’ ability to make timely payments and creditworthiness.

LIBOR Phase-Out Risk.Risk Many. Many financial instruments, including the Fund’s credit facility and certain of its debt investments, utilize or are permitted to utilize a floating interest rate based on the London Interbank Offered Rate, or “LIBOR,” which is the offered rate for short-term Eurodollar deposits between major international banks. Additionally, the Fund has derivative instruments that hedge by converting floating LIBOR based interest rates into fixed rates. On July 27, 2017, the head of the UK’s Financial Conduct Authority (“FCA”) announced a desireits intention to phase out the use of LIBOR by the end of 2021. There is thus uncertainty regardingOn May 3, 2021, the future utilizationFCA made an announcement on the end of LIBOR and confirmed that immediately after December 31, 2021, LIBOR for the naturefollowing settings will cease; in the case of any replacement rate. As such,all sterling, euro, Swiss franc and Japanese yen settings, and the 1-week and 2-month US dollar settings. Further, immediately after June 30, 2023, LIBOR in the case of the remaining US dollar settings will cease. The Fund currently utilizes LIBOR reference rates of 1-Month and 3-Months based on contractual terms of the Fund’s debt facility and derivative instruments, which we anticipate will continue to be actively quoted through June 30, 2023. Due to the limited use of LIBOR as a reference rate in the Fund’s business operations, Management believes the impact from the change to an alternative reference rate on the Fund’s results of operations, would potentially be limited to interest expense related to its
12


borrowings under the Fund’s debt facility and mark-to-market gains(losses) related to the Fund’s derivative instruments. There is uncertainty regarding what interest rate benchmark(s) will replace LIBOR in the debt capital markets, and the effect of a transition away from LIBOR on the Fund or the financial instruments in which the Fund invests cannot yet be fully determined. Management continues to evaluate the Fund’s LIBOR exposure risks, including but not limited to the potential impact on the cost of credit, the Fund’s derivative instruments, the Fund’s holdings, and the extent to which the Fund’s debt investment instruments allow for the utilization of alternative rate(s) in the absence of LIBOR.

INVESTMENT RISKS

International Investments. The Fund could invest up to, but not more than, 30% of its total assets in foreign based companies. Foreign investments are subject to most of the same risks as domestic investments, as well as the political, economic and other uncertainties associated with foreign activities, including the risk of war and political unrest, political conflict (including between the U.S. and China), the impact of laws and policies of foreign governments and the United States affecting foreign investment, and the possibility of being subject to the jurisdiction of foreign courts in connection with legal disputes or the inability to subject foreign persons to the jurisdiction of courts in the United States. Furthermore, there may be practical and local law impediments to cost-effective recovery against collateral located in a foreign country. Moreover, it is possible that taxes may be required to be withheld by the foreign company on dividend and interest payments received by the Fund with respect to such foreign investments. Although capital gains derived by the Fund with respect to such investments in such foreign company may often be exempt from non-U.S. income or withholding taxes, the treatment of capital gains varies among jurisdictions. If the income from such foreign investments is subject to non-U.S. income or withholding taxes, the Fund will attempt to negotiate offsetting gross-up payments from the foreign-based company. No assurances, however, can be given that the Fund would be able to negotiate such offsetting payments. Following Russia’s invasion of Ukraine in February 2022, the U.S., the European Union (“E.U.”) and its member states, and other countries announced and implemented major sanctions against Russia. The U.S., E.U. nations and other countries could impose wider sanctions and take other actions as the conflict continues. It is difficult to anticipate the long-term impact on the Fund of war in Ukraine, sanctions, and any retaliatory measures by Russia in response. However, any or all of these may cause significant turmoil in the global markets, including domestic and global credit markets and market liquidity, impact the domestic and global economy, further disrupt supply chains, increase the risk of inflation, limit the ability of the Fund to invest in companies impacted by the sanctions, or negatively impact the operations of portfolio companies, which could in turn have a material adverse impact on the Fund.


Foreign Currency &and Exchange Rate Risks. Fund assets and income may be denominated in various currencies. Contributions and distributions, however, will be denominated in U.S. dollars. As a result, the return of the Fund on any investment may be adversely affected by fluctuations in currency exchange rates, any future imposed devaluations of local currencies, inflationary pressures, and the success of the investment itself. In addition, the Fund may incur costs related to conversions between various currencies. As of December 31, 2021, all Fund assets and income, as well as contributions and distributions, are denominated in U.S. dollars.
Accounting &and Disclosure Standards. Accounting, auditing, financial, and other reporting standards, practices, and disclosure requirements in countries in which the Fund may invest are not necessarily equivalent to those required under United States Generally Accepted Accounting Principles in the United States (“U.S. GAAP”). Accordingly, less information may be available to investors.
Credit Risks. Most of the companies with which the Fund will enter into financing transactions will not have achieved profitability, may experience substantial fluctuations in their operating results or, in many cases, will not have significant operating revenues. The ability of any borrower to meet its obligations to the Fund, therefore, will depend to a significant extent on the willingness of such borrower’s venture capital equity investors or outside investors to provide additional equity financing, which in turn will depend on the borrower’s success in meeting its business plan, the market climate for venture capital investments generally, among other factors. The companies to which the Fund will provide financing will frequently be engaged in the development of new products or technologies, and the success of these efforts, or the ability of the companies to successfully manufacture or market products or technologies developed, cannot be assured. These companies frequently face intense competition, including competition from companies with greater resources, and may face risks of product or technological obsolescence, non-acceptance in the market, or rapidly changing regulatory environments, any of which could adversely affect their prospects. The success of such companies often depends on the management talents and efforts of one person or a small group of persons whose death, disability, resignation or other form of departure would adversely affect the company.
Remedies Upon Default.Default. In the event of a default on a portfolio loan, the available remedies to the Fund would include legal action against the borrower and foreclosure or repossession of collateral given by the borrower. However, the Fund could experience significant delays in exercising its rights as a secured lender and might incur substantial costs in taking possession of and liquidating its collateral and in taking other steps to protect its investment. The Fund generally will require that it have a first priority security interest in any equipment of a borrower financed with the proceeds of the Fund’s loans, although that security interest may extend to the borrower’s other assets in which another lender might have a senior or parity security interest. It is anticipated that the Fund will make loans to a borrower that has one or more other secured lenders. In such circumstances, the Fund may share all or a portion of its collateral with the other lender(s) and will enter into intercreditor agreements governing the respective rights of the Fund and such other lender(s), which could limit the Fund’s flexibility in pursuing its remedies as a secured creditor, and reduce the proceeds realized from foreclosing or taking possession of the collateral. In the case of growth capital or working capital loans (where the loan proceeds can be used by the company for general corporate purposes), the Fund will typically receive either a broader lien on substantially all of the borrower’s assets, including its intellectual property, or a lien on substantially all of the borrower’s assets, excluding intellectual property, and a negative pledge on such intellectual property.
As noted above, the Fund may utilize certain of its funds in investments that involve the financing of equipment assets. Equipment assets are often subject to rapid depreciation or obsolescence such that it is likely that the value of the assets underlying a loan to finance such assets will depreciate during the term of the loan transaction below the amount of the borrower’s obligations. In addition, although borrowers will be required under the transaction documents to provide customary insurance for the assets underlying a loan and will be prohibited from
13


disposing of the assets without the Fund’s consent, compliance with these covenants cannot be assured and, in the event of non‑compliance, the assets could become unavailable to the Fund due to destruction, theft, sale or other circumstances. Realization of value from intellectual property collateral can also be time consuming and present special challenges, given the often uniqueoften-unique nature and limited market for such assets. The Fund’s ability to obtain payment beyond the collateral underlying the loan from the borrower might be limited by bankruptcy or similar laws affecting creditors’ rights. In limited instances where the Fund takes security interests in a borrower’s assets located in a foreign country, there may be practical and local law impediments to cost-effective recovery against such collateral. Therefore, there can be no assurance that the Fund would ultimately collect the full amount owed on a defaulted loan.
Emerging Company Risks.Risks. The possibility that the companies in which the Fund invests will not be able to commercialize their technology or product concept presents significant risk. Additionally, although some of such companies may already have a commercially successful product or product line at the time of investment, technology products and services often have a more limited market or life span than products in other industries. Thus, the ultimate success of these companies may depend on their ability to continually innovate in increasingly competitive markets. Most of the companies in which the Fund invests will require substantial additional equity financing to satisfy their continuing growth and working capital requirements. Each round of venture financing is typically intended to provide a company with enough capital to reach the next stage of development. The circumstances or market conditions under which such companies will seek additional capital is unpredictable. It is possible that certain companies will not be able to raise additional financing or may be able to do so only at a price or on terms which are unfavorable to the Fund.
Privately-heldPrivately-Held Company Risks. The Fund invests primarily in privately-held companies. Generally, very little public information exists about these companies and the Fund will beis required to rely on the ability of the Manager to obtain adequate information to evaluate the potential returns from investing in these companies. Moreover, these companies typically depend upon the management talents and efforts of a small group of individuals and the loss of one or more of these individuals could have a significant impact on the investment returns from a particular company. Also, these companies frequently have less diverse product lines and smaller market presence than larger companies. They are thus generally more vulnerable to economic downturns and may experience substantial variations in operating results.
Due Diligence Risks. Before making investments, the Manager conducts a limited amount of due diligence that it deems reasonable and appropriate based on the facts and circumstances applicable to each investment. When conducting due diligence and making an assessment regarding an investment, the Manager will be required to rely on resources available to it, including information provided by


the target of the investment and, in some circumstances, third party investigations. The due diligence process may at times be subjective with respect to newly organized companies for which only limited information is available. Accordingly, there can be no assurance that the due diligence investigation that the Manager will carry out with respect to any investment opportunity will reveal or highlight all relevant facts that may be necessary or helpful in evaluating such investment opportunity. Further, there can be no assurance that such an investigation will result in an investment being successful.
Financial Market Risk.Risk. The ability of the Fund to provide an acceptable return may be adversely affected by economic factors to which the market place is subject. Additionally, market turmoil could have a deleterious effect on the Company’s investors which could impede the ability to provide capital to the Fund. This could impair the Fund’s ability to honor commitments to lend, pay expenses of the Fund, or repay the Fund’s loans. The volatility in the global financial markets, which reached unprecedented levels during 2008 and 2009, and continued for some period thereafter (albeit to a lesser extent), may recur in the future. This and other types of market turmoil could have a material adverse effect on the Fund’s business and operations. The tightening of the credit markets could impair the Fund’s ability to either acquire or utilize leverage to maximize the return it achieves on investments. The Fund’s predecessors (Venture Lending & Leasing I, Inc., Venture Lending & Leasing II, Inc., Venture Lending & Leasing III, Inc., Venture Lending & Leasing IV, Inc., Venture Lending & Leasing VI, Inc., Venture Lending & Leasing VII, Inc., and Venture Lending & Leasing VIII, Inc., and to a lesser extent, Venture Lending & Leasing V, Inc.), utilized leverage to increase returns to investors. If the Fund is unable to utilize leverage to the same extent as its predecessors, or unable to utilize leverage at all, there could be a material difference in the Fund’s return as compared to these funds.
It is possible that market conditions could decrease the demand for venture loans, especially where the U.S. and global economic conditions deteriorated and remained weak for an extended period of time. Furthermore, market conditions could also adversely impact either or both the ability of the Fund’s borrowers to meet their obligations to the Fund and the value of the Fund’s direct investments in companies. Most of the companies in which the Fund will invest will not have achieved profitability and will require substantial equity financing to satisfy their continuing growth and working capital requirements. An economic downturn could decrease the demand for such borrower’s products and technology, thereby impairing such borrower’s financial condition and its ability to raise additional equity financing from outside investors. Should these events occur, there could be an increase in borrower defaults under their obligations to the Fund, or a decrease in the value of the Fund’s direct equity investments.

Additionally, the Federal Reserve may raise, or may announce its intention to raise, the Federal Funds Rate in 2022. These developments, along with the United States government’s credit and deficit concerns, global economic uncertainties and market volatility and the impacts of COVID-19, could cause interest rates to be volatile, which may negatively impact the Fund's ability to access the debt markets and capital markets on favorable terms.
Other U.S. and Global Economic Risks. In addition to the crisis in the financial markets discussed above, the ability of the Fund to provide an acceptable return may be adversely affected by other economic and business factors to which the U.S. market place is subject. These factors, which generally are beyond the control of the Manager, include: general economic conditions, such as inflation and fluctuations in general business conditions; the impact of terrorist attacks within or against the United States or other countries where investments are made; the effects of strikes, labor disputes and domestic and foreign political unrest; and uncertainty in the U.S. economy.
14

Changes to U.S. trade policy may have a negative effect on the global economy and/or
Inflation.Certain of the Fund’s portfolio companies are in industries that may be impacted by inflation. If such portfolio companies are unable to pass any increases in their costs of operations along to their customers, it could adversely affect their operating results and impact their ability to pay interest and principal on the Fund’s loans. In addition, any projected future decreases in the Fund’s portfolio companies’ operating results due to inflation could adversely impact the fair value of those investments. Any decreases in the fair value of the Fund’s investments could result in future realized or unrealized losses and therefore reduce the Fund’s net assets resulting from operations.    
Changes to U.S. Trade Policy May Have a Negative Effect on the Global Economy and/or the Fund’s Portfolio Companies and, in turn, harmTurn, Harm the Fund. Significant changes to U.S. trade policy, including changes to current legislation and trade agreements and the imposition of tariffs have been discussed by the current U.S. presidential administration and certain members of Congress. Recently, the administration has imposed tariffs on a range of goods imported into the U.S., and a few countries have retaliated with tariffs against the United States. These retaliatory actions could trigger extended “trade wars” between the U.S. and its trading partners, resulting in additional barriers to the international market, inclusive of customers, vendors, and potential investors. Under these circumstances, the cost of goods for some portfolio companies could increase, resulting in lower consumer demand for their goods and reduced cash flows. While it is unknown whether and to what extent new legislation will be enacted into law, the enactment or amendment of trade legislation and/or renegotiation of trade agreements may impose additional compliance costs on portfolio companies, restrict their ability to participate in international markets and otherwise disrupt their current operations.
Special risk considerations relatingRisk Considerations Relating to China.China. The Fund may invest in portfolio companies that are based in China, have significant operations in China or are otherwise connected to China. Markets in China can be volatile due to uncertain social, economic, regulatory and political factors.factors, in addition to the effects of public health crises, such as the recent outbreak of coronavirus emanating from China. See the discussion herein under the caption “Climate Change, Natural Disaster and Public Health Crises Risk.” The severity and duration of any adverse economic conditions may be driven by governmental or quasi-governmental policies; in particular the imposition of sanctions by outside governments could severely disrupt the Chinese economy and the value of securities tied to it. For example, Fund portfolio companies may be significantly impacted by trade disputes between the United States and China involving U.S.-imposed tariffs. Among other things, such disputes could prompt a portfolio company to reduce operations in China and/or suffer of downward pricing pressure. Additionally, a portfolio company that relies on Chinese investors could experience challenges in securing additional capital investments. These factors could be exacerbated as a result of negotiations between the United States and China to resolve the trade disputes.
Speculative Nature of Warrants and Equity Investments.Investments. The value of the warrants that the Fund generally will receive and distribute to its shareholder in connection with its financing investments is dependent on the value of the equity securities for which the warrants can be exercised. The value of such warrants, direct equity investments, and equities received upon conversion of debt instruments is dependent primarily on the success of the company’s business strategy and the growth of its earnings, but also depends on general economic and equity market conditions. The prospects for achieving consistent profitability, in the case of many companies in which the Fund invests, are speculative. The warrants, equity securities for which the warrants can be exercised, direct equity investments, and equities received upon conversion of debt instruments generally will be restricted securities that cannot readily be sold for some period of time. If the value of the equity securities underlying a warrant does not increase above the exercise price during the life of the warrant, the Fund may permit the warrant to expire unexercised and the warrant would then have no value.
Illiquidity of Investments.Investments. Substantially all of the Fund’s portfolio investments (other than short-term investments) will consist of securities that, at the time of acquisition, are subject to restrictions on sale and for which no ready market will exist. Restricted securities


cannot be sold publicly without prior agreement with the issuer to register the securities under the 1933 Act, or by selling such securities under Rule 144 or other provisions of the 1933 Act which permit only limited sales under specified conditions. Venture loans and equity investments are privately negotiated transactions, and there is no established trading market in which such loans and equity investments can be sold. Special Situation Financings may also be privately negotiated transactions. In the case of warrants or equity securities, the Fund generally will realize the value of such securities only if the issuer is able to make an initial public offering of its shares or enters into a business combination with another company which purchases the Fund’s warrants or equity securities or exchanges them for publicly-traded securities of the acquirer. The feasibility of such transactions depends upon the entity’s financial results as well as general economic and equity market conditions. In the past, crises in the financial markets have dramatically reduced the volume of initial public offerings and mergers and acquisitions in the market place. If such a crisis recurs, the Fund’s ability to realize liquidity through its investments would likely be impaired. Furthermore, even if the restricted warrants or equity securities owned become publicly-traded, the Fund’s ability to sell such securities may be limited by the lack (or limited nature) of a trading market for such securities. If the Fund holds material nonpublic information regarding the issuer of the securities, the Fund’s ability to sell such securities may also be limited by insider trading laws. When restricted securities are sold to the public, the Fund, under certain circumstances, may be deemed an “underwriter” or a controlling person with respect thereto for the purposes of the 1933 Act, and be subject to liabilities as such under that Act.
Because of the illiquidity of the Fund’s investments, most of its assets will be carried at fair value as determined by the Manager in accordance with the Fund’s policy, as approved by the Fund’s Board of Directors. This value will not necessarily reflect the amount ultimately realized upon a sale of the assets.

Non-Diversified Status.Status. The Fund is classified as a “non-diversified” investment company under the 1940 Act, but the Fund may, from time to time, act as a diversified investment company within the meaning of Section 5(b)(1) of the 1940 Act. The Fund intendselected to qualifybe treated as a RIC under the Code and will thereafter seekoperates in a manner to continually meetqualify for the tax treatment applicable to RICs, including the diversification standards thereunder.requirement. Nevertheless, the Fund’s assets may be subject to a greater risk of loss than if its investments were more widely diversified.

Foreign Investment Review. Pursuant to Section 721 of the Defense Production Act of 1950, as amended (the “DPA”), the U.S. Government has the authority to restrict and prevent foreign acquisitions of and investments in U.S. companies (collectively, “Foreign Investments”) on national security grounds, actions that could adversely affect the Company’s and the Fund’s investment activities. The Committee on Foreign Investment in the United States (“CFIUS”), a U.S. Government interagency committee, conducts national security
15


reviews of Foreign Investments and, in the interest of national security, may impose mitigation (i.e., restrictions) on such investments. CFIUS-imposed mitigation can take a variety of forms, including (i) restrictions on the foreign investor’s access to the U.S. company’s technology or facilities, (ii) restrictions on the foreign investor’s role in the governance or decision making of the U.S. company, (iii) mandatory divestiture of a foreign investor’s capital contribution and termination of its participation in the Company, (iv) mandatory U.S. Government approvals of changes to the U.S. company’s suppliers or the locations of its source code repositories, and (v) the appointment of a U.S. Government-approved monitor to verify the transaction parties’ compliance with the mitigation. The President of the United States (the “President”) may block a Foreign Investment that threatens to impair U.S. national security or order a foreign investor to divest of its Foreign Investment.

If the Fund has foreign investors, its investments are potentially subject to CFIUS review. In addition, foreign investors’ indirect investments in portfolio companies could subject such companies to CFIUS review. Finally, subsequent proposed financings, investments, acquisitions, or mergers or other transactions related to portfolio companies involving foreign persons also could be subject to CFIUS review.

Parties to transactions within CFIUS’s jurisdiction, potentially including the Company, the Fund and portfolio companies, may choose to submit a voluntary declaration or notice to CFIUS for its review. Rules implementing the Foreign Investment Risk Review Modernization Act (“FIRRMA”) of 2018 revised the CFIUS process to (i) expand CFIUS’s jurisdiction—notably to certain non-controlling investments in U.S. companies that are involved in critical technologies or critical infrastructure or that hold sensitive personal data of U.S. citizens—and (ii) mandate filings in certain instances. Specifically, mandatory filings may be required when a foreign investor acquires certain rights with respect to a U.S. business that deals in critical technology, or when a foreign government has a substantial interest in the foreign investor. Some of the Company’s and the Fund’s investments could fall within this expanded jurisdiction.

Due to these CFIUS considerations, the Company, the Fund and portfolio companies could incur increased costs, including legal fees, related to (i) evaluating whether a particular portfolio investment or other transaction related to a portfolio company requires the submission of a filing to CFIUS, (ii) evaluating whether the submission of a declaration or notice to CFIUS is warranted, (iii) drafting a filing and submitting it to CFIUS, (iv) undergoing a CFIUS review or investigation, (v) negotiating and implementing CFIUS-imposed mitigation, and (vi) complying with any Presidential order. Submission of a filing to CFIUS in connection with an investment or other transaction related to a portfolio company also could result in significant delays, as the CFIUS review and investigation process can last several months. CFIUS could condition its clearance of a Foreign Investment on adjustments to the terms of such Foreign Investment or other mitigation (including, if applicable, exclusion of a foreign investor of the Company from a Foreign Investment), and these conditions could adversely affect one or more portfolio companies and decrease the Company’s and the Fund’s return on its investment in any such portfolio company. In rare cases, the President could block a Foreign Investment or order the Company and the Fund to divest of a Foreign Investment. Finally, the Company and the Fund may choose not to make certain investments, or a portfolio company may choose not to solicit or pursue certain subsequent investments or other transactions, that are otherwise attractive based on an evaluation of the associated CFIUS risks.

CONFLICTS OF INTEREST

Transactions with Venture Lending & Leasing VIII, Inc. (“Fund VIII’VIII”) and Other Funds.. The Manager also serves as the investment manager for Fund VIII. The Fund'sFund’s Board of Directors determined that so long as Fund VIII has capital available to invest in loan transactions with final maturities earlier than December 31, 2025 (the date on which Fund VIII will be dissolved), the Fund may invest in each portfolio company in which Fund VIII invests (“Investments”). Generally, the amount of each Investment will be allocated 50% to the Fund and 50% to Fund VIII, or such other allocations as may be determined by the respective fund boards.boards, so long as the Fund has capital available to invest. The ability of the Fund to co-invest with Fund VIII, and other clients advised by the Manager, is subject to the conditions (“Conditions”) set forth inwith which the Funds are currently complying while seeking certain exemptive relief currently being sought by the Fund from the SEC from the provisions of Sections 17(d) and 57 of the 1940 Act and Rule 17d-1 thereunder. After June 30, 2022, the Fund will no longer be permitted to enter into new commitments to borrowers; however, the Fund will be permitted to fund existing commitments. Thecommitments, in which Fund VIII may also be invested. In August 2019, the Manager is permittedexercised, and the Board of Directors ratified, its discretion to extend the Fund'sFund VIII's investment period by upfor two additional quarters after September 30, 2020, thereby allowing Fund VIII to two (2) additional calendar quarters in its solemake new commitments through March 31, 2020 and absolute discretion.
to fund commitments through March 31, 2021, the end of Fund VIII's investment period. To the extent that clients, other than Fund VIII, advised by the Manager (but in which the Manager has no proprietary interest) invest in opportunities available to the Fund, the Manager will allocate such opportunities among the Fund and such other clients in a manner deemed fair and equitable considering all of the circumstances in accordance with the Conditions.
Transactions with WTI Fund X, Inc. (“Fund X”). The Manager also serves as the investment manager for Fund X. The Fund’s Board of Directors determined that so long as Fund X has capital available to invest in loan transactions with final maturities earlier than December 31, 2031 (the date on which Fund X will be dissolved), the Fund may invest in each portfolio company in which Fund X invests. Generally, the amount of each Investment will be allocated 50% to the Fund and 50% to Fund X, or such other allocations as may be determined by the respective fund boards, so long as the Fund has capital available to invest. The ability of the Fund to co-invest with Fund X, and other clients advised by the Manager, is subject to the Conditions described above. After June 30, 2022, the Fund will no longer be permitted to enter into new commitments to borrowers; however, the Fund will be permitted to fund existing commitments, in which Fund X may also be invested. The Manager is permitted to extend the Fund's investment period by up to two (2) additional calendar quarters in its sole and absolute discretion.To the extent that clients, other than Fund X, advised by the Manager (but in which the Manager has no proprietary interest) invest in opportunities available to the Fund, the Manager will allocate such opportunities among the Fund and such other clients in a manner deemed fair and equitable considering all of the circumstances in accordance with the Conditions.

16


Intercreditor Agreements. In all transactions in which the Fund and Fund VIIIother funds managed by the Manager invest or those in which another lender(s) has either invested or may later invest (or in the event a successor fund is raised, in which the Fund and the successor fund invest), it is expected that the Fund Fund VIIIand, other funds managed by the Manager (or the successor fund as the case may be), and/or the other lender(s) will enter into an intercreditor agreement pursuant to which the Fund Fund VIIIand, other funds managed by the Manager (or the successor fund), and/or the other lender(s), along with any predecessor funds which still have a balance outstanding, will cooperate in pursuing their remedies following a default by the common borrower. Generally, under such intercreditor agreements, each party would agree that its security interest would be treated in parity with the security interest of the other party, regardless of which security interest would have priority under applicable law. Accordingly, proceeds realized from the sale of any collateral or the exercise of any other creditor’s rights will be allocated between the Fund Fund VIIIand, other funds managed by the Manager, and any predecessor funds as described above, pro rata in accordance with the amounts of their respective investments. An exception to the foregoing arrangement would occur in situations where, for example, one of the lenders financed specific items of equipment collateral; in that case, usually the lender who financed the specific assets will have a senior lien on that asset, and the other lenders will have a junior priority lien (even though they may ratably share liens of equal priority on other assets of the common borrower).

As a result of such intercreditor agreements, the Fund may have less flexibility in pursuing its remedies following a default than it would have had had there been no intercreditor agreement, and the Fund may realize fewer proceeds. In addition, because the Fund and Fund VIIIother funds managed by the Manager (or the successor fund) invest at the same time in the same borrower, such borrower would be required to service two loans rather than one. Any additional administrative costs or burdens resulting therefrom may make the Fund a less attractive lender and may make it more difficult for the Fund to acquire such loans.

Valuation. The Manager is responsible for valuing the Fund’s assets and liabilities, subject to oversight by the Fund’s Board of Directors, and has an inherent conflict in performing this function such that it has an incentive to increase the value of the assets for its performance record. The Fund does not intend to engage an independent valuation agent to value its assets and therefore is entirely reliant upon the Manager and its delegates for valuing the assets.


Indemnification and Exculpation. The organizational documents of the Fund provide for indemnification of directors, officers, employees, advisory board members and agents (including the Manager) of the Fund, generally to the full extent permitted by applicable state law and the 1940 Act, including the advance of expenses and reasonable counsel fees. The charter of the Fund also contains a provision eliminating personal liability of a Fund director or officer to the Fund or its stockholder for money damages, subject to specified exceptions. In addition, the Fund has entered into an indemnification with its directors and officers. A successful claim for such indemnification, including payment of any expenses and counsel fees, would reduce the Fund’s assets by the amounts paid. Furthermore, Fund assets are used to obtain insurance policies that generally protect the Fund’s directors and officers from personal liability of actions taken in their roles as the Fund’s directors and officers.
Disinterested Directors and Advisory Board Members. The members of the Fund’s Board of Directors will overlap with the members of the Company’s advisory board, and the members of the Company’s advisory board are generally the same as, or a subset of, the disinterested directors of the Fund. Although the Manager expects that, given the Company’s 100% ownership of the Fund, the interests of the two entities will not diverge, it is conceivable that a conflict of interest could exist between the Fund and the Company. In addition, as compensation for services, the disinterested directors will receive an annual fee of $20,000$30,000 (plus $1,000 per meeting attended in person and an additional $10,000 for the chair of the Audit Committee). Effective December 5, 2018, the annual fee was increased to $30,000 and the compensation for the chair of the Audit Committee was increased to $10,000 and was pro-rated for the remainder of 2018. Any future changes to the compensation to be paid to the disinterested directors will be determined by the Nominating and Corporate Governance Committee of the Fund’s Board of Directors. Upon the liquidation of the Fund, the disinterested advisory board members will receive an annual fee in an amount determined by the Member (it is currently anticipated that such annual amount shall be $10,000)$15,000). The disinterested directors and advisory board members will also be reimbursed for certain expenses. The payment of such fees may limit the objectivity and independence of the disinterested directors and the advisory board members on behalf of the Members.members.
Personal Trading. The Manager has a code of ethics that contains personal securities trading procedures that apply to its “access persons.” Access persons are required to report if they have an investment in a company in which the Fund is considering making an investment. Pre-approval is required before an access person may buy or sell securities in an initial public offering, private placement, or any security listed on a “restricted list” maintained by the Manager.
Interests in Potential Portfolio Companies. The Manager may recommend that the Fund invest in companies in which a principal or employee has a prior personal investment or for which a principal or employee may serve as a director or advisor. The Manager also may recommend that the Fund invest in companies in which venture capital funds, private equity funds or other institutional investors (“Unaffiliated Funds”) also have made investments, where one or more principals or employees of the Manager may have made an investment in, or served as an advisor to, an investing Unaffiliated Fund. Such a relationship presents potential conflicts of interest by providing the principal or employee with an incentive to influence the Manager’s decision to recommend an investment in the company in question. There is also a potential conflict of interest in that such principal or employee could use information acquired through association with the Manager to influence or benefit Unaffiliated Funds’ investment decisions. The Manager addresses these potential conflicts through its policies and procedures that are designed to insulate its investment decision-making process and its research from these incentives. For example, the policies require that principals with a prior direct investment in a company be recused from the investment decision-making process with respect to that company.
Principals that serve as advisors to Unaffiliated Funds may make investment recommendations to these funds,Unaffiliated Funds, which may be the same investment that the Fund (or a Prior Debt Fund Entity) has made or may make. The Manager’s policies and procedures require such principals to arrange for any such investment opportunity to be first offered to the Fund (or a Prior Debt Fund Entity),predecessor fund) and for such investment opportunity to only subsequently be offered to thean Unaffiliated Fund once declined by the Fund (or a Prior Debt Fund Entity)predecessor fund).
17


ITEM 1B.      
UNRESOLVED STAFF COMMENTS.
Not applicable.
ITEM 2.
ITEM 2.    PROPERTIES.
All of the Fund’s office space is provided by the Manager. The executive offices are located at 104 La Mesa Drive, Suite 102, Portola Valley, CA 94028.
ITEM 3.
LEGAL PROCEEDINGS.
ITEM 3.    LEGAL PROCEEDINGS
The Fund may become party to certain lawsuits from time to time in the normal course of business. While the outcome of any legal proceedings cannot now be predicted with certainty, the Fund does not expect any such proceedings will have a material effect upon the Fund's financial condition or results of operation. Management is not aware of any pending legal proceedings involving the Fund. The Fund is not a party to any material legal proceedings.
ITEM 4.MINE SAFETY DISCLOSURES.
ITEM 4.    MINE SAFETY DISCLOSURES
Not applicable.

18


PART II.
ITEM 5.

ITEM 5.        MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER
        PURCHASES OF EQUITY SECURITIES.
The Fund’s common stock is not listed on any securities exchange, and all holders of the Fund’s common stock are subject to agreements significantly restricting the transferability of their shares.
The number of holders of record of the Fund’s common stock at March 14, 20192022 was 1.
The Fund has a policy of distributing securities as acquired. The Fund values these securities at fair value at the time of acquisition in accordance with the Fund’s policy on valuation detailed in Note 2 to the financial statements included in this filing. In addition, some expenses of the Company may be paid by the Fund and will be deemed as distributions to the Company. The Fund has established a policy of declaring dividends on a quarterly basis to the extent that taxable income of the Fund, less applicable reserves, exceeds warrant distributions and deemed distributions. As of December 31, 2018,2021, the Fund had distributed $7.3$209.1 million to date to its sole shareholder, none of which were$137.5 million was in cash.

ITEM 6.        SELECTED FINANCIAL DATA.[RESERVED]
The following table summarizes certain financial data and should be read in conjunction with the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the financial statements and notes thereto included elsewhere in this Form 10-K. The selected financial data set forth below have been derived from the audited financial statements.
 For the Year Ended December 31, 2018 For the Period Ended December 31, 2017*
Statements of Operations Data:   
Investment income:   
Interest on loans$4,292,189
 $
Other interest and other income152,248
 
Total investment income4,444,437
 
Expenses:   
Management fees4,833,308
 
Organizational costs27,654
 184,165
Interest expense72,360
 
Banking and professional fees360,208
 
Other operating expenses115,034
 
Total expenses5,408,564
 184,165
Net investment loss(964,127) (184,165)
Net decrease in net assets resulting from operations$(964,127) $(184,165)
    
AMOUNTS PER COMMON SHARE:   
Net decrease in net assets resulting from operations$(9.64) $(1.84)
Weighted Average Shares Outstanding100,000
 100,000
    
    
 As of December 31,
 2018 2017*
Statements of Assets and Liabilities Data:   
Loans$79,045,107
 $
Net assets$74,088,727
 $(159,165)
*From June 28, 2017, sale of capital stock, through December 31, 2017. The Fund had not yet commenced investment operations.


ITEM 7.         MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
OPERATIONS

The following discussion should be read in connection with our Financial Statements and the notes thereto included elsewhere in this Annual Report on Form 10-K.

In addition to the historical information contained herein, the information in this Annual Report on Form 10-K contains certain “forward-looking statements” within the meaning of the securities laws. These forward-looking statements reflect the current view of the Fund with respect to future events and financial performance and are subject to several risks and uncertainties, many of which are beyond the Fund’s control. All statements, other than statements of historical facts included in this Annual Report, regarding the strategy, future operations, financial position, estimated revenues, projected costs, prospects, plans and objectives of the Fund are forward-looking statements. For example, statements in this Form 10-K regarding the potential future impact of the COVID-19 pandemic on the Fund’s business and results of operations are forward-looking statements. When used in this report, the words “will,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “project” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. All forward-looking statements speak only as of the date of this report. The Fund does not undertake any obligation to update or revise publicly any forward-looking statements, whether resulting from new information, future events or otherwise, except as required by law.

    The reader of this Annual Report should understand that all such forward-looking statements are subject to various uncertainties and risks that could affect their outcome. The Fund’s actual results could differ materially from those suggested by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, variances in the actual versus projected growth in assets, return on assets, loan losses, expenses, rates charged on loans and earned on securities investments, competition and macro-economic changes including inflation, interest rate expectations, among other factors including those set forth in Item 1A - “Risk Factors” in this Annual Report on Form 10-K. This entire Annual Report should be read to put such forward-looking statements in context and to gain a more complete understanding of the uncertainties and risks involved in the Fund’s business.
Overview

The Fund is 100% owned by the Company. The Fund’s shares of common stock, at $0.001 par value, were sold to its sole shareholder, the Company, under a stock purchase agreement. The Fund has issued 100,000 of the Fund’s 10,000,000 authorized shares. The Company may make additional capital contributions to the Fund.
The Fund provides financing and advisory services to a variety of carefully selected Venture-Backed Companies primarily throughout the United States, with a focus on growth-oriented companies. The Fund’s portfolio will consistconsists of companies in the communications, information services, media, and technology including(including software and technology-enabled business services, bio-technology,services), biotechnology, and medical devices industry sectors, among others. The Fund’s capital is generally used by its portfolio companies to finance acquisitions of fixed assets and working capital. On May 1, 2018, the Company called and received its first capital from investors. On May 2, 2018, the Fund made its first investment and became a non-diversified, closed-end investment company under the 1940 Act. While the Fund intends to operate as a non-diversified investment company within the meaning of Section 5(b)(2) of the 1940 Act, the Fund may, from time to time, the Fund may act as a diversified investment company withwithin the meaning of Section 5(b)(1) of the 1940 Act.
19


The Fund expects to eventually electelected to be treated as a RIC under the Code for federal income tax purposes. Pursuant to this election, the Fund generally will not have to pay corporate-level taxes on any income it distributesdistributed to the Companyits shareholder as dividends, allowing the Company to substantially reduce or eliminate its corporate-level tax liability.

The Fund will seek to meet the ongoing requirements, including the diversification requirements, to qualify as a RIC under the Code. If the Fund fails to meet these requirements, it will be taxed as an ordinary corporation on its taxable income for that year (even if that income is distributed to the members of the Company) and all distributions out of its earnings and profits will be taxable to the Membersmembers of the Company as ordinary income; thus, such income will be subject to a double layer of tax. There is no assurance that the Fund will meet the ongoing requirements to qualify as a RIC for tax purposes.

The Fund’s investment objective is to achieve superior risk adjustedrisk-adjusted investment returns and it seeks to achieve that objective by providing debt financing to Venture-Backed Companies. The Fund’s investing activities have focused primarily on private debt securities.portfolio companies, most of which are private. The Fund generally receivereceives warrants to acquire equity securities in connection with its portfolio investments. The Fundinvestments and generally distributedistributes these warrants to its shareholder upon receipt, or soon thereafter. The Fund also has guidelines for the percentages of total assets which will bethat are invested in different types of assets.

The portfolio investments of the Fund will primarily consist of debt financing to Venture-Backed Companies in the technology sector. The borrowers’borrower’s ability to repay theirits loans may be adversely impacted by several factors, and as a result, the loan may not be fully be repaid. Furthermore, the Fund’s security interest in any collateral over borrowers’the borrower’s assets may be insufficient to make up any shortfall in payments.
Some of our portfolio companies may be impacted by rising inflation, which could have a material impact in their results of operations, specifically cost and revenues. As such, rising inflation may have an adverse impact on the portfolio borrowers’ ability to maintain their good credit standing, as well as their ability to pay their interest and principal obligations to the Fund. In addition, any projected future decreases in our portfolio companies’ operating results due to inflation could adversely impact the fair value of those investments. Any decreases in the fair value of our investments could result in future unrealized losses and therefore reduce our net assets resulting from operations.

The Fund’s investment income is also expected to decline following the end of the Fund's commitment period which is on June 30, 2022. After the commitment period, the Fund may no longer make loan commitments to reinvest the proceeds of matured investments in new loans. Any proceeds will be distributed to the Company. The investment period may be extended by up to two calendar quarters at the discretion of the Manager.

COVID-19’s Impact on Results of Operations and Liquidity & Capital Resources

The effects of the COVID-19 pandemic and the related actions by governments around the world to attempt to contain the spread of the virus had an impact on a number of the Fund’s portfolio companies’ business and operations. Through December 31, 2021, as a result of an improved economic outlook and the continuing market stability, in addition to the recovering local and global economies, the Fund made valuation adjustments which reflected an improvement in certain portfolio companies' performance. For the year ended December 31, 2021, the Fund recognized lower unrealized loss from loans compared to the same period in 2020.

Although markets are continuing to stabilize and recover, uncertainty remains regarding the full extent of the long-term economic impact on the Fund’s business operations, results of operations, and access to liquidity and capital resources. The impact on the Fund will depend on many factors beyond the Fund’s control, including, without limitations, (i) the timing, extent, trajectory, and duration of the pandemic (ii) the restrictions and advisories put in place to combat the pandemic, (iii) the effects of the pandemic and measures to combat the pandemic on the financial markets, and (iv) the impact on the economy overall, all of which are highly uncertain and cannot be predicted. In addition, the impact on local economies is uncertain and the speed of economic recovery may vary across different industries both locally and globally. The Fund is continuing to maintain close communications with its loan portfolio companies to proactively assess and manage potential risks. In addition, Management is continuing to maintain oversight analysis of credits across the Fund's loan investment portfolio in an attempt to manage the potential credit risk and improve loan performance.

Management is also monitoring the Fund’s continued access to capital resources through periodic and timely communication with the bank syndicate and the Company’s members. The Fund believes its existing cash balance, scheduled monthly payments from borrowers, and access to capital from its debt facility and the Company’s members will be sufficient to satisfy its working capital needs, debt repayments, and other liquidity requirements associated with its existing operations.
Critical Accounting Policies, Practices and Estimates
Critical accounting policiesAccounting Policies and practicesPractices are those accounting policies and practices that are both the most important to the portrayal of the Fund’s net assets and results of operations and require the most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Critical accounting estimates are accounting estimates where the nature of the estimates is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change and the impact of the estimates of the on net assets or operating performance is material.

In evaluating the most critical accounting policies and estimates, the Manager has identified the estimation of fair value of the Fund’s loan investments along with the completeness of loans exhibiting indicators of potential credit deterioration as the most critical of the accounting policies and accounting estimates applied to the Fund’s reporting of net assets or operating performance. In accordance with U.S.
20


GAAP, the Fund defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; that is, an exit price. The exit price assumes the asset or liability was exchanged in an orderly transaction; it was not a forced liquidation or distressed sale. There is no readily available market price or secondary market for the loans made by the Fund to borrowers, hence the Manager determines fair value based on a hypothetical market and the estimates are subject to high levels of judgment and uncertainty. The Fund’s loan investments are considered Level 3 fair value measurements in the fair value hierarchy due to the lack of observability over many of the important inputs used in determining fair value. In particular, the Manager has identified the fair value of the Fund’s loan investments that exhibit indicators of the potential for credit deterioration and the completeness of those loan investments, as a critical accounting matter that may involve significant and material estimates and inputs from the Manager in determining the fair value of those loan investments.

Critical judgments and inputs in determining the fair value of a loan include the estimated timing and amount of future cash flows and probability of future payments, based on the assessment of payment history, available cash and “burn rate,” revenues, net income or loss, operating results, financial strength of borrower, prospects for the borrower’s raising future equity rounds, likelihood of sale or acquisition of the borrower, length of expected holding period of the loan, collateral position, the timing and amount of liquidation of collateral for loans that are experiencing significant credit deterioration and, as a result, collection becomes collateral-dependent, as well as an evaluation of the general interest rate environment. The ManagerManagement has evaluated these factors and has concluded that the effect of a deterioration in the quality of the underlying collateral, increase in the size of the loan, increase in the estimated time to recovery, and increase in the hypothetical market coupon rate would have the effect of decreasing the fair value of loan investments. The risk profile of a loan changes when events occur that impact the credit analysis of the borrower and the loan. Such changes result in the fair value being adjusted from par value of the individual loan. Where the risk profile is consistent with the original underwriting, the par value of the loan often approximates fair value.

The actual value of the loans may differ from the Manager’sManagement’s estimates, which would affect net change in net assets resulting from operations as well as assets.


Results of Operations – For the year endedYears Ended December 31, 20182021, 2020 and 2019
    For the most recent discussion on the results of operations for the period endedending December 31, 20172019, refer to the management discussion and analysis on the prior period annual report, Form 10-K, filed on March 15, 2021.
Analysis of Interest Income
Total investment income for the yearyears ended December 31, 20182021, and the period ended December 31, 2017 (i.e. the period from June 28, 2017, sale of capital stock, through December 31, 2017) were $4.42020 was $86.0 million and $0,$46.2 million, respectively, which primarily consisted of interest on venture loans outstanding. The remaining income consisted of interest and dividends on the temporary investment of cash. Increase in interest income on venture loans outstanding is a reflection of the increased volume of loans originated, average outstanding balance of the loans, and weighted-average interest rate on the loans.
Interest is calculated using the effective interest method, and rates earned by the Fund will fluctuate based on many factors including early payoffs, volatility of values ascribed to warrants and new loans funded during the year.
The following table shows the average gross outstandingbalance, interest income and weighted average interest rate for the cash and non-cash portion of interest income for the years ended December 31, 2021 and 2020.
For the Year Ended December 31, 2021For the Year Ended December 31, 2020
Average Outstanding BalanceInterest IncomeWeighted Average Interest Rate - Cash PortionWeighted Average Interest Rate - Non-Cash PortionAverage Outstanding BalanceInterest IncomeWeighted Average Interest Rate - Cash PortionWeighted Average Interest Rate - Non-Cash Portion
Performing Loans$393,012,888 $84,965,060 15.76 %5.86 %$244,644,133 $45,556,945 14.82 %3.80 %
All Loans$403,313,700 $85,555,014 15.50 %5.71 %$252,948,149 $45,711,386 14.39 %3.68 %
Interest income for performing and all loans calculated on a monthly basis was $26.3increased by $39.4 million and $39.8 million, or 86.5% and 87.2%, respectively, for the year ended December 31, 2018.2021 compared to the same period in 2020. The weighted-average interest rate onincrease is primarily due to the increased growth in our loan portfolio. The average outstanding balance for performing and all loans for the same period was 16.33%. There were no outstanding loans for the period ended December 31, 2017 as the Fund had not started investment operations.
Total organizational costsincreased by $148.4 million and $150.4 million, or 60.6% and 59.4%, respectively, for the year ended December 31, 2018 and the period ended December 31, 2017 were less than $0.1 million and $0.2 million, respectively. Organizational costs decreased in 2018 because the Fund completed a majority of the fund formation process in 2017 prior2021 compared to the startsame period in 2020.
Analysis of investment operations.Interest Expense
BankingInterest expense was comprised of amounts related to interest on debt amounts drawn down, unused credit line fees, and professionalamounts amortized from deferred fees were $0.4 millionincurred in conjunction with the debt facility.

21


The following table shows the average balance, interest expense, and $0weighted average interest rate for the year ended December 31, 20182021 and the period ended December 31, 2017, respectively.2020.
Management fees were calculated as 1.575% of committed capital and was $4.8
For the Year Ended December 31, 2021For the Year Ended December 31, 2020
Average BalanceInterest ExpenseWeighted Average Interest Expense RateAverage BalanceInterest ExpenseWeighted Average Interest Expense Rate
Bank Facility$206,569,231 $6,333,348 3.07 %$109,269,231 $4,233,746 3.87 %
Interest expense increased by $2.1 million, or 50%, for the year ended December 31, 2018. There was no management fee2021 compared to the same period in 2017 as2020. The increase is primarily due to higher average debt outstanding, offset by lower weighted average interest rate.
Analysis of Operating Expense
The following table shows the Company had not called capital.
Othercomponents of operating expenses for the year were $0.1 million and $0expense for the year ended December 31, 20182021 and 2020.
Operating ExpenseFor the Year Ended December 31, 2021For the Year Ended December 31, 2020Change ($)
Management fees$7,072,500 $7,302,500 $(230,000)
Banking and professional fees$1,395,114 $600,593 $794,521 
Other operating expenses$214,396 $175,284 $39,112 
Total Operating Expense$8,682,010 $8,078,377 $603,633 
For the period endedfrom January 1, 2020 through June 30, 2020, management fees were calculated at 1.600% of the Company's committed capital. For the period from July 1, 2020 through December 31, 2017, respectively. Operating2020, management fees were calculated at 1.575% of the Company's committed capital. Management fees were calculated at 1.575% of the Company's committed capital from January 1, 2021 through June 30, 2021. For the period from July 1, 2021 through December 31, 2021, management fees were calculated at 1.500% of the Company's committed capital.
     Banking and professional fees were comprised of legal, audit, banking and other professional fees. The increase of $0.8 million or 132% was primarily due to increased legal fees associated with non-performing loans.
     Other operating expense increasedincluded director fees, custody fees, tax fees and other expenses related to the operations of the Fund.

Non-recurring fees

The Fund may receive non-recurring fees in 2018 becauseconnection with the Fund started investment operationsorigination and servicing of portfolio loans. Transactions in May 2018.
Net decreasethis category may include forfeited commitment fees and unamortized warrants, that become recognized as other income after the loan commitment period expires. Other non-recurring fees include pre-payment fees which are recognized as other income in net assets from operationsthe period received. Legal fee reimbursements for deal due diligence and drafting of documents are recognized as offsets against legal expenses. Non-recurring fees for the year ended December 31, 20182021 and 2020 totaled $1.9 million and $1.7 million, respectively.

Net investment income for the periodyears ended December 31, 2017 were2021 and 2020 was $71.0 million and $33.9 million, respectively.
Realized and Change in Unrealized Gains (Losses)

Net realized loss from loans for the years ended December 31, 2021 and 2020 was $0.1 million and less than $0.1 million, respectively. This is due to losses incurred on written-off loans.

    Net realized loss from derivative instruments for the years ended December 31, 2021 and 2020 was $1.3 million and $1.0 million, respectively. This is due to interest paid by the Fund on the interest rate swap and $0.2floor agreements and interest rate collar agreements when the fixed rate interest of the swap and floor and collar was higher than the floating rate.

    Net change in unrealized loss from loans for the years ended December 31, 2021 and 2020 was $5.4 millionand $11.6 million, respectively. The net change in unrealized loss from loans consisted of fair value adjustments to loans and the reversal of fair value adjustments previously taken against loans paid off and written off.

    Net change in unrealized gain (loss) from derivative instruments for the years ended December 31, 2021 and 2020 was $2.1 million and $(0.4) million, respectively. The net change in unrealized gain or loss from derivative instruments consisted of fair market value adjustments to the derivative instruments and is a reflection of the market’s outlook on the economy and the future of interest rate changes. The increase in unrealized gain from derivative instruments was primarily due to the low interest rate environment as well as the realized portion paid for the year ended December 31, 2021 compared to the same period in 2020.
22


    Net increase in net assets resulting from operations for the years ended December 31, 2021 and 2020 was $66.2 million and $20.9 million, respectively. On a per share basis, the net decreaseincrease in net assets resulting from operations for the same periods was $9.64$661.96 and $1.84,$209.11, respectively.
Liquidity and Capital Resources -- December 31, 20182021 and 2020
For the most recent discussion on the liquidity and capital resources for the period ending December 31, 2019, refer to the management discussion and analysis on the annual report, Form 10-K, filed on March 15, 2021.
The Fund is owned entirely by the Company. The Company is expected, but not required, to make further contributions to the capital of the Fund to the extent of the Company’s members’ capital commitment to the Company and excess cash balances of the Company. CommittedTotal capital contributed to the CompanyFund was $345.6 million and $243.1 million as of December 31, 20182021 and 2017 was2020, respectively. As of both December 31, 2021 and 2020, the Company had subscriptions for capital in the amount of $460.0 million, and $450.0 million, respectively, of which $96.6$388.7 million and $25,000$264.5 million had been called and received.received, as of December 31, 2021 and 2020, respectively. As of December 31, 2018, $363.42021, $71.3 million of capital remains uncalled and the uncalled capital expires on the Fund’s fifth anniversary of its first investment. However, the Managerinvestment unless extended. Management is permitted to extend the Fund’s investment period by up to two (2) additional calendar quarters in its sole and absolute discretion. The Company has made $91.6 million in recallable distributions to its investors, as permitted under its operating agreement between the Company’s managing member and members of the Company.
The change in cash held by the Fund for the yearyears ended December 31, 20182021 and the period ended December 31, 2017 was:2020 was as follows:
2018 2017For the Year Ended December 31, 2021For the Year Ended December 31, 2020
Net cash used in operating activities$(86,387,259) 
Net cash used in operating activities$(141,592,182)$(101,496,769)
Net cash provided by financing activities87,195,074
 25,000
Net cash provided by financing activities136,034,065 103,239,253 
Net increase in cash and cash equivalents$807,815
 25,000
Net increase (decrease) in cash and cash equivalentsNet increase (decrease) in cash and cash equivalents$(5,558,117)$1,742,484 
As of December 31, 20182021 and the period ended December 31, 2017, 1.0%2020, 3.01% and 100.0%6.82%, respectively, of the Fund’s net assets consisted of cash and cash equivalents.
On December 20, 2018, the Fund entered into a syndicated loan agreement led by MUFG Union Bank, N.A., Wells Fargo Securities, LLC and ING Capital LLC, with participation from Zions Bancorporation, N.A., doing business as California Bank & Trust, Bank Leumi USA, Umpqua Bank, HSBC Bank USA, N.A., and First Bank, that established a secured revolving loan facility in an initial amount of up to $200,000,000$200.0 million with the option to request that borrowing availability be increased up to $400,000,000,$400.0 million, subject to further negotiation and credit approval. AllOn March 18, 2021, the Fund entered into an Amendment to the Loan and Security Agreement with MUFG Union Bank, N.A., Wells Fargo Securities, LLC, Wells Fargo Bank, N.A. and ING Capital, LLC, with participating from TIAA, FSB, Bank Leumi USA, HSBC Bank USA, N.A., Umpqua Bank, Zions Bancorporation, N.A., doing business as California Bank & Trust, Hitachi Capital America Corp, First Bank, and Bank of Hope, that increased the size of the assetsfacility to $350.0 million and extended the term of the facility (the “Amended Loan Agreement”). An additional $50.0 million is potentially available to the Fund, collateralize borrowingssubject to further negotiation and credit approval, through an accordion provision.

    Borrowings by the Fund are collateralized by all the assets of the Fund. Loans under the facility may be, at the option of the Fund, a Reference Rate Loan, a LIBOR Loan or a LIBOR Market Index Rate Loan. The Fund will paypays interest on its borrowings upon each maturity date.and also pays a fee on the unused portion of the facility. The facility terminates on December 20, 2021,March 18, 2024, but can be accelerated in the event of default, such as the failure by the Fund to make timely interest or principal payments.As of December 31, 2018, $6.02021, $263.0 million was outstanding under the facility.
The
For the year ended December 31, 2021 and since the start of its investment operations in May 2018, the Fund invested its assets in venture loans during the year ended December 31, 2018.loans. Amounts disbursed under the Fund’s loan commitments were $87.1 million.$358.8 million and $215.6 million for the years ended December 31, 2021 and 2020, respectively. Net loan amounts outstanding after amortization and valuation adjustments increased by $173.5 million for the year ended December 31, 2021 compared to the same period in 2020. Unexpired unfunded commitments totaled $97.9 million and $83.2 million as of December 31, 2018 were approximately $79.0 million. No loan commitments or loan fundings were made in 2017.
2021 and 2020, respectively.
Year EndedAs ofCumulative Amount DisbursedPrincipal AmortizationReductions and Fair Market AdjustmentsBalance Outstanding - Fair ValueUnexpired Unfunded Commitments
December 31, 20182021$87.1822.2 million$8.1338.2 million$79.0484.0 million$31.097.9 million
December 31, 2020$463.4 million$152.9 million$310.5 million$83.2 million


Unexpired unfunded commitments for the year ended December 31, 2018 were $31.0 million. There were noThe unexpired unfunded commitments for the period from June 28, 2017, sale of capital stock, through December 31, 2017, because the Fund had not commenced investment operations. The following table shows the unfunded commitments by borrowersportfolio company as of December 31, 2018:2021 and 2020 are detailed in Note 10 to the financial statements included in this filing.
23

BorrowerIndustryUnfunded CommitmentExpiration Date
Aclima, Inc.Other Technology$875,000
05/31/2019
Antheia, Inc.Biotechnology1,500,000
12/31/2019
Blockdaemon, Inc.Software250,000
01/31/2019
Brightside Benefit, Inc.Other Technology1,000,000
05/31/2019
Caredox, Inc.Other Healthcare625,000
04/30/2019
CytoVale, Inc.Medical Devices1,125,000
02/28/2019
Discover Echo, Inc.Other Healthcare1,000,000
02/28/2019
Fitplan, Inc.Other Technology250,000
01/31/2019
Hometap Equity Partners, LLCOther Technology2,000,000
03/31/2019
Invoice2Go, Inc.Software4,000,000
12/31/2019
Ipolipo, Inc.Software750,000
07/31/2019
Keyo AI Inc.Technology Services500,000
01/31/2019
Kogniz, Inc.Other Technology375,000
04/30/2019
Metricly, Inc.Software500,000
04/30/2019
OrderGroove, Inc.Software2,500,000
09/30/2019
Osix CorporationInternet150,000
07/31/2019
Plethora, Inc.Other Technology500,000
01/31/2019
PlushCare, Inc.Software750,000
07/31/2019
Relimetrics, Inc.Technology Services375,000
04/15/2019
Skillshare, Inc.Software2,000,000
04/30/2019
SkyKick, Inc.Other Technology2,500,000
02/28/2019
SnapRoute, Inc.Enterprise Networking1,500,000
02/28/2019
Stitch Labs, Inc.Software1,500,000
07/31/2019
Venuetize, LLCSoftware500,000
09/30/2019
Virtuix Holdings, Inc.Other Technology250,000
07/31/2019
Workspot, Inc.Software1,000,000
01/31/2019
Zeel Networks, Inc.Technology Services2,750,000
03/31/2019
Total $31,025,000
 

Because venture loans are privately negotiated transactions, investments in these assets are relatively illiquid. It has beenis the Management’s experience of the Manager that not all unexpired unfunded commitments will be used by the borrowers. Many credit agreements with the borrowers contain provisions whichthat are milestone dependent and not all borrowers will achieve these milestones. Finally,Additionally, the Fund’s credit agreements contain provisions that give relief from funding obligations in the event the borrower has a materialmaterially adverse change toin its financial condition. Therefore, the unexpired unfunded commitments do not necessarily reflect future cash requirements or future investment incomeinvestments for the Fund.

The Fund will seekseeks to meetmaintain the requirements to qualify for the special pass-through status available to RICs under the Code, and thus to be relieved of federal income tax on that part of its net investment income and realized capital gains that it distributes to its shareholder. To qualify as a RIC, the Fund must distribute to its shareholder for each taxable year at least 90% of its investment company taxable income (consisting generally of net investment income and net short-term capital gain) (the “Distribution Requirement”). To the extent that the terms of the Fund’s venture loans provide for the receipt by the Fund of additional interest at the end of the loan term or provide for the receipt by the Fund of a purchase price for the asset at the end of the loan term (“residual income”), the Fund would be required to accrue such residual income over the life of the loan, and to include such accrued undistributed income in its gross income for each taxable year even if it receives no portion of such residual income in that year. Thus, in order to meet the Distribution Requirement and avoid payment of income taxes or an excise tax on undistributed income, the Fund may be required in a particular year to distribute as a dividend an amount in excess of the total amount of income it actually receives. Those distributions will be made from the Fund’s cash assets, from amounts received through amortization of loans or from borrowed funds.


As of December 31, 2018,2021, the Fund had adequatea cash reservesbalance of $0.8$6.9 million and approximately $27.4$223.0 million in scheduled loan receivable payments over the next year. Additionally, the Fund has access to uncalled capital of $363.4$71.3 million and recallable capital of $91.6 million as a liquidity source, and a borrowing base that continues to growgrows as the Fund makesit funds additional commitments. These amounts are sufficient to meet the current commitment backlog and operational expenses of the Fund over the next year. The Fund constantlyregularly evaluates potential future liquidity resources and demands before making anyadditional future commitments.
ITEM 7A.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

    On April 24, 2019, the Fund's sole shareholder, the Company, approved a reduced asset coverage ratio of 150% for the Fund as permitted in Section 61(a)(2) of the 1940 Act. Accordingly, the Fund is permitted to borrow in any amount so long as its asset coverage ratio, as defined in the 1940 Act, is at least 150% after giving effect to such borrowings. As of December 31, 2021 and 2020, the Fund's asset coverage ratio was 187% and 231%, respectively.
ITEM 7A.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The Fund’s business activities contain various elements of risk, andof which Management considers interest rate and credit risk are consideredto be the principal types of market risk. Therisks. Because the Fund considers the management of risk essential to conducting its business and to maintaining profitability. Accordingly,profitability, the Fund’s risk management procedures are designed to identify and analyze the Fund’s risks, to set appropriate policies and limits and to continually monitor these risks and limits by means of reliable administrative and information systems and other policies and programs.

The Fund manages its market risk by maintaining a portfolio that is diverse by industry, size of investment, stage of development, and borrower. The Fund has limited exposure to public market price fluctuations as it willthe Fund primarily investinvests in private business enterprises and it distributes all equity investments upon receipt to the Company.

The Fund’s investments are subject to market risk based on several factors, including, but not limited to, the borrower’s credit history, available cash, support of the borrower’s underlying investors, available liquidity, “burn rate,” revenue income, security interest, secondary markets for collateral, the size of the loan, term of the loan and the ability to exit via initial public offering or merger and acquisition.

The Fund’s exposure to interest rate sensitivity to changes in interest rates will beis regularly monitored and analyzed by measuring the characteristics of assets and liabilities. The Fund utilizes various methods to assess interest rate risk in terms of the potential effect on interest income net of interest expense, the value of net assets and the value at risk in an effort to ensure that the Fund is insulated from any significant adverse effects from changes in interest rates. At December 31, 2018,2021, the outstanding debt balance was $6.0$263.0 million at a floating interest rate based on a daily 1-month LIBOR rate of 2.51%. The0.10%, for which the Fund has nohad derivative instruments in place with a weighted-average ceiling of 1.57% on $247.0 million with an interest protectionrate collar, leaving the Fund with exposure to interest rate changes on the entire outstanding debt balance.un-hedged portion of the loan.

Because all of the Fund’s loans impose a fixed interest rate upon funding, changes in short-term interest rates will not directly affect interest income associated with the loan portfolio as of December 31, 2018.2021. However, those changes could have the potential to change the Fund’s ability to originate loan commitments, acquire and renew bank facilities, and engage in other investment activities. Further, changes in short-term interest rates could also affect interest rate expense, realized gain from investments and interest on the Fund’s short-term investments.

24


Based on the Fund’s StatementStatements of Assets and Liabilities as of December 31, 2018,2021, the following table shows the approximate annualized increase (decrease) in components of net assets resulting from operations of hypothetical base rate changes in interest rates, assuming no changes in investments, borrowings, cash balances and cash balances.derivative instruments.
Effect of Interest rate change byOther Interest and Other Income/(Loss)Interest Income/(Expense)Total Income/(Loss)
Effect of Interest Rate Change ByEffect of Interest Rate Change ByIncrease (Decrease) Other Interest and Other IncomeGain (Loss) from Interest Rate CollarIncrease (Decrease) Interest ExpenseIncrease (Decrease) in Total Income
(0.50)%$(4,164)$30,000
25,836
(0.50)%$(34,696)$(1,235,000)$266,288 $(1,003,408)
1%$8,328
$(60,000)(51,672)1%$69,391 $863,500 $(2,630,000)$(1,697,109)
2%$16,656
$(120,000)(103,344)2%$138,783 $2,224,375 $(5,260,000)$(2,896,842)
3%$24,984
$(180,000)(155,016)3%$208,174 $4,560,500 $(7,890,000)$(3,121,326)
4%$33,313
$(240,000)(206,687)4%$277,565 $7,030,500 $(10,520,000)$(3,211,935)
5%$41,641
$(300,000)(258,359)5%$346,956 $9,500,500 $(13,150,000)$(3,302,544)
Additionally, a change in the interest rate may effect Netaffect the value of the derivative instruments and affect net change in unrealized gain (loss)or loss from investments.derivative instruments. The amount of any such effect will be contingent upon market expectations for future interest rate changes. Any increases in expected future rates will increase the value of the derivative instruments while any rate decreases will decrease the value.

Although Management believes that the foregoing analysis is indicative of the Fund’s sensitivity to interest rate changes, it does not take into consideration potential changes in the credit market, credit quality, size and composition of the assets in the portfolio. It also does not assume any new fundings to borrowers, repayments from borrowers or defaults on borrowings. Accordingly, no assurances can be given that actual results would not differ materially from the table above.

Because the Fund currently borrows, its net investment income is highly dependent upon the difference between the rate at which it borrows and the rate at which it invests the amounts borrowed. Accordingly, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on the Fund’s investment activities and net investment income. The Fund’s exposure to movement in short-term interest rates stems from the Fund borrowing at a floating interest rate but then making loans with a fixed rate at the time the loans are extended. The Fund, therefore, attempts to limit its interest rate risk by acquiring derivative instruments to hedge its interest rate caps, and anticipates hedging interest rate risk associated with future borrowings once borrowings reach a certain level.exposure.

The Fund is not sensitive to changes in foreign currency exchange rates, commodity prices and other market rates or prices.



ITEM 8.        FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Quarterly Results
This information has been derived from unaudited financial statements that, in the opinion of Management, include all normal recurring adjustments necessary for a fair presentation of such information. The operating results for any quarter are not necessarily indicative of results for any future year. The format of the statements has been modified, thus certain numbers have been combined in order to fit the format of the statements. Prior to June 28, 2017, the Fund had no operations other than incurring organizational expenses and the sale of 100,000 Shares to the Company and the receipt of $25,000 from the Company as consideration for the purchase of the Shares. This issuance of stock was a requirement in order to apply for a finance lender’s license from the California Commissioner of Corporations, which was obtained on September 22, 2017.
The Fund’s financial statements, together with the Report of Independent Registered Public Accounting Firm, are included elsewhere in this Annual Report on Form 10-K.

 Quarterly Information for the Three Months Ended
 March 31, 2018 June 30, 2018 September 30, 2018 December 31, 2018
Investment Income:       
Interest on loans$
 $224,753
 $1,411,618
 $2,655,818
Other interest and other income
 19,573
 87,983
 44,692
Total investment income
 244,326
 1,499,601
 2,700,510
Expenses:       
Management fees
 1,210,808
 1,811,250
 1,811,250
Organizational cost26,973
 681
 
 
Interest expense
 
 
 72,360
Banking and professional fees
 25,672
 181,443
 153,093
Other operating expenses
 40,680
 43,626
 30,728
Total expenses26,973
 1,277,841
 2,036,319
 2,067,431
Net investment income (loss)(26,973) (1,033,515) (536,718) 633,079
        
Net increase (decrease) in net assets resulting from operations$(26,973) $(1,033,515) $(536,718) $633,079
Amount per common share:       
Net increase (decrease) in net assets resulting from operations$(0.27) $(10.34) $(5.37) $6.33
Weighted average shares outstanding100,000
 100,000
 100,000
 100,000
ITEM 9.    CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
(Intentionally left blank)



 Quarterly Information for the Three Months Ended
 June 30, 2017 September 30, 2017 December 31, 2017
Investment Income:     
Interest on loans$
 $
 $
Other interest and other income
 
 
Total investment income
 
 
Expenses:     
Management fees
 
 
Organizational cost4,235
 4,921
 175,009
Interest expense
 
 
Banking and professional fees
 
 
Other operating expenses
 
 
Total expenses4,235
 4,921
 175,009
Net loss(4,235) (4,921) (175,009)
      
Net decrease in net assets resulting from organization$(4,235) $(4,921) $(175,009)
Amount per common share:     
Net decrease in net assets resulting from organization$(0.04) $(0.05) $(1.75)
Weighted average shares outstanding100,000
 100,000
 100,000

ITEM 9.CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
Not applicable.
ITEM 9A.CONTROLS AND PROCEDURES.
ITEM 9A.         CONTROLS AND PROCEDURES
Disclosure Controls and Procedures

At the end of the period covered by this report, wethe Fund carried out an evaluation under the supervision and with the participation of the Fund’sits Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of the Fund’s disclosure controls and procedures pursuant to Rules 13a-15(f)13a-15(b) and 15d-15(f)15d-15(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).Act. Based upon thatthis evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that the Fund’s disclosure controls and procedures were effective as of the end of the period in ensuring that information required to be disclosed was recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and in providing reasonable assurance that information required to be disclosed by the Fund in such reports is accumulated and communicated to the Fund’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures.
There have not been any changes in the Fund’s internal control over financial reporting identified in connection with Management’s Report that occurred during the Fund’s fiscal quarter ended December 31, 2018 that has materially affected, or is reasonably likely to materially affect, the Fund’s internal control over financial reporting.
25


Management’s Annual Report on Internal Control over Financial Reporting
Pursuant to Rules 123a-15d13a-15d and 15d-15(d) of the Exchange Act, the Fund’s management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act. Under the supervision of and with the participation of ourthe Fund’s management, including ourits Chief Executive Officer and


Chief Financial Officer, wethe Fund conducted an evaluation of the effectiveness of ourits internal control over financial reporting based on the Committee of Sponsoring Organizations of the Treadway Commission 2013 (“COSO 2013”) updated Internal Control - Integrated Framework. Based on ourits evaluation under the COSO 2013 Internal Control - Integrated Framework, ourthe Fund’s management concluded that ourits internal control over financial reporting as applicable to the Fund was effective as of December 31, 2018. During 2018, there were no significant changes to the internal control processes applicable to the Fund.2021.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements and even when determined to be effective, can only provide reasonable assurance with respect to financial statement preparation and presentation. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
This report of management on internal control over financial reporting shall not be deemed to be filed for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section.
Changes in Internal Controls
There have not been any changes in the Fund’s internal controlscontrol over financial reporting identified in connection with Management’s reportthe evaluation required by Rules 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the Fund’s fiscal quarter ended December 31, 20182021 that has materially affected, or is reasonably likely to materially affect, the Fund’s internal control over financial reporting.
ITEM 9B.OTHER INFORMATION

ITEM 9B.     OTHER INFORMATION
Not applicable.
(Intentionally left blank)


26


PART IIIIII.
ITEM 10.DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
ITEM 10.    DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
The following are thelist of executive officers and biographical information appears in Part I, Item 1 of the Fund. All officers serve at the pleasure of the Fund’s Board of Directors.
Name and Position with FundAgeOccupation During Past Five Years
Ronald W. Swenson, Chairman, and Director74Chairman, Chief Executive Officer, Director, and other positions for Westech Investment Advisors since 1994
Maurice C. Werdegar, President and Chief Executive Officer54President, Chief Executive Officer, Chief Operating Officer, Director and other positions for Westech Investment Advisors since 2001
Jay L. Cohan, Vice President, Assistant Secretary54Vice President, Assistant Secretary and other positions for Westech Investment Advisors since 1999
Martin D. Eng, Vice President, Chief Financial Officer, Treasurer, and Secretary67Vice President, Chief Financial Officer, Chief Compliance Officer, Treasurer and Secretary for Westech Investment Advisors since 2005.
David R. Wanek, Vice President45Vice President and other positions for Westech Investment Advisors since 2001
this Form 10-K.
The information required by this item concerning the directors of the Fund, the structure of its Board of Directors and Section 16(a) compliance will be contained in the Fund’s Proxy Statement filed in connection with the Annual Meeting of Shareholders to be held on May 15, 201918, 2022 (“Proxy Statement”) under the captions “Proposal 1 -- To Elect Five Directors of the Fund” and “Section 16(a) Beneficial Ownership Reporting Compliance” and is incorporated herein by reference.
The Fund has adopted a Code of Ethics that is applicable to all of its officers. A free copy of the Code of Ethics may be requested by contacting the Chief Financial Officer of the Fund at 104 La Mesa Drive, Suite 102, Portola Valley, CA 94028.  
ITEM 11.EXECUTIVE COMPENSATION
ITEM 11.    EXECUTIVE COMPENSATION
The information required by this item will be contained in the Fund’s Proxy Statement under the caption “Proposal 1 -- To Elect Five Directors of the Fund” and is incorporated herein by reference.
ITEM 12.SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
ITEM 12.    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
The information required by this item will be contained in the Fund’s Proxy Statement under the caption “Annex A -- Beneficial Ownership of Fund Shares” and is incorporated herein by reference.
ITEM 13.    CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
The information required by this item will be contained in the Fund’s Proxy Statement under the captions: “Other Information -- Managers” and is incorporated herein by reference.
ITEM 14.    PRINCIPAL ACCOUNTANT FEES AND SERVICES
The information requiredInformation about aggregate fees billed to us by this itemour principal accountant, Deloitte & Touche LLP (PCAOB ID No. 34) will be contained in the Fund’sFund's Proxy Statement under the captions: “Other Information - Independent Registered Public Accounting Firm.”


27


PART IV.
ITEM 15.EXHIBITS, FINANCIAL STATEMENT SCHEDULES
ITEM 15.    EXHIBITS, FINANCIAL STATEMENT SCHEDULES
1.     Index to Financial Statements and Financial Statement Schedules
Report of Independent Registered Public Accounting Firm    
Statements of Assets and Liabilities as of December 31, 20182021 and December 31, 20172020
Statements of Operations for the yearyears ended December 31, 20182021, 2020 and period ended December 31, 20172019
Statements of Changes in Net Assets for the yearyears ended December 31, 20182021, 2020 and period ended December 31, 20172019
Statements of Cash Flows for the yearyears ended December 31, 20182021, 2020 and period ended December 31, 20172019
Schedules of Investments as of December 31, 20182021 and 2020
Schedules of Derivative Instruments as of December 31, 20172021 and 2020
Notes to Financial Statements 
No schedules are required because the required information is not present or not present in amounts sufficient to require submission of the schedule, or because the required information is included in the financial statements and the notes thereto.
2.    Exhibits
Exhibit    
Exhibit Title
3(i)3.1
3(ii)3.2
4(i)4.1
10(i)4.2
10(iii)(A)10.1
10.2
10.3
31(i)10.4
31.1

31(ii)31.2

32(i)32.1

32(ii)32.2




ITEM 16.    FORM 10-K SUMMARY
None.

28



Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
VENTURE LENDING & LEASING IX, INC.
(Registrant)

By:/S/Maurice C. WerdegarDavid R. WanekBy:/S/Martin D. EngJared S. Thear
Maurice C. WerdegarDavid R. WanekMartin D. EngJared S. Thear
President and Chief Executive OfficerChief Financial Officer
(Principal Executive Officer)(Principal Financial Officer)
Date:  March 14, 20192022Date:March 14, 20192022
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
NAMETITLEDATE
By:NAME/S/ Maurice C. WerdegarTITLEChairman & DirectorDATEMarch 14, 2022
Maurice C. Werdegar
By:/S/David R. WanekPresident, CEO & DirectorMarch 14, 2022
David R. Wanek
By:/S/ Robert HutterDirectorMarch 14, 2022
Robert Hutter
By:/S/ Roger V. SmithDirectorMarch 14, 20192022
Roger V. Smith
By:/S/ Scott TaylorDirectorMarch 14, 20192022
Scott Taylor
By:/S/ Ronald W. SwensonChairman & DirectorMarch 14, 2019
Ronald W. Swenson
By:/S/ Robert HutterDirectorMarch 14, 2019
Robert Hutter
By:/S/ Maurice C. WerdegarPresident, CEO & DirectorMarch 14, 2019
Maurice C. Werdegar



29




REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the shareholder and the Board of Directors of Venture Lending & Leasing IX, Inc.

Opinion on the Financial Statements and Financial Highlights

We have audited the accompanying statementstatements of assets and liabilities of Venture Lending & Leasing IX, Inc. (the "Fund"), including the schedules of investments, as of December 31, 20182021 and 2017,2020, and the related statements of operations, changes in net assets, and cash flows for each of the three years in the period ended December 31, 2021, the financial highlights (presented in Note 9)11) for each of the yearfour years in the period ended December 31, 2018,2021 and the period from June 28, 2017 (inception) through(date of incorporation) to December 31, 2017, and the related notes. In our opinion, the financial statements and financial highlights present fairly, in all material respects, the financial position of the Fund as of December 31, 20182021 and 2017,2020, and the results of its operations, changes in net assets, and cash flows for each of the three years in the period ended December 31, 2021, and the financial highlights for each of the yearfour years in the period ended December 31, 2018,2021 and the period from June 28, 2017 (inception)(date of incorporation) through December 31, 2017, in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These financial statements and financial highlights are the responsibility of the Fund's management. Our responsibility is to express an opinion on the Fund's financial statements and financial highlights based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Fund in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement, whether due to error or fraud. The Fund is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements and financial highlights, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements and financial highlights. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements and financial highlights. Our procedures included confirmation of loans owned as of December 31, 2018,2021 and 2020, by correspondence with the borrowers; when replies were not received, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Fair Value — Level 3 Investments — Refer to Note 2 and Note 3 to the financial statements

Critical Audit Matter Description

As of December 31, 2021, the Fund has nonmarketable investments in loans of $484 million. There is no readily available market price or secondary market for the loans made by the Fund to its borrowers; hence the Fund determines fair value based on a hypothetical market and the estimates are subject to a higher degree of judgment and uncertainty. The Fund’s loan investments are considered Level 3 fair value measurements in the fair value hierarchy due to the lack of observability over certain significant inputs used in determining fair value.

Certain nonmarketable investments in loans held by the Fund have exhibited indicators of potential credit deterioration subsequent to the initial funding date. The valuation of these loans has an elevated risk profile because the estimates of fair value involve a higher degree of management judgment and uncertainty associated with the expectation of timing and amount of future cash flows under various cash flow scenarios. The valuation of these loans required a high degree of auditor judgment and an increased extent of effort, including the possibility to involve our fair value specialists who possess significant valuation expertise, to evaluate the appropriateness of the model and methodology.

We identified the completeness of loans exhibiting indicators of potential credit deterioration and the valuation of loans exhibiting credit deterioration as a critical audit matter.


30


How the Critical Audit Matter Was Addressed in the Audit

Our audit procedures related to the completeness of loans exhibiting indicators of potential credit deterioration and the unobservable inputs used by management to estimate the fair value of the loans with credit deterioration included the following, among others:
a.We tested loan payments throughout the year and subsequent to year end to identify inconsistent payments or missed payments which could indicate a potential credit risk.
b.With the assistance of our fair value specialists, we evaluated the reasonableness of the valuation techniques used by management to estimate fair value.
c.We tested and evaluated the appropriateness of the unobservable inputs by comparing them to external sources, including financial information provided by the borrower, and those used by management in the prior year.


/s/ Deloitte & Touche LLP

March 14, 20192022

San Francisco, California

We have served as the auditor of one or more Venture Lending & Leasing investment companies since 2001.


31



VENTURE LENDING & LEASING IX, INC.
Statements of Assets and Liabilities
As of December 31, 20182021 and 20172020
December 31, 2021December 31, 2020
ASSETS:
Loans, at estimated fair value
   (cost of $501,909,222 and $323,011,028)$484,047,644 $310,522,149 
Derivative assets962,602 — 
Cash and cash equivalents6,939,126 12,497,243 
Dividend and interest receivables6,872,798 3,856,598 
Other assets2,110,405 685,806 
Total assets500,932,575 327,561,796 
LIABILITIES:
Borrowings under debt facility263,000,000 140,000,000 
Accrued management fees1,725,000 1,811,250 
Derivative liability130,697 1,254,214 
Accounts payable and other accrued liabilities5,883,327 1,169,497 
Total liabilities270,739,024 144,234,961 
NET ASSETS:$230,193,551 $183,326,835 
Analysis of Net Assets:
Capital paid in on shares of capital stock$345,625,000 $243,125,000 
Cumulative return of capital distributions(97,253,486)(44,906,782)
Total distributable losses(18,177,963)(14,891,383)
Net assets (equivalent to $2,301.94 and $1,833.27 per share based on 100,000 shares of capital stock outstanding - See Note 5 and Note 11)$230,193,551 $183,326,835 
Commitments & Contingent Liabilities:
Unexpired unfunded commitments (See Note 10)$97,948,732 $83,200,000 


 December 31, 2018 December 31, 2017
ASSETS   
Loans, at estimated fair value   
   (Cost of $79,045,107 and $0)$79,045,107
 $
Cash and cash equivalents832,815
 25,000
Dividend and interest receivables985,020
 
Other assets1,316,366
 
Total assets82,179,308
 25,000
    
LIABILITIES   
Borrowings under debt facility6,000,000
 
Accrued management fees1,811,250
 
Due to the manager
 184,165
Accounts payable and other accrued liabilities279,331
 
Total liabilities8,090,581
 184,165
    
NET ASSETS (DEFICIT)$74,088,727
 $(159,165)
    
Analysis of Net Assets (Deficit):   
    
Capital paid in on shares of capital stock$82,525,000
 $25,000
Accumulated undistributed deficit(1,148,292) (184,165)
Distribution in excess of net investment income(7,287,981) 
Net assets (deficit) (equivalent to $740.89 and ($1.59) per share based on 100,000 shares of capital stock outstanding - See Note 5)$74,088,727
 $(159,165)
    
Commitments & Contingent Liabilities:   
Unfunded unexpired commitments (See Note 8)$31,025,000
 $



















See notes to financial statements.
32




VENTURE LENDING & LEASING IX, INC.
Statements of Operations
For the YearYears Ended December 31, 20182021, 2020 and Period Ended December 31, 2017*2019
For the Year EndedFor the Year EndedFor the Year Ended
December 31, 2021December 31, 2020December 31, 2019
INVESTMENT INCOME:
Interest on loans$85,555,014 $45,711,386 $23,613,264 
Other interest and other income410,493 514,174 195,483 
Total investment income85,965,507 46,225,560 23,808,747 
EXPENSES:
Management fees7,072,500 7,302,500 7,302,500 
Interest expense6,333,348 4,233,746 3,995,300 
Banking and professional fees1,395,114 600,593 460,935 
Other operating expenses214,396 175,284 178,282 
Total expenses15,015,358 12,312,123 11,937,017 
Net investment income70,950,149 33,913,437 11,871,730 
Net realized loss from loans(119,127)(27,819)(2,393,159)
Net realized loss from derivative instruments(1,348,685)(960,747)(73,774)
Net change in unrealized loss from loans(5,372,700)(11,584,945)(903,934)
Net change in unrealized gain (loss) from derivative instruments2,086,119 (428,640)(825,574)
Net realized and change in unrealized loss from loans and derivative instruments(4,754,393)(13,002,151)(4,196,441)
Net increase in net assets resulting from operations$66,195,756 $20,911,286 $7,675,289 
Amounts per common share:
Net increase in net assets resulting from operations
   per share
$661.96 $209.11 $76.75 
Weighted average shares outstanding100,000 100,000 100,000 
 For the Year Ended For the Period Ended
 December 31, 2018 December 31, 2017*
INVESTMENT INCOME:   
Interest on loans$4,292,189
 $
Other interest and other income152,248
 
Total investment income4,444,437
 
    
EXPENSES:   
Management fees4,833,308
 
Organizational costs27,654
 184,165
Interest expense72,360
 
Banking and professional fees360,208
 
Other operating expenses115,034
 
Total expenses5,408,564
 184,165
Net investment loss(964,127) (184,165)
    
Net decrease in net assets resulting from operations$(964,127) $(184,165)

   
Amount per common share:   
Net decrease in net assets resulting from operations per share$(9.64) $(1.84)
Weighted average shares outstanding100,000
 100,000

*From June 28, 2017, sale of capital stock, through December 31, 2017. The Fund had not yet commenced investment operations.














See notes to financial statements.
33



VENTURE LENDING & LEASING IX, INC.
Statements of Changes in Net Assets
For the YearYears Ended December 31, 20182021, 2020 and Period Ended December 31, 20172019

Common Stock
SharesPar ValueAdditional Paid-in CapitalReturn of Capital DistributionsTotal Distributable LossesNet Assets
Balance at December 31, 2018 (a)
100,000 $100 $82,524,900 $(7,287,981)$(1,148,292)$74,088,727 
Net increase in net assets resulting from operations— — — — 7,675,289 7,675,289 
Distributions of income to shareholder— — — — (9,404,796)(9,404,796)
Return of capital to shareholder— — — (24,126,847)— (24,126,847)
Contributions from shareholder— — 65,600,000 — — 65,600,000 
Balance at December 31, 2019 (a)
100,000 $100 $148,124,900 $(31,414,828)$(2,877,799)$113,832,373 
Net increase in net assets resulting from operations— — — — 20,911,286 20,911,286 
Distributions of income to shareholder— — — — (32,924,870)(32,924,870)
Return of capital to shareholder— — — (13,491,954)— (13,491,954)
Contributions from shareholder— — 95,000,000 — — 95,000,000 
Balance at December 31, 2020 (a)
100,000 $100 $243,124,900 $(44,906,782)$(14,891,383)$183,326,835 
Net increase in net assets resulting from operations— — — — 66,195,756 66,195,756 
Distributions of income to shareholder— — — — (69,482,336)(69,482,336)
Return of capital to shareholder— — — (52,346,704)— (52,346,704)
Contributions from shareholder— — 102,500,000 — — 102,500,000 
Balance at December 31, 2021100,000 $100 $345,624,900 $(97,253,486)$(18,177,963)$230,193,551 
 For the Year Ended For the Period Ended
 December 31, 2018 December 31, 2017*
Net decrease in net assets from operations:   
Net investment loss$(964,127) $(184,165)
Net decrease in net assets resulting from operations(964,127) (184,165)
    
Distributions of income to shareholder(7,287,981) 
Contributions from shareholder82,500,000
 25,000
Net increase in capital transactions75,212,019
 25,000
    
Net increase (decrease) in net assets74,247,892
 (159,165)
    
Net assets (deficit)   
Beginning of year/period*(159,165) 
    
End of year/period*$74,088,727
 $(159,165)
(a)Additional prior period information is shown for comparability with current period presentation.
*From June 28, 2017, sale of capital stock, through December 31, 2017. The Fund had not yet commenced investment operations.
















See notes to financial statements.
34



VENTURE LENDING & LEASING IX, INC.
Statements of Cash Flows
For the YearYears Ended December 31, 20182021, 2020 and the Period Ended December 31, 20172019
For the Year EndedFor the Year EndedFor the Year Ended
December 31, 2021
December 31, 2020 (a)
December 31, 2019 (a)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net increase in net assets resulting from operations$66,195,756 $20,911,286 $7,675,289 
Adjustments to reconcile net increase in net assets resulting from operations to net cash used in operating activities:
Net realized loss from loans119,127 27,819 2,393,159 
Net realized loss from derivative instruments1,348,685 960,747 73,774 
Net change in unrealized loss from loans5,372,700 11,584,945 903,934 
Net change in unrealized (gain) loss from derivative instruments(2,086,119)428,640 825,574 
Amortization of deferred costs related to borrowing facility794,264 428,638 427,523 
Origination of loans(358,801,269)(215,650,000)(160,675,000)
Principal payments on loans, net of accretion179,332,130 95,832,764 31,535,775 
Acquisition of equity securities(35,577,222)(14,623,255)(11,055,649)
Change in operating assets and liabilities:
Net increase in dividend and interest receivables(3,016,200)(1,154,885)(1,716,693)
Net (increase) decrease in other assets98,387 (174,729)(35,733)
Net increase (decrease) in accounts payable, other accrued liabilities and accrued management fees and due to manager4,627,579 (68,739)958,905 
Net cash used in operating activities(141,592,182)(101,496,769)(128,689,142)
CASH FLOWS FROM FINANCING ACTIVITIES:
Cash distributions to shareholder(85,800,000)(30,800,000)(20,900,000)
Contributions from shareholder102,500,000 95,000,000 65,600,000 
Borrowings under debt facility251,200,000 137,500,000 119,200,000 
Repayments of borrowings under debt facility(128,200,000)(97,500,000)(25,200,000)
Payments made for derivative instruments(1,348,685)(960,747)(96,231)
Payments received from interest rate swap— — 22,458 
Payments of bank facility fees and costs(2,317,250)— (15,141)
Net cash provided by financing activities136,034,065 103,239,253 138,611,086 
Net increase (decrease) in cash and cash equivalents(5,558,117)1,742,484 9,921,944 
CASH AND CASH EQUIVALENTS:
Beginning of year12,497,243 10,754,759 832,815 
End of year$6,939,126 $12,497,243 $10,754,759 
SUPPLEMENTAL DISCLOSURES:
CASH PAID DURING THE YEAR:
Interest - Debt facility$4,992,998 $3,648,316 $3,304,431 
NON-CASH OPERATING AND FINANCING ACTIVITIES:
Distributions of equity securities to shareholder$36,029,040 $15,616,824 $12,631,643 
Receipt of equity securities as repayment of loans$451,817 $993,568 $1,575,994 
(a)Certain prior period information has been merged for comparability with current period presentation.

 For the Year Ended For the Period Ended
 December 31, 2018 December 31, 2017*
CASH FLOWS FROM OPERATING ACTIVITIES:   
Net decrease in net assets from operations$(964,127) $(184,165)
Adjustments to reconcile net decrease in net assets from operations to net cash used in operating activities:   
Amortization of deferred costs related to borrowing facility35,268
 
Net increase in dividend and interest receivables(985,020) 
Net increase in other assets(46,708) 
Net increase in accounts payable, other accrued liabilities, accrued management fees and due to manager1,906,416
 184,165
Origination of loans(87,100,000) 
Principal payments on loans8,054,893
 
Acquisition of equity securities(7,287,981) 
Net cash used in operating activities(86,387,259) 
    
CASH FLOWS FROM FINANCING ACTIVITIES:   
Contributions from shareholder82,500,000
 25,000
Borrowings under debt facility6,000,000
 
Payment of bank facility fees and costs(1,304,926) 
Net cash provided by financing activities87,195,074
 25,000
Net increase in cash and cash equivalents807,815
 25,000
    
CASH AND CASH EQUIVALENTS:   
Beginning of year/period*25,000
 
End of year/period*$832,815
 $25,000
    
SUPPLEMENTAL DISCLOSURES:   
NON-CASH ACTIVITIES:   
Distributions of equity securities to shareholder$7,287,981
 $
*From June 28, 2017, sale of capital stock, through December 31, 2017. The Fund had not yet commenced investment operations.



See notes to financial statements.

35


VENTURE LENDING & LEASING IX, INC.
Schedule of Investments
As of December 31, 20182021
IndustryBorrowerPercent of Net Assets (a)CollateralInterest Rate (b)End of Term Payment (c)PrincipalCostFair Value (d)Final Maturity Date
Biotechnology
Calysta, Inc.Senior Secured11.8%$7,424,123 $6,910,615 $6,910,615 6/1/2025
Driver Bioengineering, Inc.Senior Secured11.0%210,665 196,509 196,509 4/1/2023
Driver Bioengineering, Inc.Senior Secured11.0%548,126 541,260 541,260 6/1/2023
Driver Bioengineering, Inc. Subtotal758,791 737,769 737,769 
Genomic Prediction, Inc.Senior Secured11.0%990,625 916,753 916,753 1/1/2025
GLO Pharma, Inc.Senior Secured10.5%1,982,114 1,896,155 1,896,155 12/1/2024
GLO Pharma, Inc.Senior Secured10.5%2,971,746 2,893,124 2,893,124 12/1/2024
GLO Pharma, Inc. Subtotal4,953,860 4,789,279 4,789,279 
Quartzy, Inc.Senior Secured12.0%1,054,875 1,036,987 1,036,987 7/1/2024
Quartzy, Inc.Senior Secured12.0%478,138 445,430 445,430 8/1/2023
Quartzy, Inc.Senior Secured12.0%996,046 980,260 980,260 5/1/2024
Quartzy, Inc. Subtotal2,529,059 2,462,677 2,462,677 
Biotechnology Total6.9%$16,656,458 $15,817,093 $15,817,093 
Computers & Storage
Canary Connect, Inc.Senior Secured12.0%$1,806,184 $1,774,384 $1,774,384 3/1/2024
Canary Connect, Inc.Senior Secured12.0%7,221,950 6,947,036 6,947,036 3/1/2024
Canary Connect, Inc.Senior Secured12.8%1,332,737 1,312,821 1,312,821 3/1/2023
Canary Connect, Inc.Senior Secured11.8%14,850,16914,028,46914,028,4693/1/2026
Canary Connect, Inc. Subtotal25,211,040 24,062,710 24,062,710 
Computers & Storage Total10.5%$25,211,040 $24,062,710 $24,062,710 
Enterprise Networking
Diamanti, Inc.Senior Secured11.0%$5,972,984 $5,055,959 $4,311,087 *
Enterprise Networking Total1.9%$5,972,984 $5,055,959 $4,311,087 
Internet
10club Pte Ltd. ** ^Senior Secured12.0%$4,454,692 $4,309,407 $4,309,407 11/1/2025
10club Pte Ltd. ** ^Senior Secured12.0%1,484,485 969,998 969,998 8/1/2025
10club Pte Ltd. Subtotal ** ^5,939,177 5,279,405 5,279,405 
Ainsly, Inc. ** ^Senior Secured12.5%180,970 167,037 167,037 9/1/2023
Ainsly, Inc. ** ^Senior Secured12.5%220,835 215,380 215,380 8/1/2022
Ainsly, Inc. ** ^Senior Secured12.5%73,617 73,617 73,617 8/1/2022
Ainsly, Inc. Subtotal ** ^475,422 456,034 456,034 
iZENEtech, Inc. ** ^Senior Secured12.3%4,649,564 4,449,109 4,449,109 9/1/2024
Mantra Health, Inc.Senior Secured12.0%494,777 458,710 458,710 6/1/2024
Merchbar, Inc.Senior Secured11.8%265,285 258,235 258,235 3/1/2023
MyPizza Technologies, Inc.Senior Secured11.5%2,179,705 2,160,762 2,160,762 2/1/2024
MyPizza Technologies, Inc.Senior Secured11.5%4,061,477 3,981,527 3,981,527 12/1/2023
MyPizza Technologies, Inc. Subtotal6,241,182 6,142,289 6,142,289 
OneLocal, Inc. ** ^Senior Secured12.3%844,634 794,936 794,936 3/1/2023
Osix CorporationSenior Secured12.0%4,948,467 4,694,637 4,694,637 8/1/2024
Pixalate, Inc.Senior Secured12.5%5,934,796 5,384,024 5,384,024 4/1/2025
Proper Labs, Inc.Senior Secured11.5%1,484,519 1,375,854 1,375,854 11/1/2024
RenoFi, Inc.Senior Secured12.0%157,216 155,178 155,178 6/1/2023
36


IndustryBorrowerPercent of Net Assets (a)CollateralInterest Rate (b)End of Term Payment (c)PrincipalCostFair Value (d)Final Maturity Date
RenoFi, Inc.Senior Secured12.0%157,130 150,858 150,858 6/1/2023
RenoFi, Inc.Senior Secured12.0%814,310 791,720 791,720 12/1/2023
RenoFi, Inc. Subtotal1,128,656 1,097,756 1,097,756 
Residently USA, LLC ** ^Senior Secured12.0%498,522 470,265 470,265 2/1/2023
Residently USA, LLC ** ^Senior Secured12.0%305,431 305,431 305,431 12/1/2023
Residently USA, LLC Subtotal ** ^803,953 775,696 775,696 
RetailerX, Inc.Senior Secured12.0%1,978,517 1,889,440 1,889,440 2/1/2025
RetailerX, Inc.Senior Secured12.0%960,287 923,491 923,491 5/1/2024
RetailerX, Inc. Subtotal2,938,804 2,812,931 2,812,931 
Serface Care, Inc.Senior Secured12.3%597,411 433,243 36,200 *
Shadow, PBCSenior Secured18.0%331,399 310,681 — *
Starface World, Inc.Senior Secured12.0%783,946 752,446 752,446 11/1/2023
Starface World, Inc.Senior Secured11.3%990,265 971,780 971,780 10/1/2024
Starface World, Inc.Senior Secured12.0%422,046 415,242 415,242 1/1/2024
Starface World, Inc.Senior Secured11.3%2,474,163 2,359,716 2,359,716 10/1/2024
Starface World, Inc.Senior Secured11.3%990,476 970,472 970,472 10/1/2024
Starface World, Inc. Subtotal5,660,896 5,469,656 5,469,656 
Stay Alfred, Inc.Senior Secured18.0%5,675,613 4,162,117 404,583 *
Usual Beverage Co.Senior Secured12.0%2,967,292 2,850,880 2,850,880 9/1/2024
Verishop, Inc.Senior Secured12.0%1,744,243 1,727,396 1,727,396 12/1/2023
Verishop, Inc.Senior Secured12.0%1,743,583 1,692,394 1,692,394 12/1/2023
Verishop, Inc. Subtotal3,487,826 3,419,790 3,419,790 
Internet Total20.1%$54,869,673 $50,625,983 $46,160,725 
Medical Devices
3D Bio Holdings, Inc.Senior Secured11.5%$1,806,873 $1,694,218 $1,694,218 3/1/2024
Ablacon, Inc.Senior Secured11.0%1,321,869 1,291,586 1,291,586 3/1/2023
Ablacon, Inc.Senior Secured11.0%1,322,356 1,311,100 1,311,100 3/1/2023
Ablacon, Inc. Subtotal2,644,225 2,602,686 2,602,686 
Anutra Medical, Inc.Senior Secured12.0%90,784 89,282 89,282 10/1/2022
Anutra Medical, Inc.Senior Secured12.0%643,231 611,529 611,529 7/1/2024
Anutra Medical, Inc. Subtotal734,015 700,811 700,811 
CytoVale, Inc.Senior Secured12.0%361,456 357,071 357,071 11/1/2023
CytoVale, Inc.Senior Secured12.0%1,977,671 1,897,985 1,897,985 9/1/2024
CytoVale, Inc.Senior Secured12.0%64,961 64,412 64,412 3/1/2022
CytoVale, Inc.Senior Secured12.0%989,063 967,945 967,945 11/1/2024
CytoVale, Inc.Senior Secured12.0%347,288 335,948 335,948 10/1/2023
CytoVale, Inc.Senior Secured12.0%118,901 118,390 118,390 7/1/2022
CytoVale, Inc.Senior Secured12.0%128,023 127,542 127,542 6/1/2022
CytoVale, Inc. Subtotal3,987,363 3,869,293 3,869,293 
eXo Imaging, Inc.Senior Secured11.8%1,444,176 1,379,677 1,379,677 9/1/2023
eXo Imaging, Inc.Senior Secured11.8%1,445,467 1,425,130 1,425,130 9/1/2023
eXo Imaging, Inc. Subtotal2,889,643 2,804,807 2,804,807 
Medrobotics Corporation, Inc.Senior Secured18.0%10,000,000 8,855,103 964,900 *
Norbert Health, Inc.Senior Secured12.3%989,165 902,830 902,830 6/1/2024
Siren Care, Inc.Senior Secured12.5%754,310 744,906 744,906 10/1/2023
Siren Care, Inc.Senior Secured12.5%1,508,243 1,463,777 1,463,777 10/1/2023
Siren Care, Inc. Subtotal2,262,553 2,208,683 2,208,683 
SVN Med, LLCSenior Secured15.0%1,633,7901,393,0281,393,02812/1/2023
SVN Med, LLCSenior Secured15.0%817,104693,026693,02612/1/2023
SVN Med, LLC Subtotal2,450,894 2,086,054 2,086,054 
Medical Devices Total7.7%$27,764,731 $25,724,485 $17,834,282 
37


IndustryBorrowerPercent of Net Assets (a)CollateralInterest Rate (b)End of Term Payment (c)PrincipalCostFair Value (d)Final Maturity Date
Other Healthcare
Alchera IncorporatedSenior Secured12.0%$1,483,900 $1,326,776 $1,326,776 7/1/2024
Alchera IncorporatedSenior Secured12.0%1,470,500 1,409,173 1,409,173 4/1/2025
Alchera Incorporated Subtotal2,954,400 2,735,949 2,735,949 
Artisan Development Labs, Inc.Senior Secured12.3%282,447 260,582 260,582 4/1/2023
Elysium Health, Inc.Senior Secured12.0%7,420,231 6,722,807 6,722,807 2/1/2025
GoForward, Inc.Senior Secured11.5%4,507,323 4,304,301 4,304,301 9/1/2023
GoForward, Inc.Senior Secured11.5%3,091,343 3,036,842 3,036,842 6/1/2024
GoForward, Inc. Subtotal7,598,666 7,341,143 7,341,143 
Grayce, Inc.Senior Secured11.8%990,011 932,249 932,249 9/1/2024
Grayce, Inc.Senior Secured11.8%494,614 483,462 483,462 12/1/2024
Grayce, Inc. Subtotal1,484,625 1,415,711 1,415,711 
Hello Heart Inc.Senior Secured11.0%1,979,629 1,946,247 1,946,247 6/1/2025
Hello Heart Inc.Senior Secured11.0%1,979,629 1,868,531 1,868,531 6/1/2024
Hello Heart Inc.Senior Secured11.0%586,952 580,837 580,837 11/1/2023
Hello Heart Inc.Senior Secured11.0%561,643 557,061 557,061 4/1/2023
Hello Heart Inc.Senior Secured11.0%701,855 683,970 683,970 4/1/2023
Hello Heart Inc. Subtotal5,809,708 5,636,646 5,636,646 
Honeybee Health, Inc.Senior Secured11.0%990,031 898,914 898,914 6/1/2024
Honeybee Health, Inc.Senior Secured11.0%1,980,553 1,980,553 1,980,553 6/1/2024
Honeybee Health, Inc. Subtotal2,970,584 2,879,467 2,879,467 
HumanAPI, Inc.Senior Secured11.8%1,175,103 1,145,778 1,145,778 7/1/2023
HumanAPI, Inc.Senior Secured11.8%1,979,202 1,877,319 1,877,319 8/1/2024
HumanAPI, Inc.Senior Secured11.8%990,180 961,832 961,832 2/1/2025
HumanAPI, Inc. Subtotal4,144,485 3,984,929 3,984,929 
Minded, Inc.Senior Secured12.0%1,978,973 1,865,771 1,865,771 12/1/2024
Oula Heath, Inc.Senior Secured12.0%346,309 340,210 340,210 7/1/2024
Oula Heath, Inc.Senior Secured12.0%655,346 623,750 623,750 2/1/2024
Oula Heath, Inc. Subtotal1,001,655 963,960 963,960 
PeerWell, Inc.Senior Secured12.0%902,629 860,003 860,003 3/1/2024
SchoolCare, Inc.Senior Secured18.0%395,761388,04682,551*
Therapydia, Inc.Senior Secured12.0%494,637434,026434,0264/1/2025
Therapydia, Inc.Senior Secured12.0%494,944 480,199 480,199 10/1/2025
Therapydia, Inc.Senior Secured12.0%1.7%58,588 56,636 56,636 3/1/2023
Therapydia, Inc.Senior Secured12.5%1.7%68,858 68,858 68,858 6/1/2023
Therapydia, Inc. Subtotal1,117,027 1,039,719 1,039,719 
Tia, Inc.Senior Secured11.8%1,920,749 1,754,268 1,754,268 5/1/2024
Tia, Inc.Senior Secured11.8%2,473,240 2,432,270 2,432,270 9/1/2024
Tia, Inc. Subtotal4,393,989 4,186,538 4,186,538 
Vessel Health, Inc.Senior Secured12.0%564,189 564,189 564,189 3/1/2024
Vessel Health, Inc.Senior Secured12.0%564,106 532,069 532,069 3/1/2024
Vessel Health, Inc. Subtotal1,128,295 1,096,258 1,096,258 
Yes Health, Inc.Senior Secured12.0%989,613 930,838 930,838 10/1/2024
Other Healthcare Total18.2%$44,573,088 $42,308,367 $42,002,872 
Other Technology
8E14 Networks, Inc.Senior Secured13.0%$217,430 $176,828 $176,828 9/1/2023
8E14 Networks, Inc.Senior Secured13.0%244,666 244,666 244,666 12/1/2023
8E14 Networks, Inc.Senior Secured13.0%593,274 593,274 593,274 9/1/2024
8E14 Networks, Inc. Subtotal1,055,370 1,014,768 1,014,768 
8i CorporationSenior Secured12.0%1,221,610 1,171,343 1,171,343 12/1/2023
Aclima, Inc.Senior Secured11.9%149,173 143,913 143,913 4/1/2022
Aclima, Inc.Senior Secured12.0%1,507,598 1,388,554 1,388,554 10/1/2023
Aclima, Inc. Subtotal1,656,771 1,532,467 1,532,467 
38


IndustryBorrowerPercent of Net Assets (a)CollateralInterest Rate (b)End of Term Payment (c)PrincipalCostFair Value (d)Final Maturity Date
Antitoxin Technologies Inc. ** ^Senior Secured12.0%814,262 738,781 692,140 12/1/2023
Antitoxin Technologies Inc. ** ^Senior Secured11.5%163,653 160,030 151,726 9/1/2022
Antitoxin Technologies Inc. Subtotal ** ^977,915 898,811 843,866 
ATeam Army, Inc.Senior Secured12.0%705,214 684,917 684,917 4/1/2023
Bankroll Club, LLCSenior Secured12.0%1,484,693 1,263,475 1,263,475 4/1/2025
Bankroll Club, LLCSenior Secured12.0%1,483,500 1,483,500 1,483,500 4/1/2025
Bankroll Club, LLC Subtotal2,968,193 2,746,975 2,746,975 
Beanfields, PBCSenior Secured18.0%1,126,232 1,136,604 1,005,227 *
BloomTech Inc.Senior Secured11.3%3,292,027 3,188,984 3,188,984 7/1/2023
BloomTech Inc.Senior Secured11.3%1,724,925 1,724,925 1,724,925 8/1/2023
BloomTech Inc. Subtotal5,016,952 4,913,909 4,913,909 
Brave Care Technologies, Inc.Senior Secured12.0%2,226,032 2,078,142 2,078,142 9/1/2024
Brightside Benefit, Inc.Senior Secured12.1%211,297 207,383 207,383 9/1/2022
Brightside Benefit, Inc.Senior Secured12.4%456,660 453,272 453,272 3/1/2023
Brightside Benefit, Inc. Subtotal667,957 660,655 660,655 
Bryte, Inc.Senior Secured10.0%2,478,976 2,295,843 2,295,843 4/1/2025
BW Industries, Inc.Senior Secured11.8%1,098,200 1,048,349 1,048,349 5/1/2023
BW Industries, Inc.Senior Secured11.8%1,157,127 1,144,903 1,144,903 6/1/2023
BW Industries, Inc. Subtotal2,255,327 2,193,252 2,193,252 
Candy Club Holdings, Inc. **Senior Secured12.0%2,474,741 2,474,741 2,474,741 5/1/2025
Candy Club Holdings, Inc. **Senior Secured12.0%4,945,712 3,938,353 3,938,353 10/1/2024
Candy Club Holdings, Inc. Subtotal **7,420,453 6,413,094 6,413,094 
Ceres Imaging, Inc.Senior Secured12.0%1,979,769 1,796,975 1,796,975 4/1/2025
ClipCall, Inc.Senior Secured12.5%377,537 347,225 347,225 10/1/2023
Content Adjacent, Inc.Senior Secured12.0%494,793 494,793 494,793 6/1/2024
Content Adjacent, Inc.Senior Secured12.0%1,977,137 1,920,036 1,920,036 6/1/2024
Content Adjacent, Inc. Subtotal2,471,930 2,414,829 2,414,829 
Coterie Applications, Inc.Senior Secured11.0%2,476,651 2,240,496 2,240,496 9/1/2025
Coterie Applications, Inc.Senior Secured12.5%494,338 494,338 494,338 6/1/2024
Coterie Applications, Inc.Senior Secured12.5%723,625 671,265 671,265 9/1/2023
Coterie Applications, Inc.Senior Secured12.5%903,053 903,053 903,053 3/1/2024
Coterie Applications, Inc. Subtotal4,597,667 4,309,152 4,309,152 
Daybase, Inc.Senior Secured12.0%989,639 908,021 908,021 9/1/2024
Equestrian Labs, Inc.Senior Secured12.0%1,483,577 1,398,054 1,234,057 6/1/2024
Equestrian Labs, Inc.Senior Secured12.0%742,341 725,469 640,369 6/1/2024
Equestrian Labs, Inc.Senior Secured12.0%742,058 727,787 642,415 6/1/2024
Equestrian Labs, Inc. Subtotal2,967,976 2,851,310 2,516,841 
Fakespot, Inc.Senior Secured12.0%494,493 447,448 447,448 8/1/2024
Fakespot, Inc.Senior Secured12.0%989,486 972,163 972,163 8/1/2024
Fakespot, Inc. Subtotal1,483,979 1,419,611 1,419,611 
Fitplan, Inc. ** ^Senior Secured12.5%994,922 815,498 815,498 11/1/2023
Flo Water, Inc.Senior Secured11.8%1,394,506 1,348,314 1,348,314 12/1/2023
Hadrian Automation, Inc.Senior Secured11.5%2,722,876 2,583,157 2,583,157 2/1/2025
Higher Ground Education, Inc.Senior Secured12.5%4,942,636 4,742,950 4,742,950 2/1/2025
Higher Ground Education, Inc.Senior Secured12.5%275,567 273,064 273,064 5/1/2023
Higher Ground Education, Inc.Senior Secured12.5%781,981 775,361 775,361 4/1/2023
Higher Ground Education, Inc.Senior Secured12.5%1,075,086 1,050,104 1,050,104 1/1/2023
39


IndustryBorrowerPercent of Net Assets (a)CollateralInterest Rate (b)End of Term Payment (c)PrincipalCostFair Value (d)Final Maturity Date
Higher Ground Education, Inc.Senior Secured12.5%319,321 316,022 316,022 8/1/2023
Higher Ground Education, Inc.Senior Secured12.5%6,923,164 6,611,952 6,611,952 6/1/2025
Higher Ground Education, Inc. Subtotal14,317,755 13,769,453 13,769,453 
Hint, Inc.Senior Secured12.0%3,440,711 3,234,998 3,234,998 6/1/2023
Hyphen Technologies, Inc.Senior Secured12.0%2,473,894 2,330,578 2,330,578 7/1/2024
Inscopix, Inc.Senior Secured12.0%4,946,375 4,826,097 4,826,097 4/1/2025
Intergalactic Foods CorporationSenior Secured12.0%494,826 464,110 464,110 1/1/2025
Invert Robotics Group, Ltd. ** ^Senior Secured13.0%1,978,043 1,769,078 1,769,078 1/1/2025
Jiko Group, Inc.Senior Secured12.0%2,200,833 2,142,294 2,142,294 6/1/2023
Kinoo, Inc.Senior Secured11.5%990,167 921,525 921,525 1/1/2025
Lacuna Technologies, Inc.Senior Secured12.0%1,484,897 1,347,463 1,347,463 5/1/2025
Level Home, Inc.Senior Secured11.8%9,898,880 9,735,057 9,735,057 2/1/2025
Level Home, Inc.Senior Secured11.8%9,895,966 9,267,817 9,267,817 5/1/2025
Level Home, Inc. Subtotal19,794,846 19,002,874 19,002,874 
Luva Inc.Senior Secured11.3%495,238 459,320 459,320 12/1/2024
Make School, Inc.Senior Secured18.0%79,946 45,838 19,536 *
MASC Inc.Senior Secured12.0%494,854 426,580 426,580 9/1/2024
Mavenform, Inc.Senior Secured11.5%494,974 484,719 484,719 6/1/2025
Mavenform, Inc.Senior Secured11.5%989,298 947,765 947,765 6/1/2024
Mavenform, Inc. Subtotal1,484,272 1,432,484 1,432,484 
Merlin Labs, Inc.Senior Secured11.0%115,653 114,777 114,777 1/1/2023
Merlin Labs, Inc.Senior Secured11.0%2,971,743 2,810,122 2,810,122 6/1/2025
Merlin Labs, Inc.Senior Secured11.0%110,140 109,024 109,024 6/1/2022
Merlin Labs, Inc. Subtotal3,197,536 3,033,923 3,033,923 
MinoMonsters, Inc. ** ^Senior Secured11.5%2,474,8862,387,4752,387,47510/1/2024
Momentus, Inc. **Senior Secured12.0%24,726,579 22,774,001 22,774,001 3/1/2022
Natomas Labs, Inc.Senior Secured12.3%2,473,076 2,310,655 2,310,655 9/1/2024
Natomas Labs, Inc.Senior Secured12.3%1,748,452 1,715,249 1,715,249 2/1/2024
Natomas Labs, Inc.Senior Secured12.3%2,621,376 2,492,372 2,492,372 2/1/2024
Natomas Labs, Inc.Senior Secured12.3%1,484,049 1,450,349 1,450,349 9/1/2024
Natomas Labs, Inc. Subtotal8,326,953 7,968,625 7,968,625 
NewGlobe Schools, Inc. ** ^Senior Secured12.5%4,073,677 4,012,576 4,012,576 12/1/2023
NewGlobe Schools, Inc. ** ^Senior Secured12.5%1,177,191 1,163,157 1,163,157 8/1/2022
NewGlobe Schools, Inc. ** ^Senior Secured12.5%2,423,1822,360,0352,360,0358/1/2023
NewGlobe Schools, Inc. Subtotal ** ^7,674,050 7,535,768 7,535,768 
Noteleaf, Inc.Senior Secured18.0%2,277,124 1,861,011 309,063 *
OnePointOne, Inc.Senior Secured12.0%1,748,153 1,715,659 1,715,659 2/1/2024
OnePointOne, Inc.Senior Secured12.0%1,747,2241,650,9311,650,9312/1/2024
OnePointOne, Inc. Subtotal3,495,377 3,366,590 3,366,590 
Opya, Inc.Senior Secured12.0%480,293 466,077 466,077 11/1/2023
Percepto, Inc.Senior Secured12.2%879,619 856,749 856,749 4/1/2023
Phase Four, Inc.Senior Secured11.5%1,485,295 1,388,478 1,388,478 12/1/2024
Plant Prefab, Inc.Senior Secured11.0%306,696 300,902 300,902 8/1/2022
Plant Prefab, Inc.Senior Secured11.0%2,971,403 2,786,656 2,786,656 8/1/2024
Plant Prefab, Inc.Senior Secured11.0%1,981,660 1,934,305 1,934,305 11/1/2024
Plant Prefab, Inc. Subtotal5,259,759 5,021,863 5,021,863 
Platform Science, Inc.Senior Secured12.0%94,426 93,729 93,729 2/1/2022
Platform Science, Inc.Senior Secured11.5%3,011,412 2,917,289 2,917,289 10/1/2023
Platform Science, Inc. Subtotal3,105,838 3,011,018 3,011,018 
Plethora, Inc.Senior Secured18.0%2,281,576 2,211,796 507,589 *
Privoro Holdings, Inc.Senior Secured12.0%1,718,533 1,638,692 1,638,692 4/1/2024
40


IndustryBorrowerPercent of Net Assets (a)CollateralInterest Rate (b)End of Term Payment (c)PrincipalCostFair Value (d)Final Maturity Date
Reali Inc.Senior Secured12.5%2,894,499 2,812,255 2,812,255 9/1/2023
Reali Inc.Senior Secured12.5%11,870,649 11,366,149 11,366,149 12/1/2024
Reali Inc.Senior Secured12.5%2,709,730 2,602,399 2,602,399 3/1/2024
Reali Inc. Subtotal17,474,878 16,780,803 16,780,803 
Romaine Empire, Inc.Senior Secured12.3%3,896,929 3,781,983 3,781,983 9/1/2023
Saltbox, Inc.Senior Secured12.3%269,697 263,567 263,567 6/1/2023
Setex Technologies, Inc.Senior Secured12.3%1,236,308 1,109,408 1,109,408 8/1/2024
SMS OPCO LLCSenior Secured8.0%33,875 15,125 15,125 *
Sorfeo Inc.Senior Secured11.5%989,918 981,903 981,903 9/1/2024
Sustainable Living Partners, LLCSenior Secured12.5%2,971,313 2,758,178 2,758,178 8/1/2023
Sustainable Living Partners, LLCSenior Secured12.5%9,892,044 8,598,175 8,598,175 9/1/2025
Sustainable Living Partners, LLC Subtotal12,863,357 11,356,353 11,356,353 
The Farm Project, PBC.Senior Secured12.0%3,926,667 3,714,785 3,714,785 1/1/2025
The Safe and Fair Food Company LLCSenior Secured12.3%2,471,977 2,204,367 2,204,367 9/1/2024
TomoCredit, Inc.Senior Secured12.5%289,608 289,608 289,608 9/1/2023
TomoCredit, Inc.Senior Secured12.5%434,205 409,659 409,659 9/1/2023
TomoCredit, Inc. Subtotal723,813 699,267 699,267 
Umbra Lab, Inc.Senior Secured12.0%4,944,750 4,799,256 4,799,256 6/1/2024
Umbra Lab, Inc.Senior Secured12.0%4,946,551 4,781,591 4,781,591 6/1/2024
Umbra Lab, Inc. Subtotal9,891,301 9,580,847 9,580,847 
Veev Group, Inc.Senior Secured12.5%2,360,822 2,337,325 2,337,325 6/1/2023
Veev Group, Inc.Senior Secured12.5%19,779,528 18,948,019 18,948,019 12/1/2024
Veev Group, Inc.Senior Secured12.5%786,775 740,586 740,586 6/1/2023
Veev Group, Inc. Subtotal22,927,125 22,025,930 22,025,930 
Velo Holdings LimitedSenior Secured12.0%2,471,720 1,955,642 1,539,333 *
Welcome Tech, Inc.Senior Secured10.5%153,082 150,226 150,226 5/1/2022
Wheels Labs, Inc.Senior Secured12.0%2,221,660 2,134,921 2,134,921 6/1/2023
Wine Plum, Inc.Senior Secured12.5%329,558 324,821 324,821 9/1/2022
World Wrapps II, Inc.Senior Secured12.0%480,319 480,319 480,319 6/1/2024
World Wrapps II, Inc.Senior Secured12.0%494,453 494,453 494,453 6/1/2024
World Wrapps II, Inc.Senior Secured12.0%494,418 394,196 394,196 6/1/2024
World Wrapps II, Inc. Subtotal1,469,190 1,368,968 1,368,968 
Other Technology Total102.7%$255,168,933 $240,678,546 $236,458,989 
Security
Lassen Peak, Inc.Senior Secured11.0%$371,530 $347,750 $347,750 8/1/2024
Nok Nok Labs, Inc.Senior Secured12.5%191,326 190,411 190,411 6/1/2022
Popily, Inc.Senior Secured12.5%2,036,717 1,852,544 1,852,544 8/1/2024
Security Total1.0%$2,599,573 $2,390,705 $2,390,705 
Software
Afero, Inc.Senior Secured12.3%$2,110,745 $1,925,141 $1,925,141 1/1/2024
Amino, Inc.Senior Secured11.5%8,910,784 8,465,259 8,465,259 2/1/2025
BackboneAI Inc.Senior Secured12.3%314,742 310,330 310,330 6/1/2023
BackboneAI Inc.Senior Secured12.3%480,420 471,361 471,361 5/1/2024
BackboneAI Inc.Senior Secured12.3%314,588 290,514 290,514 6/1/2023
BackboneAI Inc. Subtotal1,109,750 1,072,205 1,072,205 
Big Run Studios, Inc.Senior Secured11.5%1,979,680 1,870,020 1,870,020 8/1/2024
Big Run Studios, Inc.Senior Secured11.5%990,230 968,648 968,648 12/1/2024
Big Run Studios, Inc. Subtotal2,969,910 2,838,668 2,838,668 
Bizly, Inc.Senior Secured11.5%346,312 294,503 294,503 12/1/2024
Bizly, Inc.Senior Secured11.5%296,956 290,080 290,080 12/1/2024
Bizly, Inc.Senior Secured11.5%990,414 953,972 953,972 3/1/2025
Bizly, Inc. Subtotal1,633,682 1,538,555 1,538,555 
41


IndustryBorrowerPercent of Net Assets (a)CollateralInterest Rate (b)End of Term Payment (c)PrincipalCostFair Value (d)Final Maturity Date
Blockdaemon, Inc.Senior Secured12.0%903,100861,263861,2633/1/2024
Blockdaemon, Inc.Senior Secured11.3%55,201 54,707 54,707 6/1/2022
Blockdaemon, Inc. Subtotal958,301 915,970 915,970 
BriteCo LLCSenior Secured12.0%395,658 342,857 342,857 7/1/2024
BriteCo LLCSenior Secured12.0%346,461 346,461 346,461 2/1/2025
BriteCo LLC Subtotal742,119 689,318 689,318 
Censia Inc.Senior Secured11.0%360,514 353,690 353,690 10/1/2022
Chowbus, Inc.Senior Secured12.0%989,944 918,165 918,165 11/1/2024
Chowbus, Inc.Senior Secured12.0%3,959,556 3,303,025 3,303,025 11/1/2024
Chowbus, Inc. Subtotal4,949,500 4,221,190 4,221,190 
Cloudleaf, Inc.Senior Secured12.0%741,575 732,365 732,365 9/1/2024
Cloudleaf, Inc.Senior Secured12.0%956,267 919,269 919,269 8/1/2023
Cloudleaf, Inc. Subtotal1,697,842 1,651,634 1,651,634 
Dynamics, Inc.Senior Secured12.5%293,593 291,440 291,440 2/1/2022
Eskalera, Inc.Senior Secured10.5%527,451 518,933 518,933 3/1/2023
Grokker, Inc.Senior Secured11.5%989,743 946,783 946,783 3/1/2025
ICX Media, Inc.Senior Secured12.5%762,829 651,140 449,541 *
Ipolipo, Inc.Senior Secured12.0%568,765 544,693 544,693 9/1/2022
Medable, Inc.Senior Secured12.0%498,356 494,657 494,657 2/1/2023
Medable, Inc.Senior Secured12.0%996,585 967,179 967,179 2/1/2023
Medable, Inc. Subtotal1,494,941 1,461,836 1,461,836 
Metawave CorporationSenior Secured12.0%237,768 235,670 235,670 7/1/2022
Migo Money, Inc. ** ^Senior Secured12.5%56,63156,63156,6313/1/2022
Pixlee TurnTo, Inc.Senior Secured12.3%1,266,1621,223,9091,223,9091/1/2024
Pixlee TurnTo, Inc.Senior Secured12.0%2,226,752 2,123,863 2,123,863 8/1/2025
Pixlee TurnTo, Inc. Subtotal3,492,914 3,347,772 3,347,772 
Safe Securities Inc.Senior Secured12.0%249,200 240,930 240,930 2/1/2023
Safe Securities Inc.Senior Secured11.5%5,941,379 5,623,508 5,623,508 9/1/2025
Safe Securities Inc. Subtotal6,190,579 5,864,438 5,864,438 
SF Insuretech, Inc.Senior Secured11.8%2,969,348 2,821,808 2,821,808 8/1/2024
SmartVid.io, Inc.Senior Secured11.8%1,979,037 1,783,763 1,783,763 9/1/2024
Sonatus, IncSenior Secured12.5%723,799 663,896 663,896 9/1/2023
Splitwise, Inc.Senior Secured12.3%216,004 212,084 212,084 12/1/2022
StayTuned Digital, Inc.Senior Secured12.0%1,484,8771,473,8611,473,8612/1/2025
StayTuned Digital, Inc.Senior Secured12.0%283,336235,242235,2421/1/2025
StayTuned Digital, Inc. Subtotal1,768,213 1,709,103 1,709,103 
Swiftly Systems, Inc.Senior Secured11.5%4,713,7564,077,4674,077,46710/1/2024
Swiftly Systems, Inc.Senior Secured11.5%2,473,6262,364,6212,364,6211/1/2025
Swiftly Systems, Inc. Subtotal7,187,382 6,442,088 6,442,088 
Swivel, Inc.Senior Secured12.0%83,68083,68083,68010/1/2022
Swivel, Inc.Senior Secured12.0%67,60366,23366,2338/1/2022
Swivel, Inc. Subtotal151,283 149,913 149,913 
Terragon, Inc. ** ^Senior Secured12.0%480,496365,014365,0145/1/2024
Trucking Jobs Technologies, Inc.Senior Secured10.5%634,198584,969584,9697/1/2024
Truthset, Inc.Senior Secured10.5%185,411179,361179,3612/1/2023
Truthset, Inc.Senior Secured10.5%222,283222,283222,2835/1/2023
Truthset, Inc. Subtotal407,694 401,644 401,644 
WorkRails, Inc.Senior Secured12.0%123,625120,527120,5273/1/2025
WorkRails, Inc.Senior Secured12.0%371,239339,771339,7712/1/2025
WorkRails, Inc. Subtotal494,864 460,298 460,298 
Workspot, Inc.Senior Secured12.0%2,352,6232,265,7532,265,75311/1/2023
Workspot, Inc.Senior Secured12.0%220,008215,206215,2068/1/2022
Workspot, Inc.Senior Secured12.0%272,328270,000270,00010/1/2022
Workspot, Inc.Senior Secured12.0%903,253864,056864,0563/1/2024
Workspot, Inc. Subtotal3,748,212 3,615,015 3,615,015 
Software Total24.6%$60,818,891 $56,800,561 $56,598,962 
42


IndustryBorrowerPercent of Net Assets (a)CollateralInterest Rate (b)End of Term Payment (c)PrincipalCostFair Value (d)Final Maturity Date
Technology Services
iLearningEngines Inc.Senior Secured11.5%$1,980,078 $1,874,081 $1,874,081 1/1/2025
iLearningEngines Inc.Senior Secured11.5%2,475,711735,489735,48910/1/2024
iLearningEngines Inc.Senior Secured11.5%7,919,5507,244,0787,244,0786/1/2024
iLearningEngines Inc. Subtotal12,375,339 9,853,648 9,853,648 
Klar Holdings Limited ** ^Senior Secured12.5%91,08384,35484,35410/1/2022
Klar Holdings Limited ** ^Senior Secured12.0%3.0%2,487,2792,439,2072,439,2078/1/2024
Klar Holdings Limited ** ^Senior Secured12.0%2,473,1872,327,7762,327,7766/1/2024
Klar Holdings Limited ** ^Senior Secured14.2%4.0%171,136165,351165,3517/1/2023
Klar Holdings Limited Subtotal ** ^5,222,685 5,016,688 5,016,688 
Liftit, Inc. ** ^Senior Secured12.0%181,508180,377180,37710/1/2022
Liftit, Inc. ** ^Senior Secured12.0%146,623143,541143,5418/1/2022
Liftit, Inc. Subtotal ** ^328,131 323,918 323,918 
Loansnap Holdings Inc. **Senior Secured10.3%3,717,7803,467,9583,467,9582/1/2025
Loansnap Holdings Inc. **Senior Secured11.0%1,179,4421,145,8021,145,80212/1/2022
Loansnap Holdings Inc. Subtotal **4,897,222 4,613,760 4,613,760 
Riffyn, Inc.Senior Secured11.5%1,746,6661,699,1551,699,1552/1/2024
Riffyn, Inc.Senior Secured11.5%1,864,2301,846,0531,846,0534/1/2024
Riffyn, Inc. Subtotal3,610,896 3,545,208 3,545,208 
Zanbato, Inc.Senior Secured11.0%2,522,7542,469,4832,469,4839/1/2023
Zeel Networks, Inc.Senior Secured11.0%2,004,3621,951,3571,916,7636/1/2024
Technology Services Total12.1%$30,961,389 $27,774,062 $27,739,468 
Wireless
AirVine Scientific, Inc.Senior Secured10.8%$619,299 $604,976 $604,976 6/1/2024
AirVine Scientific, Inc.Senior Secured12.0%41,05040,22040,2209/1/2022
AirVine Scientific, Inc.Senior Secured12.0%41,07840,71840,7189/1/2022
AirVine Scientific, Inc.Senior Secured10.8%618,987586,089586,0896/1/2024
AirVine Scientific, Inc. Subtotal1,320,414 1,272,003 1,272,003 
MeshPlusPlus, Inc.Senior Secured12.5%677,531634,884634,8843/1/2024
MeshPlusPlus, Inc.Senior Secured12.5%247,256241,501241,5016/1/2024
MeshPlusPlus, Inc. Subtotal924,787 876,385 876,385 
Parallel Wireless, Inc.Senior Secured11.8%2,245,5002,223,6952,223,6958/1/2023
Parallel Wireless, Inc.Senior Secured11.8%4,080,1763,975,8283,975,8286/1/2023
Parallel Wireless, Inc.Senior Secured11.8%2,346,7872,322,8402,322,8409/1/2023
Parallel Wireless, Inc. Subtotal8,672,463 8,522,363 8,522,363 
Wireless Total4.6%$10,917,664 $10,670,751 $10,670,751 
Grand Total210.3%$535,514,424 $501,909,222 $484,047,644 

*As of December 31, 2018, all2021, loans with a cost basis of $27.1 million and a fair value of $9.6 million were valued using significant unobservable inputsclassified as non-accrual. These loans have been accelerated from their original maturity and were made to non-affiliates. Additionally, allare due in their entirety. During the period for which these loans were pledged as collateral as part of the debt facility.have been on non-accrual status, no income has been recognized.

IndustryBorrower 
Percent of Net Assets (a)
 Collateral Interest Rate End of Term Payment Principal Cost Fair Value Maturity Date
Biotechnology                 
 Antheia, Inc.   Senior Secured 11.5%   $1,485,403 $1,376,139 $1,376,139 12/1/2022
Biotechnology Total  1.9%       $1,485,403 $1,376,139 $1,376,139  
                  
Enterprise Networking                 
 SnapRoute, Inc.   Senior Secured 11.0%   $3,466,659 $3,266,067 $3,266,067 11/1/2021
Enterprise Networking Total  4.4%       $3,466,659 $3,266,067 $3,266,067  
                  
Internet                 
 Amino Payments, Inc.   Senior Secured 9.0% 4.8% $625,521 $597,770 $597,770 12/1/2021
 DreamCloud Holdings, LLC   Senior Secured 12.0%   4,948,333 4,232,618 4,232,618 12/1/2021
 Osix Corporation   Senior Secured 12.3%   98,605 80,379 80,379 12/1/2021
 Protecht, Inc.   Senior Secured 12.5%   988,684 926,867 926,867 12/1/2021
 Thrive Market, Inc.   Senior Secured 12.3%   7,420,042 7,134,488 7,134,488 4/1/2022
Internet Total  17.5%       $14,081,185 $12,972,122 $12,972,122  
                  
Medical Devices                 
 CytoVale, Inc.   Senior Secured 12.0%   $618,631 $566,206 $566,206 3/1/2022
 Medrobotics Corporation, Inc.   Senior Secured 12.0%   9,893,475 8,990,046 8,990,046 6/1/2021
 NeuMoDx Molecular, Inc.   Senior Secured 12.0%   3,463,954 3,168,810 3,168,810 4/1/2023
Medical Devices Total  17.2%       $13,976,060 $12,725,062 $12,725,062  
                  
Other Healthcare                 
 Caredox, Inc.   Senior Secured 11.8%   $1,237,487 $1,168,686 $1,168,686 10/1/2021
 Discover Echo, Inc.   Senior Secured 11.0%   610,296 571,549 571,549 12/1/2020
Other Healthcare Total  2.4%       $1,847,783 $1,740,235 $1,740,235  
                  
Other Technology                 
 Aclima, Inc.   Senior Secured 11.0% 0.5% $2,109,845 $1,987,764 $1,987,764 7/1/2021
 Brightside Benefit, Inc.   Senior Secured 12.1%   742,419 676,970 676,970 9/1/2022
 Dragonfly Vert, Inc.   Senior Secured 12.5%   984,722 928,746 928,746 12/1/2021
 Fitplan, Inc.* ^   Senior Secured 12.5%   742,195 689,277 689,277 3/1/2022
 Hint, Inc.   Senior Secured 11.0%   2,475,778 2,217,362 2,217,362 8/1/2021
 Kobo360 Inc.* ^   Senior Secured 11.3%   247,553 235,597 235,597 6/1/2020
 Kobo360 Inc.* ^   Senior Secured 11.3%   247,607 247,607 247,607 9/1/2020
 Kobo360 Inc.* ^ Subtotal         495,160 483,204 483,204  
 Kogniz, Inc.   Senior Secured 12.8%   370,935 274,751 274,751 9/1/2021
 Make School, Inc.   Senior Secured 11.3%   990,265 937,821 937,821 8/1/2021
 Nevada Nanotech Systems, Inc.   Senior Secured 12.0%   989,590 906,963 906,963 6/1/2021
 Plethora, Inc.   Senior Secured 9.5% 4.3% 500,151 462,877 462,877 6/1/2021
 Plethora, Inc.   Senior Secured 9.5% 4.3% 248,860 244,096 244,096 9/1/2021
 Plethora, Inc.   Senior Secured 9.5% 4.3% 496,863 486,908 486,908 10/1/2021
 Plethora, Inc. Subtotal         1,245,874 1,193,881 1,193,881  
 Scoot Networks, Inc.   Senior Secured 12.8%   879,262 818,310 818,310 3/1/2021
 SkyKick, Inc.   Senior Secured 11.0%   4,952,637 4,660,147 4,660,147 6/1/2022
                  
                  
                  


IndustryBorrower 
Percent of Net Assets (a)
 Collateral Interest Rate End of Term Payment Principal Cost Fair Value Maturity Date
 Strong Arm Technologies, Inc.   Senior Secured 12.0%   1,081,134 1,031,438 1,031,438 5/1/2021
 Theatro Labs, Inc.   Senior Secured 12.0%   1,484,478 1,426,311 1,426,311 8/1/2022
 Virtuix Holdings, Inc.   Senior Secured 12.3%   247,423 239,317 239,317 4/1/2022
Other Technology Total  24.9%       $19,791,717 $18,472,262 $18,472,262  
                  
Security                 
 Axonius, Inc.   Senior Secured 12.0%   $494,882 $470,235 $470,235 9/1/2021
 Nok Nok Labs, Inc.   Senior Secured 12.5%   988,949 959,222 959,222 6/1/2022
 Safetrust Holdings, Inc.   Senior Secured 12.5%   494,508 447,173 447,173 6/1/2021
Security Total  2.5%       $1,978,339 $1,876,630 $1,876,630  
                  
Semiconductors & Equipment                 
 ETA Compute, Inc.   Senior Secured 12.0%   $1,484,845 $1,404,604 $1,404,604 11/1/2021
Semiconductors & Equipment Total  1.9%       $1,484,845 $1,404,604 $1,404,604  
                  
Software                 
 Blockdaemon, Inc.   Senior Secured 11.3%   $247,555 $219,310 $219,310 8/1/2021
 Dynamics, Inc.   Senior Secured 12.5%   7,420,031 6,251,460 6,251,460 8/1/2021
 Interana, Inc.   Senior Secured 11.3%   2,970,465 2,865,164 2,865,164 6/1/2021
 Invoice2Go, Inc.   Senior Secured 12.0%   989,788 829,825 829,825 3/1/2022
 Ipolipo, Inc.   Senior Secured 12.0%   2,453,333 2,323,285 2,323,285 12/1/2021
 Metricly, Inc.   Senior Secured 12.3%   494,715 450,708 450,708 11/1/2021
 Mines.io, Inc.* ^   Senior Secured 12.3%   742,179 671,683 671,683 12/1/2021
 Mines.io, Inc.* ^   Senior Secured 12.5%   494,618 494,618 494,618 3/1/2022
 Mines.io, Inc.* ^ Subtotal         1,236,797 1,166,301 1,166,301  
 Oohlala Mobile, Inc.* ^   Senior Secured 11.5%   247,581 247,581 247,581 9/1/2021
 Oohlala Mobile, Inc.* ^   Senior Secured 11.5%   469,136 469,136 469,136 9/1/2021
 Oohlala Mobile, Inc.* ^ Subtotal         716,717 716,717 716,717  
 OrderGroove, Inc.   Senior Secured 12.0%   2,474,167 2,311,992 2,311,992 6/1/2023
 PlushCare, Inc.   Senior Secured 11.8%   990,205 917,120 917,120 5/1/2022
 Resilio, Inc.   Senior Secured 12.8%   225,964 180,310 180,310 3/1/2021
 Resilio, Inc.   Senior Secured 12.8%   240,276 240,276 240,276 5/1/2021
 Resilio, Inc. Subtotal         466,240 420,586 420,586  
 Skillshare, Inc.   Senior Secured 12.0%   1,978,640 1,862,640 1,862,640 6/1/2021
 Stitch Labs, Inc.   Senior Secured 12.0%   1,484,916 1,346,447 1,346,447 2/1/2022
 Venuetize, LLC   Senior Secured 12.3%   247,416 214,060 214,060 4/1/2022
 Workspot, Inc.   Senior Secured 12.0%   742,276 674,121 674,121 9/1/2021
 Zoomdata, Inc.   Senior Secured 11.5%   736,105 699,299 699,299 3/1/2022
Software Total  31.4%       $25,649,366 $23,269,035 $23,269,035  
                  
Technology Services                 
 Keyo AI Inc.   Senior Secured 10.0%   $495,800 $455,925 $455,925 2/1/2022
 Relimetrics, Inc.   Senior Secured 11.3%   371,450 347,197 347,197 1/1/2022
 Zeel Networks, Inc.   Senior Secured 11.0%   1,238,318 1,139,829 1,139,829 3/1/2022
Technology Services Total  2.6%       $2,105,568 $1,942,951 $1,942,951  
Grand Total  106.7%       $85,866,925 $79,045,107 $79,045,107  
**Indicates assets that the Fund deems “non-qualifying assets” underassets." As of December 31, 2021, 13.2% of the Fund’s total assets represented non-qualifying assets. Under Section 55(a) of the 1940 Act. QualifyingAct, the Fund is prohibited from acquiring any additional non-qualifying assets mustunless, at the time of acquisition, certain specified qualifying assets (e.g., securities issued by an "eligible portfolio company," as defined in Section 2(a)(46)) represent at least 70% of the Fund’sits total assets at the time of acquisition of any additional non-qualifying assets. As of December 31, 2018, 3.8% of the Fund’s assets represented non-qualifying assets. As part of this calculation, the numerator consists of the value of the Fund's investments in all eligible portfolio companies, as defined in Section 2(a)(46) of the 1940 Act; and the denominator consists of total assets less thethose assets described in Section 55(a)(7) of the 1940 Act.

^ Entity is not domiciled in the United States and does not have its principal place of business in the United States.

43


(a) The percentage of net assets that each industry group represents is shown with the industry totals (the sum of the percentages does not equal 100% because the percentages are based on net assets as opposed to total loans).


(b) The interest rate is the designated annual interest rate exclusive of any original issue discount, fees or end of term payment.

(c) The end of term payments are contractually due on the maturity date and are in addition to the interest rate shown. End of term payments are the percentage of the final payment divided by the original loan amount and are amortized over the full term of the loan.

(d) There is no readily available market price or secondary market for the Fund’s loan investments, hence the Manager determines fair value of all loan investments presented in the Schedule of Investments based on a hypothetical market and the estimates may include the use of significant unobservable inputs.

As of December 31, 2017, the Fund had not yet commenced investment operations and accordingly had no2021, all loans or other investmentswere made to report.non-affiliates.
















See notes to financial statements.
44


(Intentionally left blank)


VENTURE LENDING & LEASING IX, INC.
Schedule of Investments
As of December 31, 2020
IndustryBorrower
Percent of Net Assets (a)
CollateralInterest Rate (b)End of Term Payment (c)PrincipalCostFair Value (d)Maturity Date
Biotechnology
Antheia, Inc.Senior Secured11.5%$1,219,076 $1,181,003 $1,181,003 12/1/2022
Antheia, Inc.Senior Secured11.5%1,220,291 1,206,345 1,206,345 12/1/2022
Antheia, Inc. Subtotal2,439,367 2,387,348 2,387,348 
Driver Bioengineering, Inc.Senior Secured11.0%866,600 849,310 849,310 6/1/2023
Driver Bioengineering, Inc.Senior Secured11.0%349,662 311,553 311,553 4/1/2023
Driver Bioengineering, Inc. Subtotal1,216,262 1,160,863 1,160,863 
Quartzy, Inc.Senior Secured12.0%1,113,593 1,083,782 1,083,782 7/1/2024
Quartzy, Inc.Senior Secured12.0%722,540 648,418 648,418 8/1/2023
Quartzy, Inc.Senior Secured12.0%1,113,211 1,085,490 1,085,490 5/1/2024
Quartzy, Inc. Subtotal2,949,344 2,817,690 2,817,690 
Biotechnology Total3.5%$6,604,973 $6,365,901 $6,365,901 
Computers & Storage
Canary Connect, Inc.Senior Secured12.8%$2,256,808 $2,199,490 $2,199,490 3/1/2023
Canary Connect, Inc.Senior Secured12.0%7,918,698 7,426,948 7,426,948 3/1/2024
Canary Connect, Inc. Subtotal10,175,506 9,626,438 9,626,438 
Fetch Robotics, Inc.Senior Secured12.0%7,418,932 7,104,656 7,104,656 6/1/2024
Computers & Storage Total9.1%$17,594,438 $16,731,094 $16,731,094 
Enterprise Networking
Diamanti, Inc.Senior Secured12.3%$5,441,469 $4,811,921 $4,811,921 5/1/2024
Diamanti, Inc.Senior Secured12.3%494,824 467,988 467,988 7/1/2024
Diamanti, Inc. Subtotal5,936,293 5,279,909 5,279,909 
Enterprise Networking Total2.9%$5,936,293 $5,279,909 $5,279,909 
Internet
Ainsly, Inc. ** ^Senior Secured12.5%$519,587 $490,896 $490,896 8/1/2022
Ainsly, Inc. ** ^Senior Secured12.5%173,207 173,207 173,207 8/1/2022
Ainsly, Inc. ** ^Senior Secured12.5%247,340 217,309 217,309 9/1/2023
Ainsly, Inc. Subtotal ** ^940,134 881,412 881,412 
Amino Payments, Inc.Senior Secured10.8%471,215 449,064 380,130 *
Cesium, Inc.Senior Secured10.3%105,348 103,881 103,881 1/1/2023
Cesium, Inc.Senior Secured10.3%210,624 200,481 200,481 1/1/2023
Cesium, Inc. Subtotal315,972 304,362 304,362 
iZENEtech, Inc. ** ^Senior Secured12.3%5,000,000 4,674,880 4,674,880 9/1/2024
Lukla, Inc.Senior Secured12.5%247,208 237,422 237,422 6/1/2023
Lukla, Inc.Senior Secured12.5%407,447 363,867 363,867 12/1/2022
Lukla, Inc. Subtotal654,655 601,289 601,289 
Masse, Inc.Senior Secured18.0%304,001 144,008 10,000 *
Merchbar, Inc.Senior Secured11.8%451,293 430,995 430,995 3/1/2023
MyPizza Technologies, Inc.Senior Secured11.5%4,943,040 4,784,039 4,784,039 12/1/2023
MyPizza Technologies, Inc.Senior Secured11.5%2,471,842 2,436,444 2,436,444 2/1/2024
MyPizza Technologies, Inc. Subtotal7,414,882 7,220,483 7,220,483 
Nimble Rx, Inc.Senior Secured12.0%1,091,906 999,055 999,055 2/1/2023
Nimble Rx, Inc.Senior Secured12.0%1,236,949 1,188,381 1,188,381 11/1/2023
Nimble Rx, Inc. Subtotal2,328,855 2,187,436 2,187,436 
45


IndustryBorrower
Percent of Net Assets (a)
CollateralInterest Rate (b)End of Term Payment (c)PrincipalCostFair Value (d)Maturity Date
OneLocal, Inc. ** ^Senior Secured12.3%301,162 295,353 295,353 3/1/2023
OneLocal, Inc. ** ^Senior Secured12.3%301,078 281,207 281,207 3/1/2023
OneLocal, Inc. ** ^Senior Secured12.3%301,150 296,454 296,454 3/1/2023
OneLocal, Inc. Subtotal ** ^903,390 873,014 873,014 
Osix CorporationSenior Secured12.3%43,214 40,350 40,350 12/1/2021
RenoFi, Inc.Senior Secured12.0%247,427 242,330 242,330 6/1/2023
RenoFi, Inc.Senior Secured12.0%989,893 945,226 945,226 12/1/2023
RenoFi, Inc.Senior Secured12.0%247,292 231,778 231,778 6/1/2023
RenoFi, Inc. Subtotal1,484,612 1,419,334 1,419,334 
Residently USA, LLC ** ^Senior Secured12.0%873,899 789,139 789,139 2/1/2023
Residently USA, LLC ** ^Senior Secured12.0%371,000 371,000 371,000 12/1/2023
Residently USA, LLC Subtotal ** ^1,244,899 1,160,139 1,160,139 
RetailerX, Inc.Senior Secured12.0%989,881 927,856 927,856 5/1/2024
Serface Care, Inc.Senior Secured12.3%961,139 566,912 21,201 *
Shadow, PBCSenior Secured11.5%470,556 441,930 441,930 10/1/2022
Starface World, Inc.Senior Secured12.0%494,938 481,875 481,875 1/1/2024
Starface World, Inc.Senior Secured12.0%989,583 925,385 925,385 11/1/2023
Starface World, Inc. Subtotal1,484,521 1,407,260 1,407,260 
Stay Alfred, Inc.Senior Secured18.0%6,061,856 4,548,360 635,170 *
Verishop, Inc.Senior Secured12.0%2,472,054 2,437,550 2,437,550 12/1/2023
Verishop, Inc.Senior Secured12.0%2,471,119 2,366,934 2,366,934 12/1/2023
Verishop, Inc. Subtotal4,943,173 4,804,484 4,804,484 
Internet Total15.5%$36,468,248 $33,083,568 $28,421,725 
Medical Devices
Ablacon, Inc.Senior Secured11.0%$2,256,537 $2,168,756 $2,168,756 3/1/2023
Ablacon, Inc.Senior Secured11.0%2,257,368 2,224,508 2,224,508 3/1/2023
Ablacon, Inc. Subtotal4,513,905 4,393,264 4,393,264 
Anutra Medical, Inc.Senior Secured12.0%188,448 182,138 182,138 10/1/2022
CytoVale, Inc.Senior Secured12.0%304,420 301,225 301,225 7/1/2022
CytoVale, Inc.Senior Secured12.0%362,240 358,640 358,640 6/1/2022
CytoVale, Inc.Senior Secured12.0%306,253 296,276 296,276 3/1/2022
CytoVale, Inc.Senior Secured12.0%1,978,667 1,856,409 1,856,409 9/1/2024
CytoVale, Inc.Senior Secured12.0%494,475 470,113 470,113 10/1/2023
CytoVale, Inc.Senior Secured12.0%494,687 485,502 485,502 11/1/2023
CytoVale, Inc. Subtotal3,940,742 3,768,165 3,768,165 
eXo Imaging, Inc.Senior Secured11.8%1,978,816 1,837,427 1,837,427 9/1/2023
eXo Imaging, Inc.Senior Secured11.8%1,974,541 1,930,965 1,930,965 9/1/2023
eXo Imaging, Inc. Subtotal3,953,357 3,768,392 3,768,392 
Medrobotics Corporation, Inc.Senior Secured18.0%10,000,000 8,793,564 3,275,463 *
Siren Care, Inc.Senior Secured12.5%1,977,800 1,883,794 1,883,794 10/1/2023
Siren Care, Inc.Senior Secured12.5%989,137 969,133 969,133 10/1/2023
Siren Care, Inc. Subtotal2,966,937 2,852,927 2,852,927 
SVN Med, LLCSenior Secured15.0%1,973,663 1,525,305 1,525,305 12/1/2023
SVN Med, LLCSenior Secured15.0%987,065 756,382 756,382 12/1/2023
SVN Med, LLC Subtotal2,960,728 2,281,687 2,281,687 
Medical Devices Total11.2%$28,524,117 $26,040,137 $20,522,036 
Other Healthcare
Artisan Development Labs, Inc.Senior Secured12.3%$466,116 $408,000 $408,000 4/1/2023
Caredox, Inc.Senior Secured11.8%775,417 762,534 762,534 7/1/2022
GoForward, Inc.Senior Secured11.5%6,181,238 5,735,573 5,735,573 9/1/2023
GoForward, Inc.Senior Secured11.5%3,094,971 3,004,838 3,004,838 6/1/2024
GoForward, Inc. Subtotal9,276,209 8,740,411 8,740,411 
46


IndustryBorrower
Percent of Net Assets (a)
CollateralInterest Rate (b)End of Term Payment (c)PrincipalCostFair Value (d)Maturity Date
Grin, Inc.Senior Secured12.0%989,140 944,177 944,177 10/1/2023
Grin, Inc.Senior Secured12.0%494,743 484,898 484,898 1/1/2024
Grin, Inc. Subtotal1,483,883 1,429,075 1,429,075 
Hello Heart Inc.Senior Secured11.0%1,974,944 1,930,315 1,930,315 6/1/2025
Hello Heart Inc.Senior Secured11.0%1,164,939 1,115,829 1,115,829 4/1/2023
Hello Heart Inc.Senior Secured11.0%1,974,944 1,796,427 1,796,427 6/1/2024
Hello Heart Inc.Senior Secured11.0%932,214 919,531 919,531 4/1/2023
Hello Heart Inc.Senior Secured11.0%742,816 730,145 730,145 11/1/2023
Hello Heart Inc. Subtotal6,789,857 6,492,247 6,492,247 
HumanAPI, Inc.Senior Secured11.8%421,960 416,785 416,785 1/1/2023
HumanAPI, Inc.Senior Secured11.8%1,129,747 1,086,210 1,086,210 10/1/2022
HumanAPI, Inc. Subtotal1,551,707 1,502,995 1,502,995 
Oula Heath, Inc.Senior Secured12.0%742,000 685,839 685,839 2/1/2024
PeerWell, Inc.Senior Secured12.0%989,722 913,704 913,704 3/1/2024
Sparta Software CorporationSenior Secured11.5%2.2%304,794 297,802 297,802 5/1/2022
Therapydia, Inc.Senior Secured12.0%1.7%97,822 92,394 92,394 3/1/2023
Therapydia, Inc.Senior Secured12.5%1.7%106,892 106,892 106,892 6/1/2023
Therapydia, Inc. Subtotal204,714 199,286 199,286 
Tia, Inc.Senior Secured11.8%1,980,051 1,703,424 1,703,424 5/1/2024
Vessel Health, Inc.Senior Secured12.0%618,622 618,622 618,622 3/1/2024
Vessel Health, Inc.Senior Secured12.0%618,539 561,586 561,586 3/1/2024
Vessel Health, Inc. Subtotal1,237,161 1,180,208 1,180,208 
Other Healthcare Total13.3%$25,801,631 $24,315,525 $24,315,525 
Other Technology
8E14 NetworksSenior Secured13.0%$296,533 $296,533 $296,533 12/1/2023
8E14 NetworksSenior Secured13.0%296,678 213,094 213,094 9/1/2023
8E14 Networks Subtotal593,211 509,627 509,627 
8i CorporationSenior Secured12.0%1,476,000 1,378,649 1,378,649 12/1/2023
Aclima, Inc.Senior Secured11.9%1,089,754 1,004,091 1,004,091 4/1/2022
Aclima, Inc.Senior Secured12.0%1,979,808 1,731,899 1,731,899 10/1/2023
Aclima, Inc. Subtotal3,069,562 2,735,990 2,735,990 
Antitoxin Technologies Inc. ** ^Senior Secured11.5%361,110 344,164 344,164 9/1/2022
Antitoxin Technologies Inc. ** ^Senior Secured12.0%989,838 843,946 843,946 12/1/2023
Antitoxin Technologies Inc. Subtotal ** ^1,350,948 1,188,110 1,188,110 
Apollo Flight Research Inc.Senior Secured11.0%210,893 207,995 207,995 1/1/2023
Apollo Flight Research Inc.Senior Secured11.0%313,128 304,774 304,774 6/1/2022
Apollo Flight Research Inc. Subtotal524,021 512,769 512,769 
ATeam Army, Inc.Senior Secured12.0%1,165,134 1,109,842 1,109,842 4/1/2023
Beanfields, PBCSenior Secured12.5%564,609 553,012 553,012 3/1/2023
Beanfields, PBCSenior Secured12.5%789,585 759,532 759,532 3/1/2023
Beanfields, PBC Subtotal1,354,194 1,312,544 1,312,544 
Belong Home, Inc.Senior Secured12.0%2,968,459 2,834,624 2,834,624 3/1/2024
Benson Hill Bio, Inc.Senior Secured12.5%9,883,793 9,205,314 9,205,314 5/1/2024
Brightside Benefit, Inc.Senior Secured12.1%464,870 446,579 446,579 9/1/2022
Brightside Benefit, Inc.Senior Secured12.4%774,623 764,814 764,814 3/1/2023
Brightside Benefit, Inc. Subtotal1,239,493 1,211,393 1,211,393 
BW Industries, Inc.Senior Secured11.8%1,823,172 1,792,512 1,792,512 6/1/2023
BW Industries, Inc.Senior Secured11.8%1,770,873 1,642,182 1,642,182 5/1/2023
BW Industries, Inc. Subtotal3,594,045 3,434,694 3,434,694 
Content Adjacent, Inc.Senior Secured12.0%1,979,710 1,885,861 1,885,861 6/1/2024
Coterie Applications, Inc.Senior Secured12.5%988,889 988,888 988,888 3/1/2024
47


IndustryBorrower
Percent of Net Assets (a)
CollateralInterest Rate (b)End of Term Payment (c)PrincipalCostFair Value (d)Maturity Date
Coterie Applications, Inc.Senior Secured12.5%989,023 875,966 875,966 9/1/2023
Coterie Applications, Inc. Subtotal1,977,912 1,864,854 1,864,854 
DOSH Holdings, Inc.Senior Secured—%700,000 514,745 514,745 *
Fitplan, Inc. ** ^Senior Secured12.5%1,266,870 1,086,326 1,058,116 *
Flo Water, Inc.Senior Secured11.8%1,978,592 1,884,544 1,884,544 12/1/2023
Higher Ground Education, Inc.Senior Secured12.5%442,838 436,301 436,301 5/1/2023
Higher Ground Education, Inc.Senior Secured12.5%1,946,804 1,865,641 1,865,641 1/1/2023
Higher Ground Education, Inc.Senior Secured12.5%1,289,010 1,270,861 1,270,861 4/1/2023
Higher Ground Education, Inc.Senior Secured12.5%481,455 473,834 473,834 8/1/2023
Higher Ground Education, Inc. Subtotal4,160,107 4,046,637 4,046,637 
Hint, Inc.Senior Secured12.0%4,944,981 4,446,656 4,446,656 6/1/2023
Hint, Inc.Senior Secured11.0%727,671 706,141 706,141 8/1/2021
Hint, Inc. Subtotal5,672,652 5,152,797 5,152,797 
Jiko Group, Inc.Senior Secured12.0%3,463,686 3,318,065 3,318,065 6/1/2023
Kogniz, Inc.Senior Secured12.8%220,052 203,327 203,327 3/1/2022
Lambda School, Inc.Senior Secured11.3%4,948,041 4,701,574 4,701,574 7/1/2023
Lambda School, Inc.Senior Secured11.3%2,474,403 2,474,403 2,474,403 8/1/2023
Lambda School, Inc. Subtotal7,422,444 7,175,977 7,175,977 
Make School, Inc.Senior Secured11.3%291,677 287,406 287,406 8/1/2021
Natomas Labs, Inc.Senior Secured12.3%2,969,286 2,732,463 2,732,463 2/1/2024
Nevada Nanotech Systems, Inc.Senior Secured12.0%222,226 217,658 217,658 6/1/2021
NewGlobe Schools, Inc. ** ^Senior Secured12.5%2,769,725 2,695,080 2,695,080 8/1/2022
NewGlobe Schools, Inc. ** ^Senior Secured12.5%3,459,803 3,315,571 3,315,571 8/1/2023
NewGlobe Schools, Inc. ** ^Senior Secured12.5%4,946,802 4,825,816 4,825,816 12/1/2023
NewGlobe Schools, Inc. Subtotal ** ^11,176,330 10,836,467 10,836,467 
Noteleaf, Inc.Senior Secured12.5%2,277,124 2,161,761 1,028,982 *
OnePointOne, Inc.Senior Secured12.0%1,960,000 1,783,411 1,783,411 2/1/2024
Opya, Inc.Senior Secured12.0%989,171 958,214 958,214 11/1/2023
Ozy Media, Inc.Senior Secured12.8%2,965,665 2,775,884 2,775,884 6/1/2023
Ozy Media, Inc.Senior Secured12.8%1,483,826 1,424,222 1,424,222 9/1/2023
Ozy Media, Inc.Senior Secured12.8%1,977,806 1,977,807 1,977,807 6/1/2023
Ozy Media, Inc.Senior Secured12.8%2,470,510 2,383,782 2,383,782 6/1/2023
Ozy Media, Inc. Subtotal8,897,807 8,561,695 8,561,695 
Percepto, Inc.Senior Secured12.2%1,799,336 1,721,548 1,721,548 4/1/2023
Pitzi, Ltd. ** ^Senior Secured12.0%482,870 376,812 376,812 11/1/2023
Pitzi, Ltd. ** ^Senior Secured12.0%1,483,727 1,435,741 1,435,741 4/1/2024
Pitzi, Ltd. Subtotal ** ^1,966,597 1,812,553 1,812,553 
Plant Prefab, Inc.Senior Secured11.0%1,045,516 999,473 999,473 8/1/2022
Platform Science, Inc.Senior Secured11.5%3,960,517 3,760,439 3,760,439 10/1/2023
Platform Science, Inc.Senior Secured12.0%623,171 601,043 601,043 2/1/2022
Platform Science, Inc. Subtotal4,583,688 4,361,482 4,361,482 
Plethora, Inc.Senior Secured11.5%997,774 945,362 945,362 7/1/2022
Privoro Holdings, Inc.Senior Secured12.0%1,979,606 1,836,871 1,836,871 4/1/2024
Reali Inc.Senior Secured12.5%3,956,094 3,775,549 3,775,549 9/1/2023
Romaine Empire, Inc.Senior Secured12.3%5,454,020 5,227,539 5,227,539 7/1/2023
Saltbox, Inc.Senior Secured12.3%423,968 408,719 408,719 6/1/2023
SMS OPCO LLCSenior Secured8.0%36,875 18,125 18,125 *
Strong Arm Technologies, Inc.Senior Secured12.0%209,338 207,281 207,281 5/1/2021
Sustainable Living Partners, LLCSenior Secured12.5%4,479,984 3,999,116 3,999,116 8/1/2023
Theatro Labs, Inc.Senior Secured12.0%888,982 873,903 873,903 8/1/2022
48


IndustryBorrower
Percent of Net Assets (a)
CollateralInterest Rate (b)End of Term Payment (c)PrincipalCostFair Value (d)Maturity Date
TIER Mobility GmbH ** ^Senior Secured12.0%8,905,182 8,561,180 8,561,180 4/1/2023
TomoCredit, Inc.Senior Secured12.5%395,819 395,819 395,819 9/1/2023
TomoCredit, Inc.Senior Secured12.5%593,454 540,134 540,134 9/1/2023
TomoCredit, Inc. Subtotal989,273 935,953 935,953 
Veev Group, Inc.Senior Secured12.5%1,235,419 1,122,426 1,122,426 6/1/2023
Veev Group, Inc.Senior Secured12.5%3,707,038 3,648,364 3,648,364 6/1/2023
Veev Group, Inc.Senior Secured12.5%432,783 424,481 424,481 12/1/2021
Veev Group, Inc. Subtotal5,375,240 5,195,271 5,195,271 
Velo Holdings LimitedSenior Secured12.0%2,471,720 2,252,248 1,985,209 *
Virtuix Holdings, Inc.Senior Secured12.3%141,134 139,438 117,049 4/1/2022
Welcome Tech, Inc.Senior Secured10.5%578,778 545,308 545,308 5/1/2022
Wheels Labs, Inc.Senior Secured12.5%3,115,612 3,051,198 3,051,198 8/1/2022
Wine Plum, Inc.Senior Secured12.5%723,778 701,625 701,625 9/1/2022
World Wrapps II, Inc.Senior Secured12.0%494,667 342,954 342,954 6/1/2024
Other Technology Total69.1%$135,461,668 $128,018,460 $126,568,043 
Security
ArecaBay, Inc.Senior Secured11.0%$1,485,917 $1,417,675 $1,417,675 8/1/2023
Axonius, Inc.Senior Secured12.0%164,208 161,820 161,820 9/1/2021
Nok Nok Labs, Inc.Senior Secured12.5%540,071 533,246 533,246 6/1/2022
Popily, Inc.Senior Secured12.5%989,137 867,450 867,450 12/1/2023
Popily, Inc.Senior Secured12.5%1,484,125 1,484,125 1,484,125 12/1/2023
Popily, Inc. Subtotal2,473,262 2,351,575 2,351,575 
Safetrust Holdings, Inc.Senior Secured12.5%249,930 186,010 186,010 8/1/2021
Security Total2.5%$4,913,388 $4,650,326 $4,650,326 
Semiconductors & Equipment
ETA Compute, Inc.Senior Secured12.0%$596,190 $585,915 $585,915 11/1/2021
Semiconductors & Equipment Total0.3%$596,190 $585,915 $585,915 
Software
Afero, Inc.Senior Secured12.3%$2,474,202 $2,127,019 $2,127,019 1/1/2024
Airbrake Technologies, Inc.Senior Secured12.5%989,466 898,541 898,541 10/1/2023
ArborMetrix, Inc.Senior Secured12.5%1,482,031 1,424,994 1,424,994 9/1/2023
ArborMetrix, Inc.Senior Secured12.5%741,595 721,872 721,872 9/1/2023
ArborMetrix, Inc. Subtotal2,223,626 2,146,866 2,146,866 
BackboneAI Inc.Senior Secured12.3%494,779 483,764 483,764 6/1/2023
BackboneAI Inc.Senior Secured12.3%494,537 435,999 435,999 6/1/2023
BackboneAI Inc. Subtotal989,316 919,763 919,763 
Blockdaemon, Inc.Senior Secured11.3%72,916 70,543 70,543 8/1/2021
Blockdaemon, Inc.Senior Secured11.3%156,750 153,047 153,047 6/1/2022
Blockdaemon, Inc. Subtotal229,666 223,590 223,590 
Canary Technologies CorporationSenior Secured11.5%247,338 234,633 234,633 6/1/2023
Censia Inc.Senior Secured11.0%751,876 723,062 723,062 10/1/2022
Cloudleaf, Inc.Senior Secured12.0%739,000 724,597 724,597 9/1/2024
Cloudleaf, Inc.Senior Secured12.0%1,445,065 1,360,260 1,360,260 8/1/2023
Cloudleaf, Inc. Subtotal2,184,065 2,084,857 2,084,857 
Dynamics, Inc.Senior Secured12.5%2,208,811 2,106,703 2,106,703 8/1/2021
Eskalera, Inc.Senior Secured10.5%902,496 877,642 877,642 3/1/2023
ICX Media, Inc.Senior Secured12.5%247,171 242,813 242,813 7/1/2023
ICX Media, Inc.Senior Secured12.5%298,886 285,701 285,701 5/1/2022
ICX Media, Inc.Senior Secured12.5%240,098 236,153 236,153 5/1/2023
ICX Media, Inc. Subtotal786,155 764,667 764,667 
Invoice2Go, Inc.Senior Secured12.0%660,026 654,481 654,481 7/1/2022
Invoice2Go, Inc.Senior Secured12.0%989,486 944,616 944,616 6/1/2024
49


IndustryBorrower
Percent of Net Assets (a)
CollateralInterest Rate (b)End of Term Payment (c)PrincipalCostFair Value (d)Maturity Date
Invoice2Go, Inc.Senior Secured12.0%989,150 806,149 806,149 3/1/2024
Invoice2Go, Inc.Senior Secured12.0%988,822 957,755 957,755 6/1/2023
Invoice2Go, Inc.Senior Secured12.0%902,702 892,679 892,679 3/1/2023
Invoice2Go, Inc.Senior Secured12.0%531,244 498,925 498,925 3/1/2022
Invoice2Go, Inc.Senior Secured12.0%783,778 776,169 776,169 11/1/2022
Invoice2Go, Inc. Subtotal5,845,208 5,530,774 5,530,774 
Ipolipo, Inc.Senior Secured12.0%2,066,199 1,943,196 1,476,836 6/1/2022
Lucideus, Inc.Senior Secured12.0%436,842 411,722 411,722 2/1/2023
Medable, Inc.Senior Secured12.0%1,746,992 1,657,497 1,657,497 2/1/2023
Medable, Inc.Senior Secured12.0%873,608 862,217 862,217 2/1/2023
Medable, Inc. Subtotal2,620,600 2,519,714 2,519,714 
Metawave CorporationSenior Secured12.0%608,751 595,704 595,704 7/1/2022
Migo Money, Inc. ** ^Senior Secured12.3%324,019 313,653 313,653 12/1/2021
Migo Money, Inc. ** ^Senior Secured12.5%266,341 266,341 266,341 3/1/2022
Migo Money, Inc. Subtotal ** ^590,360 579,994 579,994 
OrderGroove, Inc.Senior Secured12.0%4,755,473 4,424,662 4,424,662 4/1/2024
Owl Cameras, Inc.Senior Secured18.0%605,050 310,170 308,414 *
Pixlee, Inc.Senior Secured12.3%1,484,210 1,403,678 1,403,678 1/1/2024
PlushCare, Inc.Senior Secured11.8%447,140 441,430 441,430 5/1/2022
PlushCare, Inc.Senior Secured11.8%595,693 579,013 579,013 5/1/2022
PlushCare, Inc. Subtotal1,042,833 1,020,443 1,020,443 
Resilio, Inc.Senior Secured12.8%28,407 27,431 27,431 3/1/2021
Resilio, Inc.Senior Secured12.8%46,851 46,850 46,850 5/1/2021
Resilio, Inc. Subtotal75,258 74,281 74,281 
Sonatus, IncSenior Secured12.5%989,255 860,419 860,419 9/1/2023
Splitwise, Inc.Senior Secured12.3%407,224 393,457 393,457 12/1/2022
Swiftly Systems, Inc.Senior Secured11.5%4,951,149 3,962,224 3,962,224 10/1/2024
Swivel, Inc.Senior Secured12.0%173,702 173,702 173,702 10/1/2022
Swivel, Inc.Senior Secured12.0%159,432 152,178 152,178 8/1/2022
Swivel, Inc. Subtotal333,134 325,880 325,880 
Trendalytics Innovation Labs, Inc.Senior Secured12.8%189,070 177,064 156,140 6/1/2022
Truthset, Inc.Senior Secured10.5%360,505 360,505 360,505 5/1/2023
Truthset, Inc.Senior Secured10.5%327,294 308,736 308,736 2/1/2023
Truthset, Inc. Subtotal687,799 669,241 669,241 
Venuetize, Inc.Senior Secured12.3%130,209 123,167 123,167 4/1/2022
Workspot, Inc.Senior Secured12.0%246,296 239,558 239,558 9/1/2021
Workspot, Inc.Senior Secured12.0%518,863 493,458 493,458 8/1/2022
Workspot, Inc.Senior Secured12.0%565,294 555,453 555,453 10/1/2022
Workspot, Inc.Senior Secured12.0%2,969,690 2,792,441 2,792,441 11/1/2023
Workspot, Inc. Subtotal4,300,143 4,080,910 4,080,910 
Software Total22.9%$46,105,784 $42,514,043 $42,025,003 
Technology Services
iLearningEngines Inc.Senior Secured11.5%$7,918,225 $6,762,096 $6,762,096 12/1/2023
Klar Holdings Limited ** ^Senior Secured14.2%4.0%248,885 235,789 235,789 7/1/2023
Klar Holdings Limited ** ^Senior Secured12.5%188,627 161,586 161,586 10/1/2022
Klar Holdings Limited Subtotal ** ^437,512 397,375 397,375 
Leap Services, Inc.Senior Secured12.0%314,353 305,005 305,005 6/1/2022
Lifit, Inc. ** ^Senior Secured12.0%345,793 329,478 329,478 8/1/2022
Lifit, Inc. ** ^Senior Secured12.0%376,772 371,984 371,984 10/1/2022
Lifit, Inc. Subtotal ** ^722,565 701,462 701,462 
Loansnap Holdings Inc. **Senior Secured11.0%2,236,556 2,118,234 1,913,394 12/1/2022
Relimetrics, Inc.Senior Secured11.3%173,675 169,806 169,806 1/1/2022
Riffyn, Inc.Senior Secured11.5%1,980,521 1,892,277 1,892,277 2/1/2024
Solugen, Inc.Senior Secured11.0%2,107,961 2,007,714 2,007,714 1/1/2023
Solugen, Inc.Senior Secured11.0%1,054,189 1,041,250 1,041,250 1/1/2023
50


IndustryBorrower
Percent of Net Assets (a)
CollateralInterest Rate (b)End of Term Payment (c)PrincipalCostFair Value (d)Maturity Date
Solugen, Inc.Senior Secured11.0%1,054,706 1,038,103 1,038,103 1/1/2023
Solugen, Inc. Subtotal4,216,856 4,087,067 4,087,067 
Thrive Financial, Inc. **Senior Secured9.3%247,981 247,981 247,981 11/1/2023
Thrive Financial, Inc. **Senior Secured11.5%752,761 724,584 724,584 10/1/2022
Thrive Financial, Inc. Subtotal **1,000,742 972,565 972,565 
Zanbato, Inc.Senior Secured11.0%3,465,417 3,347,061 3,347,061 9/1/2023
Zeel Networks, Inc.Senior Secured11.0%2,049,602 2,002,173 1,837,535 3/1/2022
Technology Services Total12.2%$24,516,024 $22,755,121 $22,385,643 
Wireless
AirVine Scientific, Inc.Senior Secured12.0%$90,366 $86,490 $86,490 9/1/2022
AirVine Scientific, Inc.Senior Secured12.0%90,429 88,729 88,729 9/1/2022
AirVine Scientific, Inc. Subtotal180,795 175,219 175,219 
Parallel Wireless, Inc.Senior Secured11.8%6,428,736 6,168,641 6,168,641 6/1/2023
Parallel Wireless, Inc.Senior Secured11.8%3,215,116 3,164,764 3,164,764 8/1/2023
Parallel Wireless, Inc.Senior Secured11.8%3,215,575 3,162,405 3,162,405 9/1/2023
Parallel Wireless, Inc. Subtotal12,859,427 12,495,810 12,495,810 
Wireless Total6.9%$13,040,222 $12,671,029 $12,671,029 
Grand Total169.4%$345,562,976 $323,011,028 $310,522,149 

* As of December 31, 2020, loans with a cost of $20.8 million and a fair value of $9.2 million were classified as non-accrual. These loans have been accelerated from their original maturity and are due in their entirety. During the period for which these loans have been on non-accrual status, no income has been recognized.

** Indicates assets that the Fund deems “non-qualifying assets.” As of December 31, 2020, 11.0% of the Fund’s total assets represented non-qualifying assets. Under Section 55(a) of the 1940 Act, the Fund is prohibited from acquiring any additional non-qualifying assets unless, at the time of acquisition, certain specified qualifying assets (e.g. securities issued by an "eligible portfolio company," as defined in Section 2(a)(46)) represent 70% of its total assets. As part of this calculation, the numerator consists of the value of the Fund's investment in all eligible portfolio companies, and the denominator consists of total assets less the assets described in Section 55(a)(7) of the 1940 Act.

^ Entity is not domiciled in the United States and does not have its principal place of business in the United States.

(a) The percentage of net assets that each industry group represents is shown with the industry totals (the sum of the percentages does not equal 100% because the percentages are based on net assets as opposed to total loans).

(b) The interest rate is the designated annual interest rate exclusive of any original issue discount, fees or end of term payment.

(c) The end of term payments are contractually due on the maturity date and are in addition to the interest rate shown. End of term payments are the percentage of the final payment divided by the original loan amount and are amortized over the full term of the loan.

(d) There is no readily available market price or secondary market for the Fund’s loan investments, hence the Manager determines fair value of all loan investments presented in the Schedule of Investments based on a hypothetical market and the estimates may include the use of significant unobservable inputs.

    As of December 31, 2020, all loans were made to non-affiliates.















See notes to financial statements.
51



VENTURE LENDING & LEASING IX, INC.

Schedules of Derivative Instruments

As of December 31, 2021 and 2020
Description and terms of payments to be received from another partyDescription and terms of payments to be paid to another partyCounterpartyMaturity DateAS OF DECEMBER 31, 2021
Notional AmountFair ValueUpfront payments/receiptsUnrealized appreciation/(depreciation)
(a)
Interest Rate Collar
Floating interest rate of USD-LIBOR-BBA with a cap rate of 1.15%, to be received monthlyFloating interest rate of USD-LIBOR-BBA with a floor rate of 0.17% to be paid monthlyMUFG Union Bank, N.A.6/30/2025$20,000,000 $255,356 — $255,356 
Floating interest rate of USD-LIBOR-BBA with a cap rate of 1.00% to be received monthlyFloating interest rate of USD-LIBOR-BBA with a floor rate of 0.35% to be paid monthlyZions Bancorporation, N.A.3/18/202487,000,000 377,254 — 377,254 
Floating interest rate of USD-LIBOR-BBA with a cap rate of 1.50% to be received monthlyFloating interest rate of USD-LIBOR-BBA with a floor rate of 0.42% to be paid monthlyZions Bancorporation, N.A.6/30/202550,000,000 329,992 — 329,992 
Floating interest rate of USD-LIBOR-BBA with a cap rate of 2.25% to be received monthlyFloating interest rate of USD-LIBOR-BBA with a floor rate of 0.53% to be paid monthlyZions Bancorporation, N.A.3/18/202490,000,000 (130,697)— (130,697)
Total$247,000,000 $831,905 $— $831,905 

AS OF DECEMBER 31, 2020
Description and terms of payments to be received from another partyDescription and terms of payments to be paid to another partyCounterpartyMaturity DateNotional AmountValueUpfront payments/receiptsUnrealized appreciation/(depreciation)
(a)
Interest Rate Swap and Floor Agreements
Floating interest rate greater of USD-LIBOR-BBA or 0.00%, to be received monthlyFixed interest rate 2.520%, to be paid monthlyMUFG Union Bank, N.A.12/20/2021$35,000,000 $(818,923)$— $(818,923)
Floating interest rate greater of USD-LIBOR-BBA or 0.00%, to be received monthlyFixed interest rate 1.899%, to be paid monthlyMUFG Union Bank, N.A.12/20/202122,000,000 (380,548)— (380,548)
Interest Rate Collar
Floating interest rate greater of USD-LIBOR-BBA with a cap rate of 1.15%, to be received monthlyFloating interest rate of USD-LIBOR-BBA with a floor rate of 0.17% to be paid monthlyMUFG Union Bank, N.A.6/30/202520,000,000 (54,743)— (54,743)
Total$77,000,000 $(1,254,214)$— $(1,254,214)

(a) The unrealized appreciation/depreciation was determined using prices or valuation based on observable inputs other than quoted price in active markets for identical assets and liabilities. See “Note 3. Fair Value Disclosures” for more information.

See notes to financial statements.
52


VENTURE LENDING & LEASING IX, INC.
Notes to Financial Statements
1. ORGANIZATION AND OPERATIONS OF THE FUND
Venture Lending & Leasing IX, Inc. (the “Fund”) was incorporated in Maryland on June 28, 2017 as a non-diversified, closed-end management investment company electing status as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (“1940(the “1940 Act”) and is managed by Westech Investment Advisors, LLC (“Manager”(the “Manager” or “Management”). The Fund will be dissolved on December 31, 2028 unless an election is made to dissolve earlier by the Board of Directors (the “Board”). opts to elect early dissolution. One hundred percent of the stock of the Fund is held by Venture Lending & Leasing IX, LLC (the “Company”). Prior to commencing operations on May 2, 2018, the Fund had no operations other than accruing organizational expenses and the sale to the Company of 100,000 shares of common stock, $0.001 par value (“Shares”)for $25,000 in June 2017 and the receipt of $25,000 from the Company as consideration for the purchase of the Shares.2017. This issuance of stock was a requirement to apply for a finance lender’s license from the California Commissioner of Corporations, in order for the Fund to apply for a finance lender’s license, which was obtained on September 22, 2017.

The Fund’s investment objective is to achieve a superior risk adjustedrisk-adjusted investment returnreturns and it seeks to achieve that objective by providing debt financing to portfolio companies;companies, most of which are private. The Fund generally receives warrants to acquire equity securities in connection with its portfolio investments and generally distributes these warrants to its shareholder upon receipt.receipt, or soon thereafter. The Fund also has guidelines for the percentagepercentages of total assets which will bethat are invested in different types of assets. The portfolio investments of the Fund primarily consist of debt financing to early and expansion stage venture capital-backed technology companies.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:POLICIES
Basis of Accounting and Use of Estimates
The preparation of financial statements in conformity with United States Generally Accepted Accounting Principles in the United States of America (“U.S. GAAP”) requires managementManagement to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Fund isAs an investment company, the Fund follows accounting and reporting guidance as set forth in accordance with Accounting Standards CodificationTopic 946 (“Financial Services - Investment CompaniesCompanies”) of the Financial Accounting Standards Board’s (“ASC 946”FASB”), which defines investment companies and prescribes specialized accounting and reporting requirements for investment companies. Accounting Standards Codification, as amended (“ASC”). Certain prior period information has been reclassified and/or disclosed to conform to current year presentation.

Cash and Cash Equivalents
Cash and cash equivalents consist of cash on hand and cash equivalentsmoney market mutual funds with maturities of 90 days or less. Included in this are moneyMoney market mutual funds thatheld as cash equivalents are valued at their most recently traded price prior to the valuation date. As of December 31, 2018, 100% ofnet asset value. Within cash and cash equivalents, wasas of December 31, 2021, the Fund held 6,939,126 units in cash. Cashthe First American Government Obligations Fund valued at $1 per unit at a yield of 0.02%, which represented 3.01% of the net assets of the Fund. Within cash and cash equivalents, were $0.8 million,as of December 31, 2020, the fund held 12,497,243 units in the Blackrock Treasury Trust Institutional Fund valued at $1 per unit at a yield of 0.01% - 0.02%, which represented 1.1%6.82% of the net assets of the Fund.
Interest Income
Interest income on loans is recognized on an accrual basis using the effective interest method including amounts resulting from the amortizationaccretion of discounts attributable to equity securities receiveddiscount on loans included as additional compensation as part of athe loan transaction.agreements. Additionally, fees received as part of the transaction are added to the loan discount and amortizedaccreted over the life of the loan.
Realized Gains and Losses from Loans
    Realized gains or losses on the sale of loans are computed using the difference between the amortized cost and the sales proceeds. Realized losses on loan write-offs are recognized when management determines a loan is uncollectible.
Investment Valuation Procedures
The Fund accounts for loans at fair value in accordance with the valuation methods below. All valuations are determined under the direction of the Manager, in accordance with thosethe valuation methods.

The Fund’s loans are valued coincident with the issuance of its periodic financial statements, the issuance or repurchase of the Fund’s shares at a price equivalent to the current net asset value per share, and at such other times as required by law. On a quarterly basis, Management submits to the Board a valuation report and valuation notes, which details the rationale for the valuation of each investment.

As of December 31, 20182021 and the period from June 28, 2017, sale of capital stock, through December 31, 2017,2020, the financial statements includeincluded nonmarketable investments of $79.0$484.0 million and $0. The$310.5 million, respectively, (or 96.6% and 94.8% of total assets, respectively), with the fair value of each investment isvalues determined by the Manager in the absence of readily determinable market values. Because of the inherent uncertainty of these valuations, estimated fair values of such investments may differ significantly from the values that would have been used had a readily availableready market for the securities existed, and the differences could be material. Below is the information used by the Manager in making these estimates.
53




Loans

The Fund defines fair value as the price that would be received to sell an asset or paid to lower a liability in an orderly transaction between market participants at the measurement date. Because there is no readily available market price and no secondary market for substantially all of the debt investments made by the Fund intoin its borrowing portfolio companies, Management determines fair value based on hypothetical markets, and on several factors related to each borrower, including, but not limited to, the borrower’s payment history, available cash and “burn rate,” revenues, net income or loss, the likelihood that the borrower will be able to secure additional financing in the future, and an evaluation of the general interest rate environment. The amount of any valuation adjustment considers the estimated amount and timing of cash payments of principal and interest from the borrower and/or liquidation analysis and is determined based upon a credit analysis of the borrower and an analysis of the expected recovery from the borrower, including consideration of factors such as the nature and quality of the Fund’s security interests in collateral, the estimated value of the Fund’s collateral, the size of the loan, and the estimated time that will elapse before the Fund achieves a recovery. Management has evaluated these factors and has concluded that, together, the effect of deterioration in the quality of the underlying collateral, increase in size of the loan, increase in the estimated time to recovery and increase in the hypothetical market coupon rate would have the effect of lowering the value of the current portfolio of loans.

Non-accrualNon-Accrual Loans

The Fund’s policy is to classify a loan as non-accrual when the portfolio company is delinquent for three consecutive months on its monthly loan payments,payment, or, in the opinion of Management, either ceases or drastically curtails its operations and Management deems that it is unlikely that the loan will return to performing status. When a loan is placed on non-accrual status, all interest previously accrued but not collected is reversed for the quarter in which the loan was placed on non-accrual status. Any uncollected interest related to quarters prior to when the loan was placed on non-accrual status is added to the principal balance, and the aggregate balance of the principal and interest is evaluated in accordance with the policy for valuation of loans in determining Management’s best estimate of fair value. Interest received by the Fund on non-accrual loans will be recognized as interest income if and when the proceeds received exceed the book value of the respective loan.

If a borrower of a non-accrual loan resumes making regular payments and Management believes that such borrower has regained the ability to service the loan on a sustainable basis, the loan is reclassified back to accrual or performing status. Interest that would have been accrued during the time a loan was classified as non-accrual will be added back to the remaining payment schedule causing a change in the effective interest rate.

As of December 31, 20182021 and 2017, there2020, loans with a cost basis of $27.1 million and $20.8 million and a fair value of $9.6 million and $9.2 million, respectively, were no loans classified as non-accrual.

Warrants and Equity Securities

Warrants and equity securities that are received in connection with loan transactions will beare measured at a fair value at the time of acquisition. Warrants are valued based on a modified Black-Scholes option pricing model which considers, among several factors, the underlying stock value, expected term, volatility, and the risk-free interest rate. It is anticipated that such securities will be distributed by the Fund to the Company simultaneously with, or shortly following, their acquisition.

The underlying asset value is estimated based on information available, including information regarding recent rounds of funding of the portfolio company, or the publicly-quoted stock price at the end of the financial reporting period for warrants for comparable publicly-quoted securities.

Volatility, or the amount of uncertainty or risk about the size of the changes in the warrant price, is based on an index of publicly traded companies grouped by industry and which are similar in nature to the underlying portfolio companies issuing the warrant (“Industry Index”). The volatility assumption for each Industry Index is based on the average volatility for individual public companies within the portfolio company’s industry for a period of time approximating the expected life of the warrants. A hypothetical increase in the volatility of the warrants used in the modified Black-Scholes option pricing model would have the effect of increasing the value of the warrants.

The remaining expected lives of warrants are based on historical experience of the average life of the warrants, as warrants are often exercised in the event of acquisitions, mergers, or initial public offerings and terminated due to events such as bankruptcies, restructuring activities, or additional financings. These events cause the expected term to be less than the remaining contractual term of the warrants. TheAs of December 31, 2021 and 2020, the Fund assumed the average duration of a warrant is 3.5 years for the year ended December 31, 2018.4.0 years. The effect of a hypothetical increase in the estimated initial term of the warrants used in the modified Black-Scholes option pricing model would have the effect of increasing the value of the warrants. However, the estimated initial term of the warrant is one factor, of many, used in the valuation of warrants, and by itself does not have a significant impact on the results of operations.

The risk-free interest rate is derived from the constant maturity tables issued by the U.S. Treasury Department. The effect of a hypothetical increase in the estimated risk-free rate used in the modified Black-Scholes option pricing model would have the effect of increasing the value of the warrants.
The Fund engages an independent valuation company to provide valuation assistance with respect to the warrants received as part of loan consideration, including an evaluation of the Fund’s valuation methodology and the reasonableness of the assumptions used from the perspective of a market participant. The independent valuation company also calculates several of the inputs used, such as volatility and risk-free rate.

54



Other Assets and Liabilities
Other Assetsassets include costs incurred in conjunction with borrowings under the Fund’s debt facility and are stated at initial cost. TheThese costs are capitalized and then amortized over the term of the facility.

As of December 31, 2018 and the period from June 28, 2017, sale of capital stock, through December 31, 2017
theThe fair values of Other Assetsother assets and Liabilitiesaccrued liabilities are estimated at their carrying values because of the short-term nature of these assets and liabilities.

As of December 31, 2018 and for the period from June 28, 2017, sale of capital stock, through December 31, 2017, based on borrowing rates available to the Fund, the estimated fair valuesThe carrying value of the borrowings under the debt facility were $6.0 million and $0, respectively.approximates their fair value based on the borrowing rates available to the Fund.

Commitment Fees
Unearned income and commitment fees on loans are recognized using the effective interesteffective-interest method over the term of the loan. Commitment fees are carried as liabilities when received for commitments upon which no draws have been made. When the first draw is made, the fee is treated as unearned income and is recognized as described above. If a draw is never made, the forfeited commitment fee, less any applicable legal costs, becomes recognized as other income after the commitment expires.
Deferred Bank Fees
The deferred bank fees and costs associated with the debt facility are included in Other assets in the Statements of Assets and Liabilities and are being amortized over the estimated life of the facility, which currently matures on December 20, 2021.March 18, 2024. The amortization of these costs is recorded as Interestinterest expense in the Statements of Operations.

Derivative Instruments
The Fund uses derivative instruments to manage its exposure to changes in interest rates on expected borrowings under its debt facility, as the Fund originates fixed rate loans (see Note 8).

Derivative instruments are primarily valued on the basis of quotes obtained from banks, brokers and dealers and adjusted for counterparty risk and the optionality of the interest rate terms. The valuation of the derivative instruments also considers the future expected interest rates on the notional principal balance remaining which is comparable to what a prospective acquirer would pay on the measurement date. Valuation pricing models consider inputs such as forward rates, anticipated interest rate volatility relating to the reference rate, as well as time value and other factors underlying derivative instruments.

The Fund is a party to master netting arrangements with MUFG Union Bank, N.A and Zions Bancorporation, N.A., however, the Fund has elected not to offset assets and liabilities under these arrangements for financial statement presentation purposes. Contracts are recorded at gross fair value in either derivative asset or derivative liability in the Statements of Assets and Liabilities, depending on whether the value of the contract is in favor of the Fund or the counterparty. The changes in fair value are recorded in net change in unrealized gain (loss) from derivative instruments in the Statements of Operations and the quarterly interest received or paid on the contract, if any, is recorded in net realized gain (loss) from derivative instruments in the Statements of Operations.

The interest rate collar instruments are contractually scheduled to terminate on March 18, 2024 and June 30, 2025.    

Recent Accounting Pronouncements

In May 2014,January 2021, the Financial Accounting Standards Board (“FASB”)FASB issued Accounting Standards Update (“ASU”) 2014-09, “Revenue from Contracts with CustomersNo. 2021-01, "Reference Rate Reform (Topic 606),”848) - Scope". The amendment clarifies that certain optional expedients and subsequently issued several amendments to the standard. ASU 2014-09 and its related amendments offer comprehensive guidance on the recognition of revenue upon the exchange of promised goods or services with customers. The main principle of the guidance is for an entity to recognize revenue upon the transfer of the promised goods or services that reflect the consideration to which the entity deems it to be entitled to for the exchange of those goods or services. The guidance has a five-step framework for the entity to follow: (i) identify the contract(s) with a customer, (ii) identify the performance obligation(s)exceptions in the reference rate reform topic for contract (iii) determinemodifications and hedge accounting apply to derivatives that are affected by the transaction price, (iv) allocate the transaction price to the performance obligation(s)discounting transition. The amendment in the contract, and (v) recognize revenue when the entity satisfies a performance obligation. ASU 2014-09 and its related amendments became2021-01 is effective January 1, 2018.for all entities immediately upon issuance. The Fund elected to adopt this ASU on January 1, 2018 with no material effect on its financial statements or disclosures.


In August 2018, FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820),” which made changes to the fair value measurement disclosure requirements in ASC 820, “Fair Value Measurements and Disclosures.” The changes included new disclosure requirements, elimination of some requirements and the modification of others. ASU 2018-13 is effective for annual reporting periods, and the interim periods within those periods, beginning after December 15, 2019. The Fund adopted the changes per ASU 2018-13amendment and there was no material impact on its financial statements orand disclosures.
3. FAIR VALUE DISCLOSURES
The Fund primarily provides asset-based financing primarily to start-up and emerging growth venture-backed companies which are generally made to borrowers pursuant to commitments whereby the Fund agrees to finance assets and provide working or growth capital up to a specified amount for the term of the commitment, upon the terms and subject to the conditions specified by such commitment. Even though these loans are generally secured by the assets of the borrowers, the Fund in most cases is subject to the credit risk of such companies. As of December 31, 2018,2021 and 2020, the Fund’s investments in loans were primarily to companies based within the United States and it is anticipated that the Fund’s portfolio will consist of companieswere diversified among borrowers in the communications, information services, media,industry segments shown in the Schedules of Investments. All loans are senior to unsecured creditors and technology, including software and technology-enabled business services, bio-technology, and medical devices industry sectors, among others. The percentageother secured creditors, unless as indicated in the Schedules of net assets that each industry group represents is shown with the industry totals above (the sum of the percentages does not equal 100 percent because the percentages are based on net assets as opposed to total loans).Investments.
    
55


The Fund defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; that is, an exit price. The exit price assumes the asset or liability was exchanged in an orderly transaction; it was not a forced liquidation or distressed sale. Because there is no readily available market price and no secondary market for substantially all of the debtloan investments made by the Fund to borrowing portfolio companies, Management determines fair value (or estimated exit value) based on a hypothetical market, and several factors related to each borrower.



Loan balances in the StatementsSchedules of Investments are summarizedlisted by borrower. Typically, a borrower’s balance will be composed of several loans drawn under a commitment made by the Fund with the interest rate on each loan fixed at the time each loan is funded. Each loan drawn under a commitment may havehas a different maturity date and amount.
    
For the for the period from May 2, 2018, the commencement of investment operations, through December 31, 2018, the weighted-average interest rate on performing and all loans was 16.33%. For period from May 2, 2018, the commencement of investment operations, through December 31, 2018, the weighted-average interest rate on the cash portion of the interest income was 12.11%. For the period from June 28, 2017, sale of capital stock, through December 31, 2017, the Fund had not yet commenced investment operations and correspondingly, there was no interest income.
Performing LoansAll Loans
For the years endedFor the years ended
December 31, 2021December 31, 2020December 31, 2021December 31, 2020
Weighted-Average Interest Rate - Cash15.76 %14.82 %15.50 %14.39 %
Weighted Average Interest Rate - Non-Cash5.86 %3.80 %5.71 %3.68 %
Weighted-Average Interest Rate21.62 %18.62 %21.21 %18.07 %

Interest is calculated using the effective interest method, and rates earned by the Fund will fluctuate based on many factors including early payoffs, volatility of values ascribed to warrants and new loans funded during the period.year.

The risk profile of a loan changes when events occur that impact the credit analysis of the borrower and loan as describeddiscussed in the Fund’s loan accounting policy. Such changes result in the fair value adjustments made to the individual loans, which in accordance with U.S. GAAP, would be based on the price that would be received to sell an asset or paid to settle a liability in an orderly transaction between market participants at the measurement date. Where the risk profile is consistent with the original underwriting, which is primarily the case for this loan portfolio, the par valuecost basis of the loan will approximateoften approximates fair value.

For the year ended    All loans as of December 31, 20182021 and 2020 were pledged as collateral for the period from June 28, 2017, saledebt facility, and the Fund’s borrowings are generally collateralized by all assets of capital stock, throughthe Fund. As of December 31, 2017,2021 and 2020, the Fund hashad unexpired unfunded commitments to borrowers of $31.0$97.9 million and $0,$83.2 million, respectively.
Valuation Hierarchy
Under the Financial Accounting Standards BoardFASB ASC Topic 820 (“FASB”) Accounting Standards Codification (“ASC”) 820-10 “FairFair Value Measurement”), the Fund categorizes its fair value measurements according to in a three-level hierarchy. The hierarchy prioritizes the inputs used by the Fund’s valuation techniques. A level is assigned to each fair value measurement based on the lowest level input that is significant to the fair value measurement in its entirety.

    The three levels of the fair value hierarchy are defined as follows:

Level 1 Unadjusted quoted prices for identical assets or liabilities in active markets that are accessible at the measurement date.
Level 2 Prices or valuations based on observable inputs other than quoted prices in active markets for identical assets and liabilities.
Level 3 Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

Transfers of investments between levels of the fair value hierarchy are recorded on the actual date of the event or change in circumstances that caused the transfer.    There were no transfers in and out of Level 1, 2 andor 3 during the period from May 2, 2018, the commencement of investment operations, throughyear ended December 31, 2018.2021 and 2020.

The Fund’s cash equivalents were valued at the traded net asset value of the money market mutual fund, and therefore,fund. As a result, these measurements are classified as Level 1. The Fund'sFund’s derivative instruments are based on quotes from the market makers that derive fair values from market data, and therefore, are classified as Level 2. The Fund’s borrowings under the debt facility are also classified as Level 2, because the borrowings are based on rates that are observable at commonly quoted intervals, which are Level 2 inputs.

The Fund’sFunds’ loan transactions are individually negotiated and unique, and because there is little to no market in which these assets trade, the inputs for these assets which are valued using estimated exit values,values. As a result, the Fund’s loan transactions are classified as Level 3.

56


The following table providestables provide quantitative information about the Fund’s Level 3 fair value measurements of itsthe Fund’s investments by industry as of December 31, 2018.2021 and 2020. In addition to the techniques and inputs noted in the tables below, the Fund may also use other valuation techniques and methodologies when determining its fair value measurements.

Investment Type - Level 3
Investment Type - Level 3
Loan InvestmentsFair Value at December 31, 2021Valuation Techniques / MethodologiesUnobservable InputRange
Weighted Average (a)
Biotechnology$15,817,093Hypothetical market analysisHypothetical market coupon rate13% - 16%15%
Computers & Storage$24,062,710Hypothetical market analysisHypothetical market coupon rate*14%
Enterprise Networking$4,311,087Asset RecoveryProbability weighting of alternative outcomes10% - 20%*
Internet$46,160,725Hypothetical market analysisHypothetical market coupon rate13% - 19%16%
Asset RecoveryProbability weighting of alternative outcomes10% - 100%^
Medical Devices$17,834,282Hypothetical market analysisHypothetical market coupon rate13% - 32%17%
Asset RecoveryProbability weighting of alternative outcomes35% - 65%*
Other Healthcare$42,002,872Hypothetical market analysisHypothetical market coupon rate14% - 24%16%
Asset RecoveryProbability weighting of alternative outcomes20% - 80%*
Other Technology$236,458,989Hypothetical market analysisHypothetical market coupon rate12% - 46%19%
Asset RecoveryProbability weighting of alternative outcomes5% - 100%^
Security$2,390,705Hypothetical market analysisHypothetical market coupon rate14% - 19%18%
Software$56,598,962Hypothetical market analysisHypothetical market coupon rate12% - 37%17%
Asset RecoveryProbability weighing of alternative outcomes10% - 40%*
Technology Services$27,739,468Hypothetical market analysisHypothetical market coupon rate13% - 26%18%
Asset RecoveryProbability weighting of alternative outcomes10% - 50%*
Wireless$10,670,751Hypothetical market analysisHypothetical market coupon rate14% - 17%14%
Total Loan Investments$484,047,644

(a) The weighted-average hypothetical market coupon rates were calculated using the relative fair value of the loans.
* There is only one loan within the industry.
^ Probability weightings vary among loan investments within each industry based on different potential future outcomes.
57


Debt Investments Fair Value at 12/31/18 Valuation Techniques / Methodologies Unobservable Input Weighted Average / Amount / Range
Investment Type - Level 3Investment Type - Level 3
Loan InvestmentsLoan InvestmentsFair Value at December 31, 2020Valuation Techniques / MethodologiesUnobservable InputRange
Weighted Average (a)
   
Biotechnology $1,376,139
 Hypothetical market analysis Hypothetical market coupon rate 15%Biotechnology$6,365,901 Hypothetical market analysisHypothetical market coupon rate 14% - 15%15%
Computers & StorageComputers & Storage16,731,094 Hypothetical market analysisHypothetical market coupon rate14% - 15%15%
   
Enterprise Networking $3,266,067
 Hypothetical market analysis Hypothetical market coupon rate 15%Enterprise Networking5,279,909 Income ApproachHypothetical market coupon rate*19%
   
Internet $12,972,122
 Hypothetical market analysis Hypothetical market coupon rate 17%Internet28,421,725 Hypothetical market analysisHypothetical market coupon rate13% - 25%15%
   Asset RecoveryProbability weighting of alternative outcomes5% - 95%^
Medical DevicesMedical Devices20,522,036 Hypothetical market analysisHypothetical market coupon rate13% - 32%17%
Asset RecoveryProbability weighting of alternative outcomes35% - 65%*
Other HealthcareOther Healthcare24,315,525 Hypothetical market analysisHypothetical market coupon rate14% - 24%15%
Other TechnologyOther Technology126,568,043 Hypothetical market analysisHypothetical market coupon rate14% - 32%16%
Asset RecoveryProbability weighting of alternative outcomes5% - 100%^
SecuritySecurity4,650,326 Hypothetical market analysisHypothetical market coupon rate14% - 99%18%
Semiconductors & EquipmentSemiconductors & Equipment585,915 Hypothetical market analysisHypothetical market coupon rate*16%
SoftwareSoftware42,025,003 Hypothetical market analysisHypothetical market coupon rate13% - 26%18%
Asset RecoveryProbability weighting of alternative outcomes5% - 75%^
Technology ServicesTechnology Services22,385,643 Hypothetical market analysisHypothetical market coupon rate13% - 23%17%
Asset RecoveryProbability weighting of alternative outcomes5% - 100%^
WirelessWireless12,671,029 Hypothetical market analysisHypothetical market coupon rate14% - 16%14%
Total Loan InvestmentsTotal Loan Investments$310,522,149 

(a) The weighted-average hypothetical market coupon rates were calculated using the relative fair value of the loans.
* There is only one loan within the industry.
^ Probability weightings vary among loan investments within each industry based on different potential future outcomes.

58


Debt Investments Fair Value at 12/31/18 Valuation Techniques / Methodologies Unobservable Input Weighted Average / Amount / Range
Medical Devices $12,725,062
 Hypothetical market analysis Hypothetical market coupon rate 19%
         
Other Healthcare $1,740,235
 Hypothetical market analysis Hypothetical market coupon rate 16%
         
Other Technology $18,472,262
 Hypothetical market analysis Hypothetical market coupon rate 16%
         
Security $1,876,630
 Hypothetical market analysis Hypothetical market coupon rate 16%
         
Semiconductors and Equipment $1,404,604
 Hypothetical market analysis Hypothetical market coupon rate 16%
         
Software $23,269,035
 Hypothetical market analysis Hypothetical market coupon rate 19%
         
Technology Services $1,942,951
 Hypothetical market analysis Hypothetical market coupon rate 15%
         
Total Debt Investments 79,045,107
      

The following tables present the balances of assets and liabilities as of December 31, 20182021 and 20172020 measured at fair value on a recurring basis:
As of December 31, 2021
ASSETS:Level 1Level 2Level 3Total
Loans†$— $— $484,047,644 $484,047,644 
Derivative assets— 962,602 — 962,602 
Cash equivalents6,939,126 — — 6,939,126 
Total$6,939,126 $962,602 $484,047,644 $491,949,372 
LIABILITIES:Level 1Level 2Level 3Total
Borrowings under debt facility$— $263,000,000 $— $263,000,000 
Derivative liability— 130,697 — 130,697 
         Total$— $263,130,697 $— $263,130,697 
As of December 31, 2018Level 1 Level 2 Level 3 Total
As of December 31, 2020As of December 31, 2020
ASSETS:       ASSETS:Level 1Level 2Level 3Total
Loans†$
 $
 $79,045,107
 $79,045,107
Loans†$— $— $310,522,149 $310,522,149 
Cash equivalentsCash equivalents12,497,243 — — 12,497,243 
Total$
 $
 $79,045,107
 $79,045,107
Total$12,497,243 $— $310,522,149 $323,019,392 
       
LIABILITIES:       LIABILITIES:Level 1Level 2Level 3Total
Borrowings under debt facility
 $6,000,000
 
 $6,000,000
Borrowings under debt facility$— $140,000,000 $— $140,000,000 
$
 $6,000,000
 $
 $6,000,000
Derivative liabilitiesDerivative liabilities— 1,254,214 — 1,254,214 
Total Total$— $141,254,214 $— $141,254,214 
† For a detailed listing of borrowers comprising this amount, please refer to the StatementSchedules of Investments.

As of December 31, 2017Level 1 Level 2 Level 3 Total
ASSETS:       
Cash equivalents$25,000
 
 
 $25,000
Total$25,000
 
 
 $25,000

The following tables provide a summary of changes in Level 3 assets measured at fair value on a recurring basis:
For the Year Ended December 31, 2021
LoansWarrantsStocks
Beginning balance$310,522,149 $— $— 
Acquisitions and originations358,801,269 34,182,382 1,846,658 
Principal payments on loans, net of accretion(179,783,947)— — 
Distributions to shareholder— (34,182,382)(1,846,658)
Net realized loss from loans(119,127)— — 
Net change in unrealized loss from loans(5,372,700)— — 
Ending balance$484,047,644 $— $— 
Net change in unrealized loss from loans relating to loans still held at December 31, 2021$(5,620,711)$— $— 

For the Year Ended December 31, 2020
LoansWarrantsStockConvertible Note
Beginning balance$203,311,245 $— $— $— 
Acquisitions and originations215,650,000 14,640,729 750,000 226,094 
Principal payments on loans, net of accretion(96,826,332)— — — 
Distributions to shareholder— (14,640,729)(750,000)(226,094)
Net realized loss from loans(27,819)— — — 
Net change in unrealized loss from loans(11,584,945)— — — 
Ending balance$310,522,149 $— $— $— 
Net change in unrealized loss from loans relating to loans still held at December 31, 2020$(11,742,270)$— $— $— 
59


 For the year ended December 31, 2018 
 Loans Warrants 
Beginning balance
 
 
Acquisitions and originations87,100,000
 7,287,981
 
Principal reductions and amortization of discounts(8,054,893) 
 
Distributions to shareholder
 (7,287,981) 
Ending balance79,045,107
 
 



For the period from June 28, 2017, sale of capital stock, through December 31, 2017, there were no investment operations and accordingly, there were no changes in Level 3 assets.
4. EARNINGS PER SHARE

Basic earnings per share (“EPS”) are computed by dividing the net increase (decrease) in net assets resulting from operations by the weighted average common shares outstanding. Diluted earnings (loss) per share are computed by dividing net income (loss)increase (decrease) in net assets resulting from operations by the weighted average common shares outstanding, including the dilutive effects of potential common shares (e.g., stock options). The Fund has no instruments that would be potential common shares; thus, reported basic and diluted earnings (loss) per share are the same. As the Fund has not yet commenced investment operations, it did not have EPS to report.
5.  CAPITAL STOCK
As of both December 31, 2018,2021 and 2020, there were 10,000,000 Sharesshares of $0.001 par value common stock authorized, and 100,000 Sharesshares issued and outstanding. The Fund was organized during 2017. Total committed capital of the Company, for the year endedas of both December 31, 20182021 and the period from June 28, 2017, sale of capital stock, through December 31, 2017 were2020, was $460.0 million and $450.0 million, respectively.million. Total contributed capital to the Company for the year ended December 31, 2018 and the period from June 28, 2017 through December 31, 20172021 and 2020 was $96.6$388.7 million and $25,000,$264.5 million, respectively, and of which $82.5$345.6 million and $25,000 were$243.1 million was contributed to the Fund.Fund, respectively.
The chart below shows the distributions of the Fund for the yearyears ended December 31, 2018 . There were no distributions to the shareholder for the period from June 28, 2017, sale of capital stock, to December 31, 2017.2021, 2020 and 2019.
For the Year EndedFor the Year EndedFor the Year Ended
 December 31, 2021December 31, 2020December 31, 2019
Cash distributions$85,800,000 $30,800,000 $20,900,000 
Distributions of equity securities and convertible notes36,029,040 15,616,824 12,631,643 
Total distributions to shareholder$121,829,040 $46,416,824 $33,531,643 
 For the Year Ended
 December 31, 2018
Distributions of equity securities and convertible notes7,287,981
  
Total distributions to shareholder$7,287,981

6. DEBT FACILITY

    The 1940 Act requires a BDC to meet certain levels of asset coverage with respect to its outstanding “senior securities,” which typically consist of outstanding borrowings under credit facilities and other debt instruments. Historically, BDCs have only been allowed to incur indebtedness by issuing senior securities if their asset coverage equals at least 200% after giving effect to such borrowings. The Small Business Credit Availability Act (the “SBCAA”), which was signed into law on March 23, 2018, added a new Section 61(a)(2) to the 1940 Act that permits BDCs like the Fund to increase the amount of indebtedness they may incur by lowering the asset coverage requirement from 200% to 150% if they make certain disclosures and obtain the approval by either (1) a “required majority,” as defined in Section 57(o) of the 1940 Act, of the BDC’s board of directors, including a majority of non-interested directors within the meaning of Section 2(a)(19) of the 1940 Act (‘Independent Directors”), with effectiveness one year after the date of such approval or (2) a majority of votes cast at a special or annual meeting of the BDC’s shareholders at which a quorum is present, which is effective the day after such stockholder approval.

    On December 5, 2018, the required majority of the Fund’s Board, including a majority of its independent directors, unanimously determined it to be in the best interests of the Fund and its sole shareholder, the Company, to provide the Fund with maximum leverage flexibility, and approved the application to the Fund of a minimum asset coverage ratio of 150%, pursuant to Section 61(a)(2) of the 1940 Act, which would double the Fund’s borrowing limits, subject to approval by the Company via the pass-through voting of its members. Thereafter, at a special meeting of shareholders held on April 24, 2019, the Fund’s sole shareholder, the Company, approved the proposal to apply the reduced asset coverage requirement to the Fund. The 150% asset coverage ratio became effective for the Fund on April 25, 2019. As of December 31, 2021 and 2020, the Fund’s asset coverage for borrowings was 187% and 231%, respectively.

On December 20, 2018, the Fund entered into a syndicated loan agreement led by MUFG Union Bank, N.A., Wells Fargo Securities, LLC and ING Capital LLC, with participation from Zions Bancorporation, N.A., doing business as California Bank & Trust, Bank Leumi USA, Umpqua Bank, HSBC Bank USA, N.A., and First Bank, that established a secured revolving loan facility in an initial amount of up to $200,000,000$200.0 million with the option to request that borrowing availability be increased up to $400,000,000,$400.0 million (the “Loan Agreement”), subject to further negotiation and credit approval.
On March 18, 2021, the Fund entered into an Amendment to the Loan and Security Agreement with MUFG Union Bank, N.A., Wells Fargo Securities, LLC, Wells Fargo Bank, N.A. and ING Capital, LLC, with participation from TIAA, FSB, Bank Leumi USA, HSBC Bank USA, N.A., Umpqua Bank, Zions Bancorporation, N.A., doing business as California Bank & Trust, Hitachi Capital America Corp, First Bank, and Bank of Hope, that increased the size of the facility to $350.0 million and extended the term of the facility (the “Amended Loan Agreement”). An additional $50.0 million is potentially available to the Fund, subject to further negotiation and credit approval, through an accordion provision.

60


All of the assets of the Fund collateralize borrowings by the Fund. Loans under the facility may be, at the option of the Fund, a Reference Rate Loan, a LIBOR Loan or a LIBOR Market Index Rate Loan. A Reference Rate Loan is defined as a loan bearing interest at the highest of: (a) the Federal Funds Rate for such day plus one half of one percent (0.50%), (b) the Prime Rate, and (c) LIBOR loan period of one month plus one percent (1%) (“Reference Rate”). A LIBOR Loan is defined as a loan bearing interest at the prevailing LIBOR rate for a period equal to the applicable LIBOR Loan Period which appears on the Reuters Screen LIBOR01 Page (or any applicable successor page) at approximately 11:00 a.m. (London time) two (2) Business Days prior to the first day of the applicable LIBOR Loan Period (rounded upward, if necessary, to the nearest 1/100th of 1%) divided by one minus the percentage (expressed as a decimal and rounded upwards, if necessary, to the next higher 1/100th of 1%) which is in effect for such day as prescribed by the Board of Governors of the Federal Reserve System ( or any successor) for determining the maximum reserve requirement (including, without limitation, any basic, supplemental or emergency reserves) in respect of eurocurrency liabilities or any similar category of liabilities for a member bank of the Federal Reserve System in New York City (“LIBOR Reserve Percentage”)(“LIBOR”). A LIBOR Market Index Rate Loan is defined as a Loan bearing interest, for any day, at a variable rate of interest equal to the one-month LIBOR. As of December 31, 2018,2021 and 2020 , the Fund’s outstanding borrowings were entirely based on the LIBOR Rate.Market Index Rate Loans. The facility terminates on December 20, 2021,March 18, 2024, but can be accelerated in the event of default, such as failure by the Fund to make timely interest or principal payments.
Borrowings underThe Fund pays interest on its borrowings and a fee on the facility are collateralized by receivables from loans to portfolio companies advanced by the Fund with assignment of such receivables to the financial institution, plus allunused portion of the other assets of the Fund.facility. Under the Loan Agreement, interest is charged to the Fund based on its borrowings at, pursuant to the election of the Fund, an annual rate equal to either (i) LIBOR plus 2.50% or (ii) the Reference Rate plus 1.50%, (ii) LIBOR plus 2.50% or (iii) the LIBOR Market Index Rate plus 2.50%. The Fund also pays an annual commitment fee under the Loan Agreement. When the Fund is using 50% or more of the maximum amount available under the Loan Agreement, the applicable commitment fee is 0.25% of the unused portion of the loan facility; otherwise, the applicable commitment fee is 0.50% of the unused portion. The Fund pays the unused credit line fee quarterly. The Fund will pay interest on its borrowings upon each maturity date. As of December 31, 2018, $6.02021 and 2020, $263.0 million wasand $140.0 million, respectively, were outstanding under the facility.


As of December 31, 2018,2021, the LIBOR Raterate was as follows:

1-month1-Month LIBOR2.5027%0.1013%
3-month3-Month LIBOR2.8076%0.2091%
Bank fees and other costs of $1.3$3.6 million were incurredincurred in connection with the acquisition of the facility have been capitalized and are amortized to interest expense on a straight-line basis over the expected life of the facility. As of December 31, 20182021 and 2020, the remaining unamortized fees and costs of $1.3$2.0 million and $0.4 million, respectively, are being amortized over the expected life of the facility, which is expected to terminate on December 20, 2021.March 18, 2024.
The facility is revolving and as such does not have a specified repayment schedule, although advances are secured by the assets of the Fund and thus repayments will be required as assets decline. The facility contains various covenants including financial covenants related to: (i) minimum debt service coverage ratio, (ii) interest coverage ratio, (iii) unfunded commitment ratio, (iv) maximum quarterly loan loss reserve ratio, (v) maximum annual loan loss reserve ratio and (vi) maximum loan loss test. There are also various restrictive covenants, including limitations onon: (i) the incurrence of liens, (ii) consolidations, mergers and asset sales and (iii) capital expenditures. As of December 31, 2018 Management believes that2021 and 2020, the Fund was in compliance with theseall financial covenants.
The following is the summary of the outstanding facility draws as of December 31, 2018:2021:
AmountMaturity Date
All-In Interest Rate (a)
LIBOR Market Index Rate Loan$263,000,000 March 18, 2024Variable based on 1-Month LIBOR rate
Total Outstanding$263,000,000 
Roll-over/Draw DateAmountMaturity Date*All-In Interest Rate**
December 27, 2018$6,000,000
1/28/20195.01%
TOTAL OUTSTANDING$6,000,000
  
* On January 11, 2019, Management borrowed $10.0 million on a LIBOR Market Index Rate loan. On January 18, 2019, Management borrowed an additional $7.0 million on a LIBOR Market Index Rate loan. On January 28, 2019, Management rolled over the $6.0 million LIBOR rate loan and $10.0 million of the LIBOR Market Index Rate loan into a $16.0 million 30-day LIBOR rate loan with an all-in rate of 5.01% and a maturity date of February 27, 2019. On January 29, 2019, Management borrowed $21.0 million on a LIBOR Market Index Rate loan, which converted to a 30-day LIBOR rate loan on February 1, 2019 with an all-in rate of 5.01% and a maturity date of February 27, 2019. On February 27, 2019, Management rolled over the $21.0 million and $16.0 million 30-day LIBOR rate loans into a $31.0 million 30-day LIBOR rate loan with an all-in rate of 4.98% and a maturity date of March 29, 2019; and paid down $6.0 million of the principal balance.
** (a)Inclusive of 2.50% applicable LIBOR margin plus LIBOR rate.

    The following is the summary of the outstanding facility draws as of December 31, 2020:
(Intentionally left blank)
AmountMaturity Date
All-In Interest Rate (a)
LIBOR Market Index Rate Loan$140,000,000 December 20, 2021Variable based on 1-Month LIBOR rate
Total Outstanding$140,000,000 

(a)Inclusive of 2.50% applicable LIBOR margin plus LIBOR rate.
The floating interest rate for the debt facility as of December 31, 2021 and 2020 was 0.10% and 0.14%, respectively.


61


7. MANAGEMENT AND RELATED PARTIES

Management
As compensation for its services to the Fund, the Manager, commencing when capital is first called from the members of the Company, the Manager will receive an investment management fee from the Fund (the “Management Fee”). The aggregate annual amount of Management Fee for each annual period (which will be comprised of four whole fiscal quarters and which, in the casedate of the first year, will commencecapital call, May 1, 2018, the Manager initially received a management fee (“Management Fee”) computed and paid at the end of the quarter at an annual rate of 1.575% of the Company’s committed equity capital (regardless of when or if the capital was called). The Management Fee percentage is 1.500% as of December 31, 2021, based on the first dayfollowing schedule of the first fiscal quarter commencing on or following the first capital commitment, and will be calculated as a percentage of committed capital, as follows:
annual percentages:
Management Fee
Year 11.575%
Year 21.600%
Year 31.575%
Year 41.500%
Year 51.250%
Year 60.900%
Year 70.600%
Year 80.350%
Year 90.150%
Management feesFees of $4.8$7.1 million, $7.3 million and $7.3 million were recognized as expenses for the period from May 1, 2018, first capital commitment, toyears ended December 31, 2018. There were no management fees paid for period from June 28, 2017, sale of capital stock, through December 31, 2017.2021, 2020 and 2019, respectively.
Related Parties
Certain officers and directors of the Fund also serve as officers and directors of the Manager. The Amended and Restated Articles of Incorporation of the Fund provide for indemnification of directors, officers, employees and agents (including the Manager) of the Fund to the full extent permitted by applicable state law and the 1940 Act, including the advance of expenses and reasonable counsel fees. The Amended and Restated Articles of Incorporation of the Fund also contain a provision eliminating personal liability of a Fund director or officer to the Fund or its shareholder for monetary damages for certain breaches of their duty of care. For this reason, the Fund has acquired a directors &and officers insurance policy.
Liabilities to the Manager

The liability due to the manager is comprised of expenses paid and to be paid by the Manager on behalf of the Fund.  The Fund reimbursed the Manager once the Fund commenced investment operations in 2018.  As of the year ended December 31, 2018 and for the period ended December 31, 2017, the total due to the Manager was $0 and $0.2 million. 

Transactions with Venture Lending & Leasing VIII, Inc. (“Fund VIII”)  
The Manager also serves as the investment manager for Fund VIII. The Fund’s Board of Directors determined that so long as Fund VIII has capital available to invest in loan transactions with final maturities earlier than December 31, 2025 (the date on which Fund VIII will be dissolved), the Fund may invest in each portfolio company in which Fund VIII invests (“Investments”). Generally, the amount of each Investment will be allocated 50% to the Fund and 50% to Fund VIII, or such other allocations as may be determined by the respective fund boards.boards, so long as the Fund has capital available to invest. The ability of the Fund to co-invest with Fund VIII, and other clients advised by the Manager, is subject to the conditions (“Conditions”) set forth inwith which the Funds are currently complying while seeking certain exemptive relief currently being sought by the Fund from the SEC from the provisions of Sections 17(d) and 57 of the 1940 Act and Rule 17d-1 thereunder. After June 30, 2022, the Fund will no longer be permitted to enter into new commitments to borrowers; however, the Fund will be permitted to fund existing commitments. Thecommitments, in which Fund VIII may also be invested. In August 2019, the Manager is permittedexercised, and the Board of Directors ratified, its discretion to extend the Fund'sFund VIII's investment period by upfor two additional quarters after September 30, 2020, thereby allowing Fund VIII to two (2) additional calendar quarters in its solemake new commitments through March 31, 2020 and absolute discretion.
to fund commitments through March 31, 2021, the end of Fund VIII's investment period. To the extent that clients, other than Fund VIII, advised by the Manager (but in which the Manager has no proprietary interest) invest in opportunities available to the Fund, the Manager will also allocate such opportunities among the Fund and such other clients in a manner deemed fair and equitable considering all of the circumstances in accordance with the Conditions.
Transactions with WTI Fund X, Inc. ("Fund X")
The Manager also serves as the investment manager for Fund X. The Fund’s Board of Directors determined that so long as Fund X has capital available to invest in loan transactions with final maturities earlier than December 31, 2031 (the date on which Fund X will be dissolved), the Fund may invest in each portfolio company in which Fund X invests. Generally, the amount of each Investment will be allocated 50% to the Fund and 50% to Fund X, or such other allocations as may be determined by the respective fund boards, so long as the Fund has capital available to invest. The ability of the Fund to co-invest with Fund X, and other clients advised by the Manager, is subject to the Conditions described above. After June 30, 2022, the Fund will no longer be permitted to enter into new commitments to borrowers; however, the Fund will be permitted to fund existing commitments, in which Fund X may also be invested. The Manager is permitted to extend the Fund's investment period by up to two (2) additional calendar quarters in its sole and absolute discretion.To the extent that clients, other than Fund X, advised by the Manager (but in which the Manager has no proprietary interest) invest in opportunities available to the Fund, the Manager will allocate such opportunities among the Fund and such other clients in a manner deemed fair and equitable considering all of the circumstances in accordance with the Conditions.

62


Intercreditor Agreements  
In all transactions in which the Fund and Fund VIIIother funds managed by the Manager invest or those in which another lender/lenderslender(s) has either invested or may later invest (or in the event a successor fund is raised, in which the Fund and the successor fund invest), it is expected that the Fund Fund VIIIand, other funds managed by the Manager (or the successor fund as the case may be), and/or the other lender/lenderslender(s) will enter into an intercreditor agreement pursuant to which the Fund Fund VIIIand, other funds managed by the Manager (or the successor fund), and/or the other lender/lenders will cooperate,lender(s), along with any predecessor funds which still have a balance outstanding, will cooperate in pursuing their remedies following a default by the common borrower. Generally, under such intercreditor agreements, each


party would agree that its security interest would be treated in parity with the security interest of the other party, regardless of which security interest would have priority under applicable law. Accordingly, proceeds realized from the sale of any collateral or the exercise of any other creditor’s rights will be allocated between the Fund Fund VIIIand, other funds managed by the Manager, and any predecessor funds as described above, pro rata in accordance with the amounts of their respective investments. An exception to the foregoing arrangement would occur in situations where, for example, one of the lenders financed specific items of equipment collateral; in that case, usually the lender who financed the specific assets will have a senior lien on that asset, and the other lenderlenders will have a junior priority lien (even though they may ratably share liens of equal priority on other assets of the common borrower).

As a result of such intercreditor agreements, the Fund may have less flexibility in pursuing its remedies following a default than it would have had had there been no intercreditor agreement, and the Fund may realize fewer proceeds. In addition, because the Fund and Fund VIIIother funds managed by the Manager (or the successor fund) invest at the same time in the same borrower, such borrower would be required to service two loans rather than one. Any additional administrative costs or burdens resulting there fromtherefrom may make the Fund a less attractive lender and may make it more difficult for the Fund to acquire such loans.
8.DERIVATIVE INSTRUMENTS

The Fund uses derivative instruments to manage its exposure to interest rates on expected borrowings under its debt facility, as the Fund originates fixed rate loans.

Interest Rate Swap and Floor

    On February 7, 2019, the Fund entered into an interest rate swap and floor agreement with MUFG Union Bank, N.A. The floor allows the Fund to match the swap with the terms of the variable rate index of the debt facility. The Fund may adjust the notional principal amount in order to remain in compliance with hedging requirements of the Fund's debt facility. As of December 31, 2020, the notional principal amount of the interest rate and swap and floor instrument was $57.0 million. The interest rate swap and floor agreement terminated on December 20, 2021.

The Fund paid a weighted-average rate of 2.28% and received from the counterparty a floating rate based upon a 1-Month LIBOR rate. Payments were made monthly. Payments to and from the counterparty were recorded to net realized gain (loss) from derivative instruments.

Interest Rate Collar

The Fund entered into an interest rate collar transactions with MUFG Union Bank, N.A. and Zions Bancorporation, N.A. dba California Bank & Trust. Certain information related to the Fund's interest rate collar contracts is presented below:
CounterpartiesEffective DateNotional AmountCapFloorIndexMaturity Date
MUFG Union Bank N.A06/29/2020$20,000,000 1.15%0.17%1-Month LIBOR rate06/30/2025
Zions Bancorporation, N.A.02/26/2021$87,000,000 1.00%0.35%1-Month LIBOR rate03/18/2024
Zions Bancorporation, N.A.08/31/2021$50,000,000 1.50%0.42%1-Month LIBOR rate06/30/2025
Zions Bancorporation, N.A.12/22/2021$90,000,000 2.25%0.53%1-Month LIBOR rate03/18/2024

The interest rate collar mitigates the Fund's exposure to interest rate fluctuations on variable rate index of the debt facility. The collar establishes a range where the Fund pays the counterparty if the 1-Month LIBOR rate falls below the established floor rate, and the counterparty will pay the Fund if the 1-Month LIBOR rate exceeds the established cap rate. The interest rate collar settles monthly.

The following table shows the Fund's derivative instruments at fair value on the Fund's Statement of Assets and Liabilities as of December 31, 2021 and 2020.
Derivative AssetsDerivative Liabilities
Derivative InstrumentsDecember 31, 2021December 31, 2020December 31, 2021December 31, 2020
Interest rate swap and floor$— $— $— $1,199,471 
Interest rate collar$962,602 $— $130,697 $54,743 
    


63


The following table shows the effect of the Fund's derivative instruments on the Fund's Statement of Operations for the years ended December 31, 2021, 2020 and 2019.

For the Year Ended
December 31,
Derivative InstrumentsStatements of Operations Caption202120202019
Interest rate swap and floorNet change in unrealized gain (loss) from derivative instruments$1,199,471 $(373,898)$(825,574)
Net realized loss from derivative instruments$(1,220,269)$(959,173)$(73,774)
Interest rate collarNet change in unrealized gain (loss) from derivative instruments$886,648 $(54,742)$— 
Net realized loss from derivative instruments$(128,416)$(1,574)$— 

The following table shows the Fund's assets and liabilities related to derivatives by counterparty, net of amounts available for offset under the master netting agreement and net of any collateral received or pledged by the Fund for such assets and liabilities as of December 31, 2021 and December 31, 2020:

As of December 31, 2021
CounterpartiesDerivative Asset Subject to Master Netting AgreementDerivatives Available for OffsetNon-cash collateral receivedCash Collateral Received
Net Amount (1)
MUFG Union Bank, N.A.$255,356 $— $— $— $255,356 
Zions Bancorporation, N.A.707,246 (130,697)— — 576,549 
Total$962,602 $(130,697)$— $— $831,905 
As of December 31, 2021
CounterpartyDerivative Liability Subject to Master Netting AgreementDerivatives Available for OffsetNon-cash Collateral PledgedCash Collateral Pledged
Net Amount (2)
Zions Bancorporation, N.A.$(130,697)$130,697 $— $— $— 
Total$(130,697)$130,697 $— $— $— 
As of December 31, 2020
CounterpartyDerivative Asset Subject to Master Netting AgreementDerivatives Available for OffsetNon-cash collateral receivedCash Collateral Received
Net Amount (1)
MUFG Union Bank, N.A.$— $— $— $— $— 
Total$— $— $— $— $— 
As of December 31, 2020
CounterpartyDerivative Liability Subject to Master Netting AgreementDerivatives Available for OffsetNon-cash Collateral PledgedCash Collateral Pledged
Net Amount (2)
MUFG Union Bank, N.A.$(1,254,214)$— $— $— $(1,254,214)
Total$(1,254,214)$— $— $— $(1,254,214)
(1) Net amount of derivative assets represents the net amount due from the counterparty to the Fund.
(2) Net amount of derivative liabilities represents the net amount due from the Fund to the counterparty.
64



9. TAX STATUS
The Fund had no taxable income for the year ended December 31, 2018. The Fund anticipates electinghas elected to be treated as a Regulated Investment Companyregulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code (the “Code”) and anticipates operatingoperates in a manner so as to qualify for the tax treatment applicable to RICs.
9. UNFUNDED COMMITMENTS
Failing to maintain at least 70% of total assets in “qualifying assets” will result in the loss of BDC status, resulting in losing its favorable tax treatment as a RIC. As of December 31, 2018,2021, the Fund has met the BDC and RIC requirements. The Fund elected to be treated for federal income tax purposes as a RIC under the Code with the filing of its federal income tax return for 2019.
    In order to qualify for favorable tax treatment as a RIC, the Fund is required to distribute annually to its shareholder at least 90% of its investment company taxable income, as defined by the Code. To avoid federal excise taxes, the Fund must distribute annually at least 98% of its ordinary income and 98.2% of net capital gains from the current year and any undistributed ordinary income and net capital gains from the preceding years. The Fund, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4% excise tax on this income. If the Fund chooses to do so, all other things being equal, this would increase expenses and reduce the amount available to be distributed to its shareholder. The Fund will accrue excise tax on estimated undistributed taxable income as required.

    Below is a table summarizing the cost of investments for federal income tax purposes and the appreciation and depreciation of the investments reported on the Schedules of Investments and Statements of Assets and Liabilities as of December 31, 2021 and 2020:

As of December 31, 2021
AssetCostUnrealized AppreciationUnrealized DepreciationNet Appreciation (Depreciation)
Loans$501,909,222 $— $(17,861,578)$(17,861,578)
Derivative assets— 962,602 — 962,602 
Total$501,909,222 $962,602 $(17,861,578)$(16,898,976)
As of December 31, 2021
LiabilityCostUnrealized AppreciationUnrealized DepreciationNet Appreciation (Depreciation)
Derivative liability$— $— $(130,697)$(130,697)
Total$— $— $(130,697)$(130,697)
As of December 31, 2020
AssetCostUnrealized AppreciationUnrealized DepreciationNet Appreciation (Depreciation)
Loans$323,011,028 $— $(12,488,879)$(12,488,879)
Total$323,011,028 $— $(12,488,879)$(12,488,879)
As of December 31, 2020
LiabilityCostUnrealized AppreciationUnrealized DepreciationNet Appreciation (Depreciation)
Derivative liability$— $— $(1,254,214)$(1,254,214)
Total$— $— $(1,254,214)$(1,254,214)
    
    Dividends from net investment income and distributions from net realized capital gains are determined in accordance with U.S. federal income tax regulations, which may differ from those amounts determined in accordance with U.S. GAAP. These book/tax differences are either temporary or permanent in nature. To the extent these differences are permanent, they are charged or credited to paid-in-capital or accumulated net realized gain (loss), as appropriate, in the period that the differences arise. Temporary and permanent differences are primarily attributable to differences in the tax treatment of certain loans and the tax characterization of income and non-deductible expenses. These differences are generally determined in conjunction with the preparation of the Fund’s annual RIC tax return.

65


Book and tax basis differences relating to shareholder dividends and distributions and other permanent book and tax differences are reclassified among the Fund’s capital accounts. As of December 31, 2021 and 2020, there were no book reclassification of dividends and distributions, and other permanent book and tax differences, among the Fund's capital accounts. In addition, the character of income and gains to be distributed is determined in accordance with income tax regulations that may differ from U.S. GAAP. For income tax purposes, the distributions paid to the shareholder are reported as ordinary income, return of capital, or a combination thereof. For the years ended December 31, 2021 and 2020, the tax character of distributions paid was ordinary income in the amount of $69.5 million and $32.9 million, and return of capital of $52.3 million and $13.5 million, respectively.

    As of December 31, 2021 and 2020, the components of distributable losses on a tax basis were as follows:

December 31, 2021December 31, 2020
Accumulated capital losses$(4,923,311)$(3,455,498)
Other temporary differences(1,105,931)(1,120,052)
Distributions in excess of net investment income(92,372,533)(41,479,523)
Net unrealized depreciation(17,029,674)(13,743,092)
Components of distributable losses$(115,431,449)$(59,798,165)


    As of December 31, 2021, the Fund had no undistributed earnings. The Fund may pay distributions in excess of its taxable net investment income. This excess would be a tax-free return of capital in the period and reduce the shareholder’s tax basis in its shares.

    The Fund’s tax returns remain open for examination by the federal government for a period of three years and California tax authorities for a period of four years from when they are filed. As of December 31, 2021, the Fund had no uncertain tax positions and no capital loss carryforwards.



66


10. UNEXPIRED UNFUNDED COMMITMENTS
     As of December 31, 2021 and 2020, the Fund’s unexpired unfunded commitments to borrowers totaled $31.0 million. There were no unfunded commitments for the period from June 28, 2017, sale of capital stock, through December 31, 2017, as the Fund had not commenced investment operations.

$97.9 million and $83.2 million, respectively. Because venture loans are privately negotiated transactions, investments in these assets are relatively illiquid. It has beenis the Manager’s experience of the Manager that not all unexpired unfunded commitments will be used by the borrowers. Many credit agreements with the borrowers contain provisions which are milestone dependent and not all borrowers will achieve these milestones. Finally,Additionally, the Fund’s credit agreements contain provisions that give relief from funding obligations in the event the borrower has a material adverse change to its financial condition. Therefore, the unexpired unfunded commitments do not necessarily reflect future cash requirements or future investment incomeinvestments for the Fund.
The tabletables below containsare the Fund’s unexpired unfunded commitments for the year endedas of December 31, 2018:2021 and 2020:
BorrowerIndustryUnexpired Unfunded Commitment as of December 31, 2021Expiration Date
 10club Pte Ltd.Internet$25,000,000 09/30/2022
 Amino, Inc.Software11,000,000 12/31/2022
 Bryte, Inc.Other Technology2,500,000 01/31/2023
 Ceres Imaging, Inc.Other Technology1,750,000 10/31/2022
 Coterie Applications, Inc.Other Technology5,000,000 01/31/2022
 Fakespot, Inc.Other Technology500,000 01/31/2022
 Genomic Prediction, Inc.Biotechnology1,000,000 03/31/2022
 iLearningEngines Inc.Technology Services7,500,000 07/31/2022
 Invert Robotics Group, Ltd.Other Technology1,000,000 01/31/2022
 Kinoo, Inc.Other Technology1,000,000 04/30/2022
 Lacuna Technologies, Inc.Other Technology2,500,000 07/31/2022
 Lassen Peak, Inc.Security375,000 01/31/2022
 Loansnap Holdings Inc.Technology Services3,750,000 04/30/2022
 Luva Inc.Other Technology500,000 02/28/2022
 MASC Inc.Other Technology1,500,000 07/31/2022
 Mavenform, Inc.Other Technology2,000,000 04/30/2022
 Merlin Labs, Inc.Other Technology1,000,000 03/31/2022
 Norbert Health, Inc.Medical Devices1,000,000 01/31/2022
 Phase Four, Inc.Other Technology1,000,000 04/01/2022
 RenoFi, Inc.Internet6,000,000 10/31/2022
 Safe Securities Inc.Software2,000,000 04/15/2022
 SF Insuretech, Inc.Software5,000,000 03/31/2022
 StayTuned Digital, Inc.Software3,213,732 12/31/2022
 Taptap Send, Inc.Other Technology9,000,000 12/31/2022
 Therapydia, Inc.Other Healthcare1,000,000 04/30/2022
 Trucking Jobs Technologies, Inc.Software610,000 01/31/2022
 Usual Beverage Co.Internet1,000,000 01/31/2022
 WorkRails, Inc.Software250,000 05/31/2022
Total$97,948,732 

67


BorrowerIndustryUnfunded CommitmentExpiration Date
Aclima, Inc.Other Technology$875,000
05/31/2019
Antheia, Inc.Biotechnology1,500,000
12/31/2019
Blockdaemon, Inc.Software250,000
01/31/2019
Brightside Benefit, Inc.Other Technology1,000,000
05/31/2019
Caredox, Inc.Other Healthcare625,000
04/30/2019
CytoVale, Inc.Medical Devices1,125,000
02/28/2019
Discover Echo, Inc.Other Healthcare1,000,000
02/28/2019
Fitplan, Inc.Other Technology250,000
01/31/2019
Hometap Equity Partners, LLCOther Technology2,000,000
03/31/2019
Invoice2Go, Inc.Software4,000,000
12/31/2019
Ipolipo, Inc.Software750,000
07/31/2019
Keyo AI Inc.Technology Services500,000
01/31/2019
Kogniz, Inc.Other Technology375,000
04/30/2019
Metricly, Inc.Software500,000
04/30/2019
OrderGroove, Inc.Software2,500,000
09/30/2019
Osix CorporationInternet150,000
07/31/2019
Plethora, IncOther Technology500,000
01/31/2019
PlushCare, Inc.Software750,000
07/31/2019


BorrowerIndustryUnexpired Unfunded Commitment as of December 31, 2020Expiration Date
303 Holdings, Inc.Technology Services$3,000,000 12/31/2021
8E14 NetworksOther Technology600,000 07/31/2021
Aclima, Inc.Other Technology2,000,000 03/31/2021
Afero, Inc.Software1,500,000 05/31/2021
Antitoxin Technologies Inc.Other Technology1,000,000 06/30/2021
BackboneAI Inc.Software1,000,000 04/30/2021
Bizly, Inc.Software1,650,000 03/31/2021
Canary Connect, Inc.Computers & Storage2,000,000 01/31/2021
Content Adjacent, Inc.Other Technology500,000 07/31/2021
Coterie Applications, Inc.Other Technology500,000 03/31/2021
CytoVale, Inc.Medical Devices1,000,000 01/31/2021
Exo Imaging, Inc.Medical Devices2,000,000 09/30/2021
Fetch Robotics, Inc.Computers & Storage2,500,000 06/30/2021
GoForward, Inc.Other Healthcare3,125,000 07/31/2021
Hello Heart Inc.Other Healthcare2,000,000 09/30/2021
Honeybee Health, Inc.Other Healthcare3,000,000 07/31/2021
iLearningEngines Inc.Technology Services2,000,000 07/31/2021
Invoice2Go, Inc.Software13,000,000 03/31/2021
Lukla, Inc.Internet500,000 01/31/2021
Mavenform, Inc.Other Technology1,500,000 04/30/2021
Natomas Labs, Inc.Other Technology2,000,000 04/15/2021
OnepointOne, Inc.Other Technology2,000,000 03/31/2021
Oula Health, Inc.Other Healthcare750,000 11/30/2021
Peerwell, Inc.Other Healthcare500,000 07/30/2021
Pixlee, Inc.Software2,500,000 06/30/2021
Privoro Holdings, Inc.Other Technology1,000,000 01/31/2021
Reciprocity, Inc.Software1,950,000 01/31/2021
Residently USA, LLCInternet375,000 03/31/2021
Riffyn, Inc.Technology Services2,000,000 01/31/2021
Sonatus, Inc.Software1,000,000 03/31/2021
Swiftly Systems, Inc.Software5,000,000 08/30/2021
Tia, Inc.Other Healthcare7,000,000 10/31/2021
TIER Mobility GmbHOther Technology8,000,000 02/15/2021
Vessel Health, Inc.Other Healthcare3,750,000 03/31/2021
World Wrapps II, Inc.Other Technology1,000,000 12/31/2021
Total$83,200,000 

BorrowerIndustryUnfunded CommitmentExpiration Date
Relimetrics, Inc.Technology Services375,000
04/15/2019
Skillshare, Inc.Software2,000,000
04/30/2019
SkyKick, Inc.Other Technology2,500,000
02/28/2019
SnapRoute, Inc.Enterprise Networking1,500,000
02/28/2019
Stitch Labs, Inc.Software1,500,000
07/31/2019
Venuetize, LLCSoftware500,000
09/30/2019
Virtuix Holdings, Inc.Other Technology250,000
07/31/2019
Workspot, Inc.Software1,000,000
01/31/2019
Zeel Networks, Inc.Technology Services2,750,000
03/31/2019
Total $31,025,000
 
10.11. FINANCIAL HIGHLIGHTS
U.S. GAAP requires disclosure of financial highlights of the Fund for the years ended December 31, 2021, 2020, 2019, 2018 and the period presented. ended December 31, 2017.
The total rate of return is defined as the return based on the change in value during the period of a theoretical investment made at the beginning of the period.  The total rate of return assumes a constant rate of return for the Fund during the period reported and weights each cash flow by the amount of time held in the Fund. This required methodology differs from an internal rate of return.
The ratios of expenses and net investment income (loss) to average net assets calculated below,for the period from June 28, 2017, commencement of the Fund’s operations, through December 2017, are not annualized and are computed based upon the aggregate weighted-average net assets of the Fund for the period. The annualizing of these ratios would not be meaningful given the short duration of this period. For the years ended December 31, 2021, 2020, 2019 and 2018, the ratios of expenses and net investment income (loss) to average net assets, calculated below, are computed based upon the aggregate weighted average net assets of the Fund for the periodperiods presented. Net investment income (loss) is inclusive of all investment income net of expenses and excludes realized or unrealized gains and losses.
68



Beginning and ending net asset values per share are based on the beginning and ending number of shares outstanding. Other per share information is calculated based upon the aggregate weighted average net assets of the Fund for the periodperiods presented.
The following per share data and ratios have been derived from the information provided in the financial statements:
 For the Year EndedFor the Year EndedFor the Year EndedFor the Year EndedFor the Period Ended
 December 31, 2021
December 31, 2020(a)
December 31, 2019(a)
December 31, 2018December 31, 2017*
 
Total return33.72 %13.87 %9.70 %160.39 %(1,101.20)%**
 
Per share amounts:
Net asset value, beginning of year/period$1,833.27 $1,138.32 $740.89 $(1.59)$— 
Net investment income (loss)709.5 339.13 118.72 (9.64)(1.84)
Net realized and change in unrealized loss from loans and derivative instruments(47.54)(130.01)(41.97)— — 
Net increase (decrease) in net assets resulting from operations661.96 209.12 76.75 (9.64)(1.84)
Distributions of income to shareholder(694.82)(329.25)(94.05)(72.88)— 
Return of capital to shareholder(523.47)(134.92)(241.27)— — 
Contributions from shareholder1,025.00 950.00 656.00 825.00 0.25 
Net asset value, end of year/period$2,301.94 $1,833.27 $1,138.32 $740.89 $(1.34)
 
Net assets, end of year/period$230,193,551 $183,326,835 $113,832,373 $74,088,727 $(159,165)
 
Ratios to average net assets:
Expenses6.69 %8.17 %14.78 %16.60 %1,057.92 %**
Net investment income (loss)31.60 %22.50 %14.70 %(2.96)%(1,057.92)%**
Portfolio turn-over rate— %— %0.54 %— %— %
Average debt outstanding$206,569,231 $109,269,231 $61,169,231 $6,000,000 ^$— 
 For the Year Ended For the Period Ended 
 December 31, 2018 December 31, 2017* 
     
Total return160.39 % (1,101.20)%**
     
Per share amounts:    
Net asset value, beginning of period$(1.59) $
 
     
Net loss(9.64) (1.84) 
Net decrease in net assets resulting from operations(9.64) (1.84) 
     
Distributions of income to shareholder(72.88) 
 
Contributions from shareholder825.00
 0.25
 
Net asset value, end of period$740.89
 $(1.59) 
     
Net assets, end of period$74,088,727
 $(159,165) 
     
Ratios to average net assets:    
Expenses16.60 % 1,057.92 %**
Net loss(2.96)% (1,057.92)%**
Portfolio turn-over rate0%
 0%
 
Average debt outstanding$6,000,000
^$
 

* From June 28, 2017 sale of capital stock, through December 31, 2017. The2017, during this period, the Fund had not yet commenced investment operations.
** These ratios reflect the organizational costs for the formation of the Fund.
^ The average debt outstanding is over the period from the establishment of the debt facility, December 20, 2018, through December 31, 2018.

(a)Certain prior period information has been disclosed to conform to current presentation.

11.
12. SUBSEQUENT EVENTS
On February 7, 2019, the Fund entered into a interest rate swap with MUFG Union Bank, N.A. with a preliminary notional amount of $35.0 million to convert floating liabilities to fixed rates. The termination date of the swap is December 20, 2021.
The Fund evaluated additional subsequent events through the date the financial statements were issued and determined that no additional subsequent events had occurred that would require accrual or disclosure in the financial statements.



4869